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PREFACE

This dissertation will start with review of the literature, pertinent to understanding the

background from which these studies were derived. The four studies performed will then be

presented in the manuscript form followed by a general discussion of the findings.
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ABSTRACT
Propanil [3,4-dichloropropionaniline] is a post-emergent herbicide which has been

extensively used for control of weeds in rice and wheat field. The acute toxicity of propanil in
intraperitoneally exposed animals includes central nervous system depression, loss of righting

reflex, and cyanosis.

Propanil induces methemoglobinemia in experimental animals and

occupational exposure to propanil has been associated with methemoglobinemia in humans. The
immunotoxic effects of propanil on animals include (1) changes of lymphoid organ weight and

cellularity, i.e. reduction of thymus weight and cellularity with increase of spleen weight and

cellularity; (2) inhibition of humoral and cell-mediated immune response such as Independent

and T-independent antibody responses, reduction of mixed lymphocyte responses and contact
hypersensitivity responses; (3) alteration of non-specific immune responses which are

represented by an inhibition of NK cell activity and an increase of macrophage cytotoxicity; (4)
inhibition of bone marrow hematopoiesis.

T cells are one of the major classes of lymphocytes. They originate in the bone marrow

and then migrate to, and mature in, the thymus.

T cells are involved in multiple immune

responses including humoral and cell-mediated immunity and inflammatory response.

CD4+

cells exert their functions via the production of cytokines, acting on the T cells, as well as other

cells such as B cells, macrophage, and NK cells. The overall goal of this project is to investigate
the mechanism and recovery of propanil induced thymic atrophy and the effect of propanil on T
cell cytokine production. This is based on the hypothesis that propanil affects T cell function

through the inhibition of T cell development in thymus and T cell cytokine production.

xvi
We first analyzed the thymocyte subpopulations in the thymus, spleen, and mesenteric
lymph nodes in mice at 7 days post exposure to graded doses of propanil using either 2 or 3 color

surface staining with flow cytometry.

We found that at doses of 100-200 mg/kg, propanil

induced significant thymic atrophy which is characterized by a depletion of CD4+CD8+
population. Although the size and cellular!ty of the spleen were increased, no change in CD4+
and CD8+ cell distribution was observed. Similarly, mesenteric lymph nodes showed no changes

in the cell subpopulation distribution between propanil-treated and control animals.

Further

studies on thymus showed that the atrophy started at 1 day post treatment, peaked at 2-4 days and

recovered to normal by 14 days.

We then performed cell cycle analysis of thymocyte

populations using the DNA binding dye 7-aminoactinomycin D to determine whether thymic
atrophy was associated with changes in the percentages of cells in the S, G2, and M phases of the

cell cycle.

We found a high percentage of proliferating CD4+CD8+ thymocytes 4 days after

exposure. Thus, recovery of the thymus occurs following increases in thymocyte proliferation,
most notably the immature CD4+CD8+

thymocytes.

We also tested the hypothesis that

glucocorticoids play a role in the observed atrophy by examining thymuses in adrenalectomized,
propanil-treated mice. No atrophy was observed in those animals. These results suggest that the

immunotoxic effect of propanil on thymus appears to be mediated, in part, by endogenous
glucocorticoids.

We used both in vivo and in vitro models to study the effect of propanil on T cell

cytokine production. We first investigated the ConA stimulated spleen cell cytokine production
2 days after intraperitoneal propanil exposure at a dose of 200 mg/kg. The result showed a

decrease in IL-2, IL-6, GM-CSF, and IFN-y production.

Further studies revealed that the

xvii

production of IFN-y and GM-CSF recovered at day 4 after exposure, while IL-2 and IL-6 levels
continued to be reduced by propanil at 7 days after exposure. These in vivo results indicated that

propanil selectively affects cytokine production. To further assess the direct effect of propanil on

spleen cells, we then used an in vitro exposure model. When normal spleen cells were treated in
vitro with propanil and stimulated with ConA, they produce significantly less IL-2, IL-6, IFN-y
and GM-CSF compared to control groups, whereas cell viability and proliferation assays showed

no difference between propanil-treated and control groups. These data indicate that propanil
reduces cytokine production by inhibiting their production, not by decreasing cell numbers. We

then used a T cell line, EL-4 to further investigate the mechanism of propanil-induced inhibition

of IL-2 production at the protein, message and gene expression levels. Quantitative northern blot

analysis of IL-2 mRNA showed a dose-dependent decrease in propanil treated EL-4 cells upon
PMA stimulation. To determine if reduced mRNA production was due to reduced signaling or
message stability, nuclear run-on and mRNA stability assays were performed. Nuclear run on

assays revealed that the transcription rate of the IL-2 gene was decreased by approximately 50%

in the presence of 0.02 mM propaml. IL-2 message stability assays also revealed a reduction in

message stability. Taken together, these results suggest that propanil inhibits IL-2 production at
both transcriptional and post-transcriptional levels.

INTRODUCTION
PROPANIL
I.

Nomenclature, chemical and physical properties of the pure chemical

Chemical name: 3',4'-dichloropropionanlide, [N-(3,4-dichlorophenyI)propionamide].
Common name: Propanil (WSSA), DPA

Product names and manufacturer: STAM P-34, STAM M-4, STAM LV-10 - Rohm and Haas
(Philadelphia, PA).

Structural formula:

nk

Cl-Z

^-NH-C-CHgCHa

Molecular formula: C9H9C12NO
Molecular weight: 218.0

Physical state, color, and odor: light brown to gray-black solid

Specific gravity: 1.25
Melting point: 85 to 89 °C

Solubility: gram in dl

Solvent

Solubility, %

Hexalene glycol

>25

Isophorone

>25

Isopropyl alcohol

>25

Methy ethyl ketone

>25

Toluene

>25

1

Water

0.05

Xylene

> 25

(Mullison el al., 1979)
Benzene

7

Acetone

170

Ethanol

110

(Izmerov, 1984)

IL

Herbicide use
Propanil is used for postmergence control of grasses (Echinochloa) and broadleaf weeds in

cultivated rice grown in the southern United States (Mullison et al., 1979; Smith, 1961).

It is

applied by aerosol spray or ground spray at the level of 0.45-2.72 kg/acre (Bartha and Pramer,
1970). Of the approximately 3.3 million acres of rice planted each year in the U.S., 80% of it is

treated with propanil and often with multiple applications of the same acreage in a given year. It is

estimated that 7-9 million pounds of propanil are produced annually in the U.S. (U.S.
Environmental Protection Agency, 1987).
Herbicides may be classified in several ways. Chemically, propanil is a member of the
amide family of herbicide. If classified based on physiology, propanil is a postmergence herbicide.

A third classification by the mode of action can regard propanil as a contact, selective herbicide
(Ashton and Crafts, 1973).

The initial injury of plants from the foliar applied propanil includes either localized or

general necrosis. This injury may be associated with alteration of the cellular membranes. Propanil

is reported to inhibit photosynthesis, respiration, RNA synthesis, protein synthesis, and amylase

2

activity in plants that are sensitive to its effects (Ashton and Crafts, 1973).

Detoxification of propanil by higher plant such as rice and wheat is a basis for selectivity.
Propanil degradation in plants has been studied thoroughly by different groups of investigators.

This work has been reviewed by Casida and Lykken (1969) and Matsunaka (1969).

Several

investigators have reported that rice plants can hydrolyze propanil to 3,4-dichloroaniline (DCA)

(McRae et al., 1964; Adachi et al., 1966; Ishizuka and Mitsui, 1966; Still and Kuzirian, 1967; Yih
et al., 1968; Yih et al., 1968). These studies suggest that propionic acid is a degradation product.

The formation of 3,4-dichloroaniline was reported to be catalyzed by a macromolecule (Still and

Kuzirian, 1967) which was partially purified and characterized by Frear and Still (1968). They
refer to it as an aryl acylamidase (aryl-acylamine amidohydrolase, EC3.5.1a).

The propionate

moiety is rapidly degraded to CO2 via ^-oxidation (Still, 1968). The 3,4-dichloroaniline moiety is
converted to four complexes (1) the N-(3,4-dichlorophenyl)-glucosylamine, (2) an unstable
complex which readily decomposed to the glucosylamine, (3) a complex which contained glucose,

xylose, and fructose, and (4) a sugar derivative of 3,4-dichloroaniline but not further identified

(Still, 1968; Yih et al., 1968). Yih et al. (1968) reported that relatively large amounts of the 3,4dichloroaniline moiety also complexes with cell wall components namely cellulose, hemicellulose
and lignin.

Table 1. Inactivation of Propanil by Homogenates of Various Plants (Adachi et al. 1966)

Monochoria

Smart weed

Barnyardgrass

Dayflower

Crabgrass Rice plant

55

7X)

3ÔÔ

584

695

^Percent of propanii hydrolyzed in 24 hours

The resistance of rice to propanil has been attributed to the ability of this species to degrade

propanil more rapidly than most weedy species.
3

Adachi et al. (1966) reported the rate of

inactivation of propanil by homogenates of several species and found that rice homogenates was

about ten times more effective than barnyard grass homogenates (Table 1).

Still and Kuzirian

(1967) reported that rice was at least twenty times more effective than barnyard grass in

inactivating propanil (Table 2). Frear and Still (1968) reported that the degradation of propanil

takes place at a much faster rate in the leaves of rice than the roots but little degradation occurs in
barnyard grass leaves or roots (Table 3). Although these results suggest lower specific enzyme

levels in the susceptible species, Ishizuka and Mitsui (1966) proposed that the selectivity results
from differences in the substrate specificity of the enzyme from different plants rather than the level

of the enzyme.

Table 2. Formation of DCA in extracts of rice and barnyard grass (Still and Kuzirian, 1967)
Extract

Fresh weight (g)

pgof DCA7h

U7ml

Seeds
Three leaf plants

Rice
200
283

Rice
52.1
24.5

Rice
20.84
4.9

Bygc
200
723

Byg
0.95
low

Total U/g of
fresh weight
Byg
0.38

Rice
2.5
13.0

Byg
0.12
0.5

a3,4-dichloroaniline.

bOne unit is the amount of enzyme required to catalyze the hydrolyses of I pm ole of propanil per
hour.

cBarnyard grass.

III.

Toxicological Properties

A.

Pathways into the environment
The main source of environmental pollution by propanil is the aerial and ground spraying of

agricultural crops (Barnes et al., 1987). In aerial spraying of paddy fields, propanil travels beyond

the treated areas and was found not only in the working zone air at the application sites, but also in

ambient air at a distance of 200-400 meters from the treated field (Izmerov, 1984). Therefore,
several possible routes, including air, water, soil, and food exist for human exposure to propanil.

4

Table 3. Distribution of a Propanil Hydrolyzing Aryl Acylamidase in Rice and

Ramyardgrass Tissue (Frear and Still, 1968)
Tissue

UnitsVgm (Fresh Wt)

Total Units

Specific Activity

Rice leaves

314.4

6288

9.8

Bamyardgrass leaves

5.2

103

0.5

Rice roots

5.7

226

2.2

Bamyardgrass roots

5.8

230

2.1

aAn enzyme unit is the amount of enzyme required to catalyze the hydrolyses of I pinole of propanil per

hour.

B.

Metabolic pathway in animals
Williams and Jacobson (1966) found an acylamidase in livers of rats, rabbits, mice and dogs

which hydrolyzed propanil to DCA and propionic acid. The enzyme was localized largely (70%)
within the microsomal fraction of rat liver. DCA is then oxidated into N-hydroxy-DCA and 6hydroxy-DCA by cytochrome P450 (Singleton and Murphy, 1973; McMilian et al., 1990).
Propanil is not hydrolyzed by plasma or red blood cells nor by homogenates of spleen, lung,

stomach, and intestine (Chow and Murphy, 1975).
Propanil was found in blood and tissues after 5 minutes following oral administration of a

single 0.5 lethal dosage to half of the test subjects (LD50) to rat. Maximum accumulation in organs
was observed 1-6 hours after administration: 1 hour in the lungs and liver; 3-6 hours in kidneys and
spleen; 1-6 hours in adrenals and heart. The blood concentrations of propanil remained almost
constant during one day and no propanil was detectable in organisms after 48-72 hours (Izmerov,
1984; Klisenko and Panshina, 1975). Primary metabolites, DCA and lactic or succinic acid were

detected at 48 hours and persisted for as long as 3 days after exposure.
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Distribution and elimination ofpropanil in fish

C.

Schlenk and Moore (1993) examined the uptake, elimination and tissue distribution of total
radioactivity derived from [,4C]propanil and its metabolites in individual farm-raised channel

catfish.

They found that the absorption of propanil by catfish was rapid with peak body

concentrations occurring between 8 and 12 hours during water exposure. In Fathead Minnow, Call
et al (1983) found that propanil uptake was also rapid with an equilibrium established between

water and tissue concentrations within 24 h. In catfish, approximate 38% of the absorbed
radioactivity remaining in the animal after 144 h of depuration. Whole body depuration of
radioactivity was biphasic with a and p half-lives of 20 and 444 h, respectively.

Intestine,

abdominal fat and liver possessed the greatest levels of radioactivity per gram of tissue, other whole

tissue possessing > 10% of radiolabel after 48 h were blood, and muscle (Schlenk and Moore,
1993).

D.

Toxicity

1.

Acute toxicity
The acute mammalian toxicity of propanil has been examined by several investigators

(Williams and Jacobson, 1966; Singleton and Murphy, 1973). Both rats and dogs exhibit acute
toxicity to propanil, characterized by the depression of the central nervous system within 12 hours
following gastric intubation without positive gross autopsy findings. The oral LD50 values were

1384 and 1217 mg/kg, respectively. Singleton and Murphy (1973) reported that at doses of 200 to

800 mg/kg, administered intraperitoneally to mice, propanil induces nervous system depression,
loss of righting reflex, and cyanosis. The estimated LD50 in mice is 700 mg/ml (Williams and

Jacobson, 1966; Singleton and Murphy, 1973). Animals which recovered their righting reflex
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within 24 hr survived and appeared normal within a day or two. Death occurred at higher dosages
between 6 and 24 hr after injection. Loss of righting reflex usually occurred within 15 to 45 min

and was preceded by visible cyanosis. The appearance of cyanosis is consistent with the increase of

methemoglobin content in animal blood (Singleton and Murphy, 1973; Chow and Murphy, 1975).

In vivo and in vitro studies by McMillan group showed that the metabolites, N-hydroxy-DCA and
6-hydroxy-DCA may mediate propanil-induced methemoglobinemia (McMillan et al., 1990).

McMillan et al. (1991) demonstrated that propanil induces hemolytic anemia in vivo in rat and their
in vitro study indicates that the metabolite N-hydroxy-DCA mediates propanil induced anemia.

Acute lethality of propanil to fish (Chaiyarach et al., 1975; Davey et al., 1976) and aquatic

invertebrates has been documented (Crosby and Tucker, 1966; Sanders, 1970).

The lethal

concentration to half of the test subjects (LC50) values for fathead minnows are 11.5, 10.2, 8.6, and
3.4 mg/L at 24, 48, 96, and 192 h, respectively (Call et al., 1983). Other researchers have also
observed similar acute lethality (LC50) values for mosquitofish and green sunfish and for fingerling

channel catfish (Davey et al., 1976; Chaiyarach et al., 1975; McCorkle et al., 1977). Wellborn et al.

(1984) reports 96 h LC50 of 6 mg/L of propanil to channel cat fish. Early life-stage toxicity was
observed when fish were exposed to 3.8 pg/L propanil, which resulted in a significantly lower egg

hatch than in the controls. Death or deformity (edema in the pericardial region with swollen yolk
sacs) of nesty hatched fry was also observed (Call et al., 1983). The surviving fish at exposures of

23.3 and 51.1 pg/L showed swollen bodies with reddish zones of hemorrhaging along with the
visceral mass (Call et al., 1987). In a field plot study by Popova (Popova, 1973), fish growth was
considerably less in a propanil-treated pond after 60 days.

Morphological and physiological

characteristics of propanil-exposed fish were altered and did not revert to normal even when the
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fish were maintained for a long time in propanil-free water. The "no effect" propanil concentration
range, based on dry weight and length of fish, was determined to be between 0.4 and 0.6 pg/L of

propanil at an exposure rate of 0.6 and 1.2 pg/L of propanil (Call et al., 1983).
Propanil was also found to be a potent inhibitor of photosynthetic O2 production.

The

effective concentration to half of the test subjects (EC50) values over a 3 h period ranged from 51 to
109 pg propanil/L for the 11 plankton communities tested. Concentrations ranging from 24 to 54

pg/L were estimated to cause a 25% reduction in O2 production (Tucker, 1987).

The U.S.

Environmental Protection Agency has characterized propanil as slightly to moderately toxic to
estuarine and marine organisms (EPA, 1987).
2.

Subchronic and Chronic toxicity

In rats after subchronic (13 wk) exposure to propanil on 0, 100, 330, 1000, 3300, 10,000,
and 50,000 ppm diets, the survival of rats on the 50,000 ppm diet was affected, and at 10,000 and

3300 ppm, growth and feed consumption were depressed (Ambrose et al., 1972). Chronic toxicity
was observed to result in increased mortality of male rats, which occurred over a period of 2 yr

when they were fed 1600 mg/kg of propanil, and a significant decrease in the body weight occurred

for rats of both sexes. In dogs, significant weight losses were evident with 4,000 mg/kg propanil

over a 2 yr period (Ambrose et al., 1972).
3.

Human toxicity
There is a paucity of information in the literature regarding the toxicity of propanil on

humans. In occupationally exposed humans, the acute toxicity of propanil has been reported to lead

to cyanosis due to methemoglobin formation (Morse et al., 1979; Kimbrough, 1980). Morse and
Baker ( 1977), in a health hazard evaluation study, found that 11% of workers at a herbicide
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production plant in Arkansas were hospitalized for acute illness over a period of 2 years. Chloracne,

an eruption on skin resembling acne, was detected in 38% of these patients and was attributed to

propanil. At another pesticide manufacturing plant producing propanil, 61% of workers in the
production area had chloracne (Morse et al., 1979).

E.

Teratogenicity and Carcinogenicity
Early studies on the biological activity of propanil indicated that the herbicide and its

degradation products DCA were bacterial mutagens (Prasad, 1970).

However, other studies

showed propanil to be inactive in Salmonella typhimurium (Andersen et al., 1972; Moriya et al.,
1983), and in unscheduled DNA synthesis (UDS) assays using human fibroblasts with exogenous
metabolic activation (Mitchell et al., 1983). McMillan et al. (1988) found that propanil, DCA and

their N-hydroxy derivatives were not mutagenic in the Samonella typhimurium reversion assay in
both the presence and absence of exogenous metabolic activation.

The U.S. Environmental Protection Agency (EPA) also reports a negative oncogenic
potential of propanil to mice at the highest dose tested (180 mg/kg of propanil in the food). At this

dose level, bilateral retinal degeneration in both sexes and thyroiditis in female mice were observed.

The maternal toxicity and developmental No Observable Effect Level (NOEL) were set at 20
mg/kg per day. The reproductive and systemic NOEL is 300 mg/g (propanil in the food) for rats,
which was determined in a three-generation study.

Except for one direct DNA damage assay,

mutagenicity was negative, whereas teratogenic potential was negative in both rat and rabbit (EPA,
1987).
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PHENOTYPIC AND FUNCTIONAL DEVELOPMENT OF T CELLS IN

THYMUS
I.

Overview
T cells are one of the major classes of lymphocytes. They originate in the bone marrow

and then migrate to and mature in the thymus.

Beginning at about day 11 of fetal life,

approximately 100 to 1000 bone marrow-derived stem cells enter the thymus daily to begin the «3
week long process of differentiation (Owen and Ritter, 1969; Fowlkes and Pardoll, 1989). This
differentiation results in functional, self- Major Histocompatibility Complex (MHC)-restricted,

self-tolerant T cells (Fowlkes and Pardoll, 1989; Shortman et al., 1990). The various stages of

intrathymic development can be monitored by the status of the T cell receptor (TCR) a and -p
chain genes and the cell surface expression of molecules such as CD16 (FcyRIII), CD44 (Pgp-1),

CD25 (the a-chain of the IL-2 receptor), Thy-1, and the TCR and its CD4 and CD8 coreceptors
(Nikolic-Zugic, 1991; Godfrey and Zlotnik, 1993). Thymocytes can be divided into three main
categories based on their expression of CD4 and CD8 molecules.

thymocytes are CD4CD8

Double-negative or “DN”

(or low), double-positive or “DP” thymocytes are CD4+CD8+, and

single-positive or “SP” thymocytes are either CD4+CD8" or CD4 CD8+. The bulk (approximately

80%) of thymocytes are DP, while DN cells comprise 3-5% and SP comprise 15% of the total

lymphoid compartment in a normal young adult mouse thymus (Fink and Bevan, 1995). The
sequence of T cell maturation — from CD4 CD8TCR to CD4+CD8+TCR" to CD4TD8TCR",

and finally, to CD4+CD8TCR+ or CD4'CD8+TCR+ cells — has been most clearly established in
mice. The developmental pathway for T cells is diagrammed in Figure 1 (page 11).

In terms of maturation versus compartment, the differentiation of the principal aP TCR"
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lineage of thymocytes follows a generally centripetal pattern, beginning with the least mature DN

cells in the outer rim of the thymic cortex and ending with functionally and phenotypically mature
SP cells in the medulla (Sprent and Webb, 1987) (Figure 1).
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Figure 1. Schematic diagram of the intrathymic maturation of ap TCR+ T cells in young adult mice
(Fink and Bevan, 1995).

II

Early phase of development: DN cells
The earliest thymocytes are CD8CD25CD16+CD44+, (Matsuzaki et al., 1993; Rodewald et

al., 1993) and low levels of CD4 (Wu et al., 1991). They have TCR genes in the germ line
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configuration (Rodewald et al., 1993; Wu et al., 1991) and if adoptively transferred to the thymus

of irradiated mice can give rise not only to yS and a0 T cells but also to B cells (Matsuzaki et al.,
1993; Wu et al., 1991), natural killer cells (Matsuzaki et al., 1993; Rodewald et al., 1992), and
dendritic cells (Ardavin et al., 1993).

The initial steps in the intrathymic differentiation of CD 16* CD44*CD8"CD4,OWCD25‘

(CD44*CD25) progenitors are associated with downregulation of CD4 and expression of CD2 and
CD25 molecules resulting in CD44+CD25" (Rodewald et al., 1993). This may be preceded by
transient expression of the IL-2R0 chain (Falk et al., 1993) that is never coexpressed with CD25 in

fetal thymic ontogeny (Takeuchi et al., 1992). A fraction of the IL-2R0*CD25' cells express yS

TCR on their surface, following in vitro reconstitution of fetal thymic lobes show that IL2R0*TCR" cells develop into both a0 TCR* and yô TCR* cells (Falk et al., 1993). The data of
Godfrey et al. (1993) suggests that stem cell factor (SCF), the ligand for c-kit, may play a role in

controlling these initial steps in intrathymic development. Eventually, those CD44*CD25* cells

become CD16 CD44 CD25* (CD44CD25*, in short). The majority of CD44 CD25* cells show
TCR0 but not TCRa rearrangement and produce full-length TCR0 transcripts (Pearse et al., 1989;
Rodewald et al., 1993). These cells also transcribe the recombination activation gene 1 (RAG-1)

and RAG-2 (Wilson et al., 1994), and express CD3e proteins on the cell surface (Levelt et al., 1993;

Jacobs et al., 1994). In addition, they express high levels of bcl-2 mRNA and protein (Andjelic et
al., 1993). Heat stable antigen (HSA) molecules also show a characteristic developmental pattern,

that is low on CD44*CD25" cells but high on all subsequent stages until after the CD4*8* stage then

they again decline (Howe and Macdonald, 1988; Wilson et al., 1988). Thus, the probable sequence
of a phenotypic maturation can be described as:.
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HSA-CD44+IL-2R.pCD25TCRa°TCRP"CD3e-RAG-

♦
t
HSA+CD44+IL-2Rp-CD25+TCRa°TCRp°CD3£-RAGt
HSA+CD44"IL-2Rp-CD25 +TCRa°TCRpRCD3£+RAG+
HSA'CD44+IL-2Rp+’CD25*TCRa°TCR0°CD3e*RAG'

In an abbreviated form the above developmental sequence among early CD4’CD8" thymocytes of
the ap lineage can be delineated as:

CD44+CD25 -> CD44+CD25+ —> CD44 CD25+ -> CD44 CD25

CD44CD25CD4CD8" cells apparently represent the latest developmental stage which can give
rise to yô T cells (Petrie et al., 1992) suggesting that the final point of divergence of yÔ and ap

lineages may lie just before the onset of CD4 and CD8 expression.

III.

Intermediate stage: CD8+CD4+
The next critical intracellular event in the maturation of a thymocyte is the expression of

CD4 and CDS coreceptors.

The exact mechanism of this shift is still obscure.

TCR-p chain

expression plays a critical role in this major control point at a developmental stage that precedes
TCRa chain gene rearrangement and expression. It is at this juncture that cells terminate TCRp

chain gene rearrangement, transit from the DN to the DP compartment, and begin clonal expansion.
Several lines of experimentation have demonstrated that productive TCRp chain gene
rearrangement is required to traverse this barrier. The thymuses of mice genetically lacking TCRp

chain gene are very small and contain thymocytes arrested at the DN stage (Mombaerts et al.,
13

1992). The introduction of a productively rearranged TCRp chain gene into these mice results in

thymuses of nearly normal cellularity and permits the initiation of both CD4 and CD8 expression
(Kishi et al., 1991; Shinkai et al., 1993). Furthermore, the fact that there is selection for cells
carrying productive rearrangements of TCRp chain genes prior to the rearrangement of TCRa

genes strongly suggests that P-chain protein is a key factor in early T cell differentiation (Dudley et
al., 1994). The biochemical basis for this selection is currently being unraveled. Recent evidence

demonstrates that the surface expression on immature thymocytes of TCRp chains disulfidebonded to a 33-kDa glycoprotein designated pre-TCRa or pTa (Groettrup and von Boehmer, 1993;

Saint-Ruf et al., 1994). Although pTa genes are not somatically rearranged, their expression is
under tight developmental control,

analogous to the expression of X5 and VpreB that serve as

substitute immunoglobulin light chains during early B cell development (Melchers et al., 1993). It
is likely that pTa serves as a surrogate TCRa chain, enabling the surface expression of TCRp
chains prior to the appearance of their TCRa chain partners. Crosslinking of TCRp chains or

CD3s molecules (to which the pre-TCR is tightly associated) on immature thymocytes induces
mobilization of intracellular stores of Ca2+, indicating that the pre-TCR can transduce signals
(Groettrup et al., 1992; Groettrup and von Boehmer, 1993). The subunit responsible for this signal

transduction is likely to be the pTa chain, whose cytoplasmic tail contains two potential
phosphorylation sites and a Src homology sequence (Saint-Ruf et al., 1994). The signaling may

require p56lck, since thymocyte maturation to the DP stage is blocked in mice deficient in p56,ck and
overexpression of p56lck kinase activity drives the DN to DP transition in thymocytes that lack a

productive TCRp chain gene rearrangement (Molina et al., 1992; Mombaerts et al., 1994). Another
event of potential physiological importance for the development and selection of thymocytes,
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which occurs during transition of CD4CD8

cells into CD4+CD8* thymocytes, is the

downregulation of Bcl-2 protein levels (Andjelic et al., 1993; Veis et al., 1993) and increased
expression of APO-1/Fas (Andjelic et al., 1994). The transition of CD4 CD8" cells into CD4+CD8+

thymocytes occurs in such a way that either CD8 is expressed before CD4 (more common)

(Kisielow et al., 1984) or in some mice CD4 is expressed before CD8 (Hugo et al., 1992). It is
important to distinguish the early CD4 or CD8 single-positive cells from mature single positive T

cells in the medulla of the thymus. An easily utilized criterion for this distinction is the large size of

these immature single positive cells that upon culture in vitro (von Boehmer, 1986) or upon
intrathymic injection (Nikolic-Zugic and Bevan, 1988) become CD4+CD8+ cells within hours.
CD4+CD8+ thymocytes go through a limited number of divisions and begin to express apTCRs on
the cell surface, some cells at higher levels and others at relatively low levels, when compared with

mature T cells. The fate of CD4+CD8+ blast cells with high TCR levels is not clear. It could be that

TCR levels will be downregulated in this population, i.e., that some cells that have relatively
quickly made a productive TCRot rearrangement express the receptor at high levels and then TCR
expression is downregulated by an unknown mechanism probably related to the stability of TCRa

protein (Kearse et al., 1994). Alternatively, it could be that these CD4+CD8+ blasts are undergoing
positive selection and upregulate the TCR as a consequence of binding to an intrathymic ligand.

While the latter possibility cannot be excluded, data in TCR transgenic mice are more compatible

with the first theory: early CD4"CD8+ and CD4 CD8 blasts with relatively high receptor levels
were found in mice that cannot positively select the transgenic TCR (Swat et al., 1992).

The CD4+CD8+ thymocytes represent an interesting population of cells because they have a
relatively short, programmed lifespan, i.e., these cells will die in a cell autonomous fashion after
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about 3.5 days of their life. This was analyzed in continuous labeling studies with DNA precursors

that labeled more than 95% of these cells in a linear fashion in 3.5 days (Egerton et al., 1990;
Huesmann et al., 1991).

No other cell type in the thymus was labeled with similar kinetics

suggesting that CD4+CD8+ thymocytes die rather than change their phenotype intrathymically.

Thus, CD4+CD8+ thymocytes are programmed to die unless they interact with their environment in
a specific way that can result in either prolongation or shortening of their life span (Ellis et al.,
1991).

IV.

Final maturation: SP thymocytes
The relationship between CD4+CD8+ thymocytes and CD4+CD8" and CD4"CD8+ cells could

be established based on the following evidence: 1) Smith (1987) showed that the generation of
CD4+CD8" cells could be inhibited with CD8 antibodies, suggesting that some precursors of
CD4+CD8' cells expressed CD8; 2) direct evidence was obtained in experiments that involved

purification of CD4+CD8+ cells and intrathymic injection which came to the conclusion that
CD4+CD8+ cells are not dead end cells but can be rescued to become single positive cells after

intrathymic injection (Guidos et al., 1989; Swat et al., 1994).

Positive and negative selections also occur during the transition from DP to SP. These two
control points require the surface expression of both TCRa and ~p chains and are initiated by the
interaction between the cc0 TCR and an intrathymic ligand.

This interaction during positive

selection leads to the termination of TCRa chain gene rearrangement brought about by the

extinction of RAG-1 and RAG-2 gene expression (Turka et al., 1991; Brandie et al., 1994).
Positive selection also results in the rescue of thymocytes from programmed cell death and initiates
the transition of thymocytes from the DP to SP compartments (Janeway, 1994). Thymuses from
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mice deficient in TCRa chain gene expression exhibit nearly normal cellularity and are filled with

DP cells (Mombaerts et al., 1992; Philpott et al., 1992). Negative selection is responsible for the
induction of self-tolerance through the clonal elimination of thymocytes whose TCRs recognize

self-MHC (filled with self-peptides) with an inappropriately high affinity or avidity (Robey and
Fowlkes, 1994).

Negative selection can occur at any time in the life history of an immature

thymocyte once it expresses an a0 TCR at the cell surface. Thus, if the deleting self-antigen is
expressed in the thymic cortex, clonal elimination can remove cells at an early developmental stage,

whereas if thymic expression of the deleting self-antigen is limited to the medulla, clonal

elimination spares the DP stage and operates at the DP to SP transition (Janeway, 1994; Robey and

Fowlkes, 1994). While some thymocytes may never succeed in expressing a TCR on the cell
surface, the vast majority of cells that did do so may still fail to traverse the barriers imposed by
positive and negative selection (Surh and Sprent, 1994). After positive selection, TCR expression

gradually reaches mature levels. Class-I-restricted thymocytes have co-recognized self-peptide-

MHC class I complexes by TCRs and CD8, and will downregulate the CD4 molecule.

The

opposite will happen in successfully selected class-II-restricted CD8+CD4+ thymocytes. The final

maturation is gradual and slow, involving numerous changes. At first it is hard to distinguish
phenotypically positively selected CD8+ cells that downregulate CD4 from immature CD8+ cells

that acquire high levels of CD4. Eventually, the difference becomes more obvious, the loss of HSA
and higher levels of TCR are typical of a selected maturing thymocyte (Fowlkes and Pardoll, 1989).

T CELL ACTIVATION AND SIGNAL TRANSDUCTION
Under physiological conditions, T cells are activated and induced to differentiate by antigen
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peptides associated with MHC molecules in combination with additional signals provided by
antigen-presenting cells. These “activated” T cells then display genetically determined effector

functions, such as secretion of immunoregulatory cytokines and, in the case of CTL cells, specific
lysis of target cells. There has been considerable progress in the understanding the mechanisms of
signal transduction by the TCR. Interactions between CD28 on the T cell and B7 on the APC
appear to provide the major costimulatory signals (Fraser and Weiss, 1992). The T cell antigen

receptor is a complex of TCR/CD3 molecules. The TCR a and p subunits form a polymorphic
complex responsible for the antigen binding, whereas TCR Ç chains and the y, 5, and e chains of the

CD3 complex is involved in the signaling process (Weiss, 1993). The capacity of the TCR to

transduce signals across the T cell membrane is mediated by the cytoplasmic domains of the

subunits of the CD3 and Ç chains (Weiss and Littman, 1994). The intracellular tails of the CD3 and

Ç molecules contain a common motif called immunoglobulin receptor family tyrosine-based

activation motif (ITAM). This motif is crucial for TCR coupling to intracellular tyrosine kinases
and hence absolutely required for all subsequent TCR signaling responses (Cantrell, 1996). Based

on the experimental data, several T cell signal transduction pathways have been predicted from the

triggering of TCR or CD28 molecule to the activation or translocation of nuclear factors which bind
to the enhancer of IL-2 and other cytokines.

The following description of these pathways is

schematically diagrammed in Figure 2.

I.

TCR/CD3 pathway

A.

Phospholipase Cpathway
The earliest biochemical response elicited by the TCR is the activation of protein tyrosine

kinase (PTK) (Samelson and Klausner, 1992; Gauen et al., 1994). TCR ligation is followed by
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Figure 2. Schematic diagram of signal transduction pathways in T cell activation.
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phosphorylation of p59fyn and ITAMs, probably by the src-family kinase p56lck associated with CD4
(Xu and Littman, 1993). This is followed by the recruitment, phosphorylation and activation of
ZAP-70, another member of PTK (Iwashima et al., 1994; Weil et al., 1995). The association of

ZAP-70 with the TCR complex is mediated by Src-Homology 2 (SH2) domain interactions with
ITAMs. ZAP-70 has two SH2 domains and binds preferentially to a doubly phosphorylated ITAM;
both tyrosines within the ITAM are required for full ITAM function (Gauen et al., 1994; Isakov et

al., 1995). One of the cellular substrates for ZAP-70 (TCR regulated PTK), is phospholipase C yl

(PLCyl). The TCR also induces the formation of a protein complex between the SH2 domains of
PLCyl and p36, a 36-kDa TCR-induced tyrosine phosphoprotein (Sieh et al., 1994).

This

interaction between p36 and PLCyl causes the recruitment of PLCyl to the plasma membrane to
regulate the hydrolysis of inositol phospholipids such as phosphatidylinositol 4,5-bisphosphate
(PIP2) which are in the plasma membrane. PIP2 hydrolysis generates two products, inositol 1,4,5trisphosphate (IP3) and diacylglycerol (DAG), which act in concert as second messengers to

increase free intracellular Ca2+ concentration and activate protein kinase C (PKC) (Imboden and
Stobo, 1985), respectively, thereby stimulating subsequent events leading to cellular activation and

proliferation (Altman et al., 1990).

B.

Ras pathway
The TCR can regulate the activation of p21ras, a guanine nucleotide binding protein via a

PTK-dependent mechanism independent of TCR coupling to PLCy (Izquierdo et al., 1992). The
TCR regulates via two mechanisms. First, it may regulate p21ras activity through the control of

guanine nucleotide exchange proteins such as the homologue of the Drosophila 'Son of sevenless'

(Sos) gene product (Bowtell et al., 1992; Buday et al., 1994). In fibroblasts, growth factors regulate
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p21ras by stimulating Sos via a mechanism involving the adapter protein Grb2 (McCormick, 1993),
Grb2 is a 26 kDa polypeptide composed of one SH2 domain and two SH3 domains. The SH3

domains of Grb2 bind to the C-terminal proline-rich domain of Sos, whereas, the SH2 domain

interacts with tyrosine phosphorylated molecules that regulate the cell localization/function of this
p21ras exchange protein (McCormick, 1993).

Studies of Grb2 in T cells have identified two

proteins that, when tyrosine phosphorylated, can potentially bind to the Grb2 SH2 domain. These
are the SH2 domain-containing adaptor proteins She and p36 (Buday et al., 1994; Sieh et al., 1994).

She is expressed in T cells as either a 46 or 52 kDa isoform (Ravichandran et al., 1993), whereas
p36 is a 36 kDa membrane-located tyrosine phosphoprotein (Sieh et al., 1994; Buday et al., 1994).

It is proposed that p36, as an adaptor, links the TCR-activated PTKs (such as ZAP-70) to Grb2-Sos
(Buday et al., 1994; Reif et al., 1994). It is speculated that She transiently interacts with Ç chain

and then is dissociated from it and forms a complex with cytoplasmic adaptor molecules (Izquierdo

Pastor et al, 1995).

The TCR can also regulate the GTPase activity of Ras through GTPase activating proteins
The level of active p21ras-GTP complexes is determined by a balance of the rate of

(GAP).

hydrolysis of bound GTP and the rate of exchange of bound GDP for cytosolic GTP. The GTPase

activity of p21ras is controlled by GAPs such as pl20-GAP, neurofibromin, and inositol 1,3,4,5-

tetraphosphate (IP4) binding protein (McCormick, 1993; Downward, 1992; Cullen et al., 1995).
Experiments have shown that TCR triggering inhibits the activity of such p21ras-GAPs (Graves et
al., 1991).
The transmission of signals from p21ras to the nucleus is proposed to involve the

p21 ras/Raf-1 /ERK kinase cascade. The ‘activated’ GTP bound p21ras can interact directly with the
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N-terminal regulatory domain of the serine/threonine kinase Raf-1 (Marshall, 1994; Sieh et al.,

1994).

Raf-1, also called mitogen-activated protein kinase kinase kinase (MAPKKK), then

phosphorylates MEK which is a MAP kinase kinase (MAPKK) (Howe et al., 1992). The activated
MEK in turn phosphorylates ERK (extracellular signal-regulated protein kinase), a member of

Map kinases (mitogen-activated protein kinases). Two ERK members have been reported, ERK1
and ERK2 (Cooper, 1994). The MAP kinase ERK2 can phosphorylate and regulate ELK1, which is
one of a family of proteins that play a key role in regulation of Eos gene expression (Marais et al.,
1993; Hunter and Karin, 1992). Eos proteins are components of the AP-1 complex that is clearly
important for the cytokine gene induction. The schematic representation of this protein kinase

cascades is shown in Figure 2 of page 19.

IL

CD28 pathway
CD28 is a 44-kDa glycoprotein member of the immunoglobulin superfamily that is

expressed as a homodimer on the surface of human and mouse T cells (Aruffo and Seed, 1987;

Hara et al., 1985). Treatment of T cells with monoclonal antibodies (MAbs) directed against CD28

induces an poorly identified but distinct signal transduction pathway that synergizes with TCRgenerated signals to increase both T-cell proliferation and cytokine production (Ledbetter et al.,

1985; Weiss et al., 1986). CD28 can bind at least two ligands B7-1 (CD80) and B7-2 (CD86)

which are differentially expressed on presenting cells (Azuma et al., 1993; Freeman et al., 1993;
Hathcock et al., 1993; June et al., 1994). Triggering of the costimulatory molecule CD28 activates

cellular PTKs which in turn activate lipid kinase phosphatidylinositol 3-kinase (PI 3-kinase)

(Prasad et al., 1994; Truitt et al., 1994; August and Dupont, 1994; Rudd et al., 1994). PI 3-kinase is
comprised of a heterodimer consisting of an adaptor subunit (p85) with two SH2 domains and the
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pl 10 catalytic subunit (Carpenter et al., 1990; Parker and Waterfield, 1992).

PI 3-kinase

phosphorylates the D-3 position of the inositol ring of phosphatidylinositol, phosphatidylinositol di

phosphate generating PI 3-P, PI 3,4-P2 and PI 3,4,5-P3.

but it has been reported that triggering

The function of PI 3-kinase is not clear,

CD28 results in the activation of small monomeric

guanosine triphosphate (GTP)-binding proteins such as Rac 1 or Cdc42 that can induce the kinase

cascade PAK->MEKK->SEK->JNK (Figure 2) (Coso et al., 1995; Minden et al., 1995; Knaus et
al., 1995; Sanchez et al., 1994; Minden et al., 1994). Rael and Cdc42 are members of Rho

subfamily of GTP-binding proteins which belongs to Ras superfamily (Boguski and McCormick,

1993; Ridley and Hall, 1992). The GTP-bound forms of Rac 1 and Cdc42 associate and activate
PAK (p21-activated kinase) (Manser et al., 1994; Minden et al., 1995). Activated PAK then
phosphorylates MEKK, a MAP kinase kinase (Manser et al., 1994; Minden et al., 1995). MEKK,

upon activation, can phosphorylate SEK (SAPK/ERK kinase) (Lange-Carter et al., 1993). SEK is a

MAP kinase which will activate c-jun amino-terminal kinases (JNK) (Sanchez et al., 1994). JNKs
are thought to be responsible for phosphorylating the transactivating domain of c-JUN protein in

vivo (Derijard et al., 1994; Kyriakis et al., 1994), and in turn, phosphorylated c-JUN can form AP-1

with c-fos or c-jun homodimers have potent AP-1 activity and can control the expression of a
number genes, including c-JUN itself (Angel et al., 1988).
It has been speculated that Ras may act as a bridge between TCR/CD3 and CD28 mediated

pathway by associating and activating Rac/CDC42 (Williams, 1996; Minden et al., 1995). That

explains the fact that signaling from TCR/CD3 complex leads to the activation of molecules
downstream of CD28 pathway.

In summary, evidence from recent reports (Minden et al., 1994; Sanchez et al., 1994; Yan et
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al., 1994; Derijard et al., 1995) suggests that mammalian cells have independent signaling pathways

connecting cell surface receptors with each member of the MAPK superfamily. This situation is

remarkably similar to that of the budding yeast Saccharomyces cerevisiae, in which genetic studies

have revealed the existence of parallel cascades of kinases leading to the activation of MAPK.related enzymes (Herskowitz, 1995). As depicted in Figure 3 of page 25, following the mating
pheromone response, each level of the cascade can be functionally defined as MAPK, MAPKK,
MAPKKK, and MAPKKKK, represented in this case by Fus3/Kssl, Stel 1, and Ste20, respectively.

In the mammalian system, as shown in Figure 2 and Figure 3, two independent pathways have

been identified, i.e. MAPK pathway, from Ras, Raf, MEK, to ERK (a member of MAPK), and
JNK pathway, from PAK, MEKK, SEK, to JNK.

Thus, these MAP kinase mediated signal

pathways appear conserved in eukaryotes.

T CELL CYTOKINE PRODUCTION
I.

Overview
T lymphocytes play a central role in immune responses, carrying out a number of effector

and regulatory functions. T cells have been divided into two groups based on expression of CD4
and CD8 cell surface molecules. CD4+ T cells carry out "helper" function and thus have been
designated helper T cells (Th), while CD8+ T cells are cytotoxic lymphocytes. Expression of these

cell surface molecules correlates with the class of MHC molecules that restricts antigen recognition.

The response of CD4+ T cells usually is restricted by class-II MHC molecules while the response
of CD8+ T cells usually is restricted by class-I MHC antigens. Although CD4 mediated cytotoxicity

has been reported (Hahn et al., 1995), CD4+ cells appear to exert most of their functions via the
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production of cytokines, acting on the T cells that produce them in an autocrine fashion, as well as

modulating responses of other cells through paracrine pathways (Prystowsky et al., 1982;
Glasebrook and Fitch, 1980). The predominant function of the majority of CD8+ cells is commonly

believed to be the generation of cytolytic effector cells after antigenic stimulation.

Cytolytic

activity may result either from the release of perforin molecules together with granzyme molecules

(Griffiths and Mueller, 1991) or from the recently discovered interaction of Ras protein with the
Fas-ligand (Vignaux and Golstein, 1994; Rouvier et al., 1993).

The importance of perforin-

mediated cytotoxicity was documented in perforin-deficient mice that were severely compromised

in their ability to cope with viral infections (Kagi et al., 1994). However, CD8+ cells with helper

activity have also been described (Swain, 1981; Horvat et al., 1991).

CD8+ cells can grow for at

least short periods by producing small amounts of IL-2 which acts in an autocrine fashion (von

Boehmer et al., 1984). In addition, when antigenically stimulated they can also secrete IFN-y,

TNF-a, and TNF-fl (Rothenberg, 1992). Thus, T cells exert their function by either producing
cytokine or direct cytolytic effect.

IL

T helper cells
In 1986, Mosmann and colleagues reported that most cloned lines of murine CD4+ T cells

could be classified into two groups, Thl and Th2, based on the cytokines they produced and their
related functional activities (Mosmann et al., 1986). Since then, the subset model has evolved to

encompass several newly discovered cytokines and many new observations. Thl cells are now
defined by their production of IL-2, IFN-y, and TNF-p, and Th2 cells are defined by their

production of IL-4, IL-5, IL-6, IL-10, and IL-13; both cell types produce IL-3, TNF-a and

Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) (Mosmann and Moore, 1991;
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Mosmann and Moore, 1991).
After the description of the Thl and Th2 patterns among mouse CD4* T cell clones, initial
studies on human CD4* clones indicated that the cytokines produced did not fit the Thl/Th2

classification (Paliard et al., 1988; Maggi et al., 1988). Subsequent data has revealed that mouse
and human T clones are, in fact, quite similar in their range of cytokine secretion patterns. In
addition, in both species, coexpression of Thl and Th2 cytokines in various conditions are present
(Romagnani, 1994; Kelso and Gough, 1988; Firestein et al., 1989; Street et al., 1990; Paliard et al.,

1988; Maggi et al., 1988). Clones of the latter phenotype have been classified as a third subset,

ThO, and were proposed to be precursors of Thl and Th2 clones both in mouse and human T cell
clone studies (Firestein et al., 1989; Street et al., 1990).

A.

Functions of Thl and Th2 cells

1.

Delayed-Type Hypersensitivity (DTH)
DTH is an inflammatory reaction mediated by the products of T cells, mainly the Thl cell

phenotype (Vadas et al., 1976). In an experimental system in which T cells and antigen were

injected directly into mouse footpads, Thl clones cause an antigen-specific and MHC-restricted

inflammatory reaction that peaks at about 24 hours (Cher and Mosmann, 1987). Th2 clones do not

produce a swelling reaction under these conditions (Cher and Mosmann, 1987).

One of the

essential mediators of this DTH response is IFN-y, which is responsible for some but not all of the
antigen-specific swelling reaction induced by most Thl clones (Fong and Mosmann, 1989). IFN-y

has also been implicated in the migration of macrophages into inflammatory sites (Issekutz et al.,
1988), and other Thl cytokines that may be involved in DTH reactions are Lymphotoxin (LT) and
GM-CSF. LT and GM-CSF, induces macrophages and granulocytes to migrate and differente.
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The DTH can occur in different forms, notably the Jones Mote reaction and tuberculin-type

reaction. Tuberculin-type DTH is characterized by a mononuclear cell infiltrate, slow kinetics
(peaking at about 48 hours), and substantial induration (Fong and Mosmann, 1989; Mosmann and

Coffman, 1989). In contrast, Jones-Mote DTH involves more granulocytes in the infiltrate, more
rapid kinetics (peaking at about 24 hours), and causes softer swelling, with more edema than

cellular infiltration (Richerson et al., 1969). By these criteria, DTH induced by Thl clones is more
similar to the Jones Mote reaction than the tuberculin reaction (Fong and Mosmann, 1989). Thus,

the cells inducing the tuberculin type reaction are not yet known. Possibilities include Thl cells in
conjunction with Th2 cells, or Thl acting with other accessory cells.

2.

B-cell help
It is generally agreed that murine Th2 clones can be excellent “helpers”, both in antigen

specific and polyclonal in vitro cultures (Kim et al., 1985; Tony et al., 1985). Th2 cytokines, such
as IL-4, IL-5 and IL-6, stimulate various aspects of B cell-growth and differentiation.

The

synthesis of IgE is greatly enhanced by Th2 cells since IL-4 induces the switching of B cells to IgE
secretion (Coffman and Carty, 1986; Lehman and Coffman, 1988). This effect is mediated at the
DNA level; IL-4 induces first the transcription of the s region (Stavnezer et al., 1988) and

subsequently the recombination of the VDJ region from the p to £ constant region. In addition to

IgE switching, IL-4 and IL-5 can both act to enhance the growth and differentiation of activated B
cells (Coffman et al., 1988). Large B cells can proliferate and secrete Ig in response to IL-5,

whereas purified small B cells require the contact-mediated Th signal to become responsive to IL-5

(Herron et al., 1988; Rasmussen et al., 1988). IL-5 thus appears to be the factor responsible for the
factor-mediated bystmder response induced by Th2 clones (Rasmussen et al., 1988).
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The ability of the Thl subset to function as helpers for B cells is considerably more

controversial. Several groups have reported Thl clones that can help antigen-specific secondary
responses in primed B-cell populations (Giedlin et al., 1986; Dekruyff et al., 1989), and the ability

of one Thl clone to stimulate primary antihapten antibody responses in unprimed, hapten-purified
B cell populations has been characterized (Stevens et al., 1988). However, others have shown that
Thl cells can suppress B-cell responses. Both Tite (1984) and Janeway (1988), independently,
reported that Thl clones are directly cytotoxic for activated B cells. Therefore, the helper activity

of Thl clones in vitro appears to dominate at low antigen concentrations (suboptimal Th activation)

or at low T:B ratios (< 0.2) (Coffman et al., 1988; Tite et al., 1984; Giedlin et al., 1986), whereas
the cytotoxic activity begins to dominate at ratios exceeding 1.0 (Tite and Janeway, Jr. 1984).

3.

Macrophage activation
Both Thl and Th2 clones produce cytokines that activate macrophages, although Thl cells

are much more effective.

IFN-y activates macrophages to kill intracellular parasites more

effectively, increases synthesis of la antigens and Fey receptors, and synergizes with LT to activate

Antibody-Dependent Cellular Cytotoxicity (ADCC). GM-CSF also enhances the differentiation of
macrophages and their migration to the site of an immune reaction, so that it may act in concert

with the macrophage-activating factors to increase macrophage function at a local site. Activation

of macrophages by IL-4 has also been reported for la expression and intracellular killing (Crawford
et al., 1987; Zlotnik et al., 1987), although in both cases these functions may be induced by IL-4

much less effectively than by IFN-y (Crawford et al., 1987; Ralph et al., 1988). In addition to the
cytokine effects, Th cells also deliver cell-mediated activation signals to macrophages, and as in the

case of T-B interactions, both Thl and Th2 are able to deliver the cell-mediated signals (Stout and
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Bottomly, 1989).

B.

Crossregulation of Thl and Th2 response

1.

IFN-y inhibits proliferation but not cytokine production by Th2 cells.
IFN-y, produced by Thl cells, at relatively low concentrations (50-100 units/ml), inhibits

proliferation of murine Th2 clones stimulated with antigen, mitogen, anti-T cell receptors, or anti-T

cell receptor monoclonal antibody (mAb) (Gajewski and Fitch, 1988).

However, secretion of

cytokines, including IL-4, in response to these stimuli is not affected (Gajewski and Fitch, 1988).
IFN-y also inhibits proliferation of murine Th2 clones exposed to IL-2 or IL-4 (Gajewski and Fitch,

1988; Femandez-Botran et al., 1988). IFN-y does not inhibit proliferation and cytokine production

by Thl cells (Femandez-Botran et al., 1988).

Coffman (1988) and Boom (1988) reported

separately that IFN-y can inhibit IL-4 dependent B cell differentiation. Thus, IFN-y serves as an
immunoregulatory molecule through which Thl or CD8+ lymphocytes can interfere with both the

clonal expansion and the effector functins of Th2 cells.

2.

IL-10 inhibits APC-induced cytokine production by Thl but not by Th2 cells
IL-10, a cytokine produced by Th2 cells, B cells, and LPS-stimuIated macrophages, can

inhibit cytokine production by Thl in the presence of APC (Fiorentino et al., 1989). IL-10 is

believed to act indirectly by suppressing MHC class I expression (de Waal Malefyt et al., 1991) and

IL-12 production (Murphy et al., 1994; D'Andrea et al., 1993), as well as expression of B7, (Ding et
al., 1993; Kubin et al., 1994), in APC.

3.

IL-12 controls CMI by the expansion of Thl cells
IL-12, also called natural killer cell stimulatory factor, is produced by macrophages and B

cells.

It can increase ADCC and NK cell cytotoxicity and induce NK cell TNF-a and IFN-y
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production. Those cytokines then act back on macrophages to enhance their cytotoxicity and
cytokine production (Scott, 1993). IL-12 was recently shown to induce a typical Thl response

(Manetti et al., 1993; Schmitt et al., 1994). It has been proposed that the effect of IL-12 is mediated
by its ability to stimulate IFN-y production which induces the differentiation of Thl cells from an

uncommitted T cell and, consequently, initiates cell-mediated immunity (Scott, 1993).

PRODUCTION AND GENE REGULATION OF IL-2, IL-6, IFN-y, AND

GM-CSF
I. IL-2
Interleukin-2 (IL-2) is a cytokine produced by T cells upon antigenic or mitogenic
stimulation and plays an important role in the clonal expansion of activated T cells by interacting

with its specific cell surface receptor- IL-2 receptor (IL-2R) (Morgan et al., 1976; Smith, 1984). In
addition to its potent T cell growth-stimulatory activity, IL-2 also mediates multiple biological

processes, including growth and differentiation of B cells (Waldmann et al, 1984; Jung et al.,

1984). It also stimulates the growth of NK cells (Henny et al., 1981). Secreted IL-2 is a 14-17 kDa

glycoprotein encoded by a single gene in chromosome 4. Resting T cells do not produce IL-2
unless they are stimulated by specific antigen or mitogenic

agents such as ConA,

Phytohemagglutinin (PHA) or 12-O-Tetradecanoylphorbol- 13-Acetate (TPA).

A.

Transcriptional regulation ofIL-2 gene expression
The IL-2 gene has served as a paradigm for the regulation of cytokine gene transcription

during T cell activation. The IL-2 gene transcription is mediated by a region extending 275 bp

upstream of the transcription initiation site. It is this relatively short piece of DNA that integrates
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numerous signaling pathways leading to IL-2 synthesis and the activation and proliferation of T
cells. Although all of the positively and negatively acting transcription factors that bind to the IL-2

promoter have also been detected in cells other than T cells, it is the fine-tuned cooperation of these
factors that

creates

the

inducible T cell-specific

activity

for the

characteristic

IL-2

promoter/enhancer (diagrammed in Figure 4).

IL-2 CRE

AP-1

NF-A
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NFIL-6
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F-kB
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Figure 4. Structure of promoter/enhancer region of IL-2, IL-6, IFN-y, and GM-CSF genes.
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1.

NFIL-2E, NFIL-2B sites and NF-AT factor
Nuclear Factor of Activated T cells (NF-AT) was originally described as an inducible T

cell-specific factor which binds to one site of both the human IL-2 and HIV-1 promoters (Shaw et

al., 1988). However, NF-AT factors occur in numerous hematopoietic cells, including B cells, NK

cells, mast cells, monocytes and macrophages (Brabletz et al., 1991; Verweij et al., 1990), as well
as in neuronal cells (Serfling et al., 1995; Omokawa et al., 1993). They participate in the control of

promoters of numerous cytokine genes. The human and murine IL-2 promoters contain two NF-AT
binding sites (the proximal NFIL-2B and distal NFIL-2E) which are essential for promoter function

(Thompson et al., 1992).

Multiple NF-AT binding sites were also identified in the

promoters/enhancers of IL-3, IL-4, GM-CSF and TNF-cc genes (Cockerill et al., 1993; Chuvpilo et
al., 1993; Szabo et al., 1993; Goldfeld et al., 1993). This indicates that NF-AT factors play an

important role in the expression of cytokine genes in hematopoietic cells. The NF-AT complex

binding to the distal NF-AT site of the IL-2 promoter was described as a heterodimer consisting of
two components, a ubiquitous nuclear component, NF-ATn, and a T cell-specific cytosolic

component, NF-ATc (Flanagan et al., 1991).

NF-AT is a target through which the immunosuppressive agent cyclosporin A (CsA) and
FK506, inhibit IL-2 promoter induction (Emmel et al., 1989; Randak et al., 1990). The mechanism,

as reported by Fruman et al. (1992) is through the inhibition of calcineurin phosphatase activity.

The important role that calcineurin plays in the induction of the NF-AT and IL-2 promoter activity
has been shown by overexpressing calcineurin in Jurkat cells (O'Keefe et al., 1992; Clipstone and
Crabtree, 1992). Calcineurin (phosphatase 2B, PP2B) is ubiquitously distributed and found in high
concentrations in the brain (Kincaid et al., 1990).
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Calcineurin consists of two subunits, a

calmodulin binding 59 kDa subunit, calcineurin A, and a Ca2+ binding regulatory 19 kDa subunit,

calcineurin B. In response to an increase of intracellular Ca2+, the Ca2+-calmodulin complex binds

to the C-terminal part of calcineurin A and induces conformational changes resulting in the

stimulation of calcineurin activity. It is likely that in vivo the dephosphorylation of cytosolic NFAT by calcineurin leads to the nuclear translocation of NF-AT (Hashimoto et al., 1990).

2.

NFIL-2C site and NF-kB

NF-kB was first described to be a lineage and stage-specific factor regulating the expression

of the Ig k light chains in B cells (Sen and Baltimore, 1986). Subsequent! studies demonstrated that
RcI/NF-kB factors are ubiquitously distributed (Chilli et al., 1993; Baeuerle and Henkel, 1994).

Both the murine and human IL-2 promoters contain one binding site for NF-kB factor with the
identical sequence of GGGATTTCAC (Serfling et al., 1989; Lenardo et al., 1988; Hoyos et al.,

1989; Shibuya et al., 1989). The NFIL-2C site located around nucleotide position -200 is a low
affinity, but nevertheless functionally important kB binding site (Serfling et al., 1995; Wan et al.,

1986).

The rapid induction of active nuclear NF-kB in T cells and other cells is dependent on posttranslational control mechanisms. A group of Rel-related inhibitory proteins, the IkBs, are able to

form complexes with

kB

factors, thereby retaining NF-kB in the cytoplasm (Baeuerle and

Baltimore, 1988; Beg and Baldwin, Jr. 1993).

In addition to the tight control of kB factor's

subcellular localization, IkB can also dissociate NF-kB/DNA complexes in vitro (Zabel and

Baeuerle, 1990). Structural features of the IkBs are the so-called ankyrin repeats. Each member of
the IkB family contains between five to seven repeats which are thought to mask the nuclear

localization signal (NLS) located in the Rei homology domain (RHD) of Rei proteins, thereby
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inhibiting the nuclear uptake of these transcription factors (Henkel et al., 1992; Ganchi et al., 1992).
The IkBs are a primary target for activation signals in T cells and other cells.

IkB is

proteolytically degraded within minutes after exposure of T cells to TNF-a or TPA/ionomycin
(Beg and Baldwin, Jr. 1993).

This degradation of IkB is accompanied by a signal-induced

phosphorylation at two serine residues near its N-terminus (Brown et al., 1995).

The

phosphorylation appears to label the IkB proteins for degradation, but is not sufficient to cause
either their dissociation from NF-kB or to activate cytosolic NF-kB (Finco et al., 1994; DiDonato

et al., 1995). Growing evidence (Chen et al., 1995; Scherer et al., 1995) supports the theory that the
phosphorylation

event

multiubiquitination.

is

required

for

an

additional

modification

of

IkB,

namely,

The ubiquitinated IkB remains associated with NF-kB and is specifically

degraded by 26S proteasomes. Thus, the sequence of events leading to NF-kB activation may
require phosphorylation of IkB at serine residues, followed by phosphorylation-dependent

multiubiquitination of IkB and degradation of IkB by ubiquitin-dependent proteasome and finally
the release of free NF-kB transcription factor (Verma et al., 1995). It has been reported that IkB is

readily phosphorylated by a variety of kinases, including PKC and PKA in vitro (Serfling et al.,
1995; Walker et al., 1986; Yssel et al., 1986). The activation of Ca2+ signaling pathway in T cells

exerts a co-stimulatory effect on

kB

factors which seems to be less important compared to the

stimulation ofNF-AT (Brabletz et al., 1991; Emmel et al., 1989; Randak et al., 1990).

NF-IL-2C seems to be a site for both positive and negative regulation of IL-2 gene

expression, since nuclear p50 homodimers were detected in high concentrations in resting
peripheral T cells or uninduced untransformed T cell lines (Kang et al., 1992). However, antigen
stimulation led to the replacement of p50 homodimers by p50/p65 heterodimers in these cells.
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3.

CD28RE
CD28 is one of the most important surface receptors for the co-stimulation of T cells.

Although CD28-stimulation also has a stabilizing effect on cytoplasmic RNAs (Umlauf et al.,

1995), its major stimulatory effect is at the transcriptional level.

Two laboratories identified a

CD28 responsive element (CD28RE) within the IL-2 promoter located around nucleotide position -

160 (Fraser et al., 1991; Verweij et al., 1991). Both groups tested a series of internal
deletion/substitution mutants of the IL-2 enhancer directing expression of a reporter gene. Fraser
and coworkers (1991) looked for the capacity of anti-CD28 to increase PMA plus ionomycin-

induced reporter gene expression, whereas Verweij et al.(1991) tested the ability of anti-CD28 to

induce reporter gene expression in the presence of anti-CD3. In combination with EMSA assay, it

was demonstrated that the sequence from -162 to -153 specifically interacts with an inducible
nuclear factor.

While it was initially suggested that induction of CD28RE binding activity

(CD28RC) is specific for the CD28 signaling pathway, Civil et al (1992) reported that CD28 signal

is not critical in the induction of CD28RC. Treatment of Jurkat cells with a combination of antiCD3 plus PMA led to the appearance of binding activity that is indistinguishable from that induced

by the combination of anti-CD3 plus anti-CD28. Since anti-CD28 and PMA are known to exert
different effects on intracellular signaling events, this observation suggests that the induction of
CD28RC is not specific for CD28 signaling.

What proteins bind to the CD28RE? Although progress has been made in the identification

of proteins able to interact wit the CD28RE motif, no clear-cut picture has emerged. Comparison
of the sequence with that of binding motifs of known transcription factors reveals similarity to the
consensus NF-kB binding motif (Baeuerle, 1991). Studies with recombinant p50, p65 and c-Rel
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proteins showed the ability of CD28RE to bind c-Rel (Ghosh et al., 1993). The question is whether
these proteins are actually present in the CD28RE protein complex formed in nuclear extracts of
stimulated cells. Ghosh and colleagues (1993) reported that the CD28RE protein complex

generated in nuclear extracts from peripheral blood T cells stimulated for 7 h with PMA plus antiCD28 or anti-CD3 plus anti-CD28 constitutes at least three members of the NF-kB/RcI family: c-

Rel, p50 and p65. However, the data from Fraser et al. (1992) do not confirm the involvement of
known NF-kB family members in the CD28RE protein complex.

4.

The TREp site and the AP-1 factors
The inducible transcription factor, AP-1 (Activator Protein 1), binds to the TPA-responsive

element (TRE) of the consensus sequence TGA(G/C)TCA. TREs are found in the promoters of
numerous inducible genes (Angel et al., 1987; Lee et al., 1987). Cellular AP-1 is a heterodimer
consisting of the products of the two proto-oncogenes jun and fos (Curran and Vogt, 1992; Angel

and Herrlich, 1994). Jun and Fos represent families of related proteins which belong to the class of
leucine zipper factors (Landschulz et al., 1988) that contain a basic DNA binding domain. In

addition to c-Jun and c-Fos, the prototypes of both families, two other Jun proteins, JunB and JunD,

and three Fos proteins, FosB, Fra-1 and Fra-2 have been isolated and studied (Angel and Herrlich,
1994).

Using the DNase I footprint protection technique, a AP-1 binding site called TREp is found
in IL-2 promoter (Serfring et al., 1989). TREp shares six out of seven nucleotides with the TRE
consensus sequence, (-153)AGAGTCA(-147).

This result was confirmed by EMSA supershift

experiments using antibodies raised against Jun and Fos (Vacca et al., 1992). In vivo footprint

experiments revealed protein binding to the TREp in TPA/inomycin-induced Jurkat cells, but not in

37

uninduced cells (Brunvand et al., 1993).

TREp is not the only IL-2 promoter element interacting with AP-1 factors. In the footprint
experiments, purified AP-1 was also found to bind to the so-called 'upstream promoter site' (UPS)

(Serfling et al., 1989), where it is tightly associated with Octamer factors.

Furthermore, AP-1

factors bind to the two NF-AT binding sites (purine boxes) of the IL-2 promoter. At these sites,
AP-1 seems to stabilize the DNA binding of NF-AT. Several stimulatory as well as inhibitory
effects of AP-1 on the IL-2 promoter activity have been identified.

Stimulation of peripheral

human T cells with CD69 (plus TP A and inomycin) resulted in the generation of AP-1/TREp

complexes. Deletion of TREp within the IL-2 promoter blocked the CD69-stimulated increase of

IL-2 promoter activity in Jurkat cells (D1 Ambrosio et al., 1993).
The expression of Jun and Fos protein is mainly controlled at two levels, at the level of

transcription and at the level of protein modification. The rapid induction of c-fos transcription in
vivo is controlled by a ternary protein complex consisting of a dimer of serum responsive factor

(SRF) and Elkl, a member of the family of Ets factors (Janknecht and Nordheim, 1993; Treisman,
1994). Upon induction of cells, Elk-1 is phosphorylated through the Raf/MEK/ERK signaling

cascade following TCR/CD3 pathway (see Ras pathway).

c-Jun is activated by JNK1 which

interacts with the transactivation domain of c-Jun and phosphorylates the amino acids Ser-63 and

Ser-73 (Davis, 1994). Phosphorylation of these sites is essential for c-Jun-mediated transactivation
(Serfling et al., 1995; Barnett et al, 1988). Triggering of TCR/CD3 and CD28 exerted a synergistic
effect on JNK activity (see TCR/CD3 and CD28 pathway section).

5.

NRE-A site and NiL-2

Williams et al. (1991) reported that the replacement of eight nucleotides between the
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positions -102 to -109 of the human IL-2 promoter by a 8 bp linker had a profound stimulatory

effect on the promoter's activity in Jurkat cells. Stimulation of cells by TPA/PHA resulted in an

increase of promoter induction compared to the induction of the wild-type promoter. The use of

this so-called negative regulatory element A (NRE-A) for the screening of a cDNA expression
library prepared from Jurkat cells, resulted in the cloning of a DNA binding factor, NiL-2-a,

containing 735 amino acids and three Zn2+ finger motifs. When NiL-2-a was overexpressed in
Jurkat cells, the induction of a wild-type IL-2 promoter was distinctly suppressed, but not a

promoter containing a mutated NRE (Williams et al., 1991), NiL-2-a appears to play an important
role in the inactivation of the IL-2 promoter in anergic and apoptotic T cells (Becker et al., 1993). It

is presently unclear how NiL-2-a might exert its inhibitory effect on IL-2 promoter activity.
6.

UPS/NF-IL-2A/ARRE-1 sites and Octamer factors
The 'upstream promoter site', UPS, of the murine IL-2 promoter (which was also referred to

as antigen receptor response element 1, ARRE-1, or NF-IL2A site for human IL-2 promoter
(Durand et al., 1988; Flanagan and Crabtree, 1992)) spans approximately 30 bp from nucleotide
position -64 to -94. Introduction of mutations into this site had a deleterious effect on the IL-2

promoter induction (Ullman et al., 1991; Pfeuffer et al., 1994) whereas multiple copies of the UPS

cloned in front of a tk/CAT reporter gene showed a strong inducible activity in Jurkat or EL4 T
cells (Durand et al., 1988; Brabletz et al., 1991) but not in B cells (Serfling et al., 1995; Bekoff et

al., 1986). The ubiquitous Octamer factor Oct-1 and the lymphocyte-specific factor Oct-2 which
are expressed in peripheral T lymphocytes and EL4 cells (Pfeuffer et al., 1994; Brabletz et al.,

1993; Kamps et al., 1990; Kang et al., 1992) bind with identical affinities to the UPS-Oct motif.
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7.

Other factors
The result of in vivo footprint analyses revealed factors binding to several G-rich sequences

of the IL-2 promoter in activated EL4 cells (Garrity et al., 1994). One of them is located just in
front of the distal NF-AT binding site and was tentatively identified as a Spl binding site (Serfling

et al., 1995; Ramos et al., 1987). There are several other low affinity Spl binding sites within the
IL-2 promoter which, at least in part, are also bound by Zn2* finger containing factors other that
Spl. However, it remains to be shown whether they contribute to the activity of the IL-2 promoter.

B.

Post-transcriptional regulation ofIL-2 gene expression
In addition to transcriptional mechanisms, post-transcriptional mechanisms have been

implicated in the regulation of IL-2 gene expression (Shaw et al., 1988; Lindstein et al., 1989). The
AU-rich element (ARE), frequently containing the motif AUUUA, is conserved in the 3'-

untranslated regions of many unstable, inducible mRNAs, including those of many oncogenes and
cytokines (Caput et al., 1986). These sequences appear to mediate the instability of several of these

species and to bind specific factors (Bohjanen et al., 1991; Maker, 1989). Furthermore, a number of
unstable mRNAs are stabilized by cycloheximide treatment, implicating these AU-rich sequences

as a target for a labile mechanism that destabilizes these mRNAs and consequently mediates their

rapid degradation (Shaw et al., 1987). IL-2 mRNA has at least three reiterated copies of the
sequence AUUUA, which is known to confer instability to mature mRNA (Lindstein et al., 1989;
Shaw and Kamen, 1986; Bohjanen et al., 1991). Cytoplasmic regulatory proteins, that appear to be

specific for IL-2 and several other cytokine messages, recognize these AUUA sequences to regulate
mRNA stability. Bohjanen et al. (Bohjanen et al., 1992) further showed that a minimum of 3
AUUUA sequences were necessary for these proteins to bind to the mRNA.
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IL

IL-6
IL-6 is a glycoprotein with molecular weight in the range 20 to 30 kDa, depending on the

cellular source and preparation.

The molecular weight difference of IL-6 is due to the post-

translational modifications such as N- and O-linked glycosylation and phosphorylation (May et al.,
1988; May et al., 1988). These differences in molecular size do not play a role in the biological
activity of IL-6.

IL-6 is produced by Th2 cells, monocytes/macrophages, B cells, fibroblasts,

endothelial cells, granulocytes, and mast cells (Isshiki et al., 1990).

It is involved in B cell

differentiation and antibody production (IgG, IgM, and IgA)(Taga et al., 1987) and promotes acute

phase protein synthesis in hepatocytes (Gauldie et al., 1987).
Human IL-6 was cloned by Hirano group in 1986 (Hirano et al., 1986), which consists of

212 amino acids with a 24-amino-acid signal peptide. In 1988, Van Snick and coworkers (1988)

cloned mouse IL-6 cDNA which is a 211 amino acid protein with a 24-anuno-acid signal sequence.
The genes for human and mouse IL-6 are located on the short arm of chromosome 7 and the

proximal region of chromosome 5, respectively (Sehgal et al., 1987; Ferguson-Smith et al., 1988;
Mock et al., 1989). Potential transcriptional control elements are identified within the conserved

region of IL-6 promoter. From proximal to distal, they are NF-kB, NF-IL6, CRE (cyclic AMP

response element), AP-1, and two GRE (glucocorticoid response element), as shown in Figure 4.

NF-IL6 (Figure 4) was initially identified as a nuclear factor binding to a 14 bp palindromic
sequence (ACATTGCACAATCA) within an IL-1 responsive element in the human IL-6 gene

(Isshiki et al., 1990). The cloned NF-IL6 contained a region highly homologous to the C-terminal

portion of C/EBP, the first nuclear factor proposed to contain a leucine zipper structure (Landschulz

et al., 1988; Landschulz et al., 1988). It was found that NF-IL-6 is expressed at an undetectable or
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minor level in all normal tissues, but is drastically induced by stimulation of EPS, IL-1, TNF, or IL-

6. NF-IL6 can bind to the regulatory region of various genes including IL-8, G-CSF, IL-1,

immunoglobulin, and acute-phase protein genes (Natsuka et al., 1992). These results indicate that
NF-IL6 may be a pleiotropic mediator of many inducible genes involved in acute-phase immune
and inflammatory responses (Akira and Kishimoto, 1992).
An NF-kB binding motif is also present at position -737-64. Several groups demonstrated
that NF-KB is responsible for IL-6 induction (Shimizu et al., 1990; Libermann and Baltimore,

1990; Zhang et al., 1990). Distal to AP-1 binding site are two repeats of glucocorticoid response

element (GRE). Ray et al. (1991) have investigated the molecular basis for the repression of the IL6 promoter by the glucocorticoid dexamethasone. The results showed that the activated GR binds
to the IL-6 promoter and its binding interferes with the binding of positive-acting, inducible and

basal transcription factors, resulting in the highly efficient repression of this gene by
dexamethasone.

III.

IFN-y
IFN-y is an important immunomodulatory molecule produced by activated T cells and NK

cells (Cippitelli et al., 1995; Mosmann and Moore, 1991; Lewis and Wilson, 1990). Its function
includes macrophage activation, upregulating class I and class II MHC molecule expression,

enhancing NK cell cytotoxicity, and regulating T helper cell differentiation and B cell isotype
expression (Farrar and Schreiber, 1993; Bikoff et al., 1991; Mosmann et al., 1991; Swain et al.,
1991). IFN-y is a 15.4 kDa polypeptide consisting of 134 amino acids (Gray and Goeddel, 1983).

Like IL-2, IFN-y is an early response gene expressed by T cells upon activation. Yet the IL-2 and

IFN-y genes are independently regulated as demonstrated by their differential expression in certain
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subsets of T cells. Production of IL-2 is comparable in naive and memory T cell populations; and

in both populations IL-2 is expressed predominately by the CD4+ T cell subset (Mosmann et al.,
1991; Lewis et al., 1991). IFN-y is produced to a greater extent by the CD8+ subset than by the

CD4+ subset, and in both subsets it is produced almost solely by memory T cells, with very little

expression by naive T cells (Lewis and Wilson, 1990; Lewis et al., 1991; Budd et al., 1987; Sanders
et al., 1988; Lewis et al., 1988). Moreover, NK cells express IFN-y but not IL-2 (Turner et al.,
1990). The differential regulation of the IFN-y and IL-2 genes in T cells has been shown to occur

primarily at the level of gene transcription (Lewis et al., 1991; Kang et al., 1992).
The IFN-y gene is located in human chromosome 12 and murine chromosome 10 (Naylor et

al., 1983; Nayloar et al., 1984). Unlike the relatively well-characterized promoter-enhancer of the

IL-2 gene, much less is known about the regulation of IFN-y transcription. Analysis in the human

Jurkat T cell line and short-term cultured human T cells suggested that elements regulating the IFN
y promoter are contained with 550 bp of the transcription start site and that the key elements may be

located within the proximal 200 bp (Chrivia et al., 1990; Brown et al., 1992). Further studies by

Penix et al. (1993) have revealed two regions within -108 to -40 bp 5' to IFN-y gene which were
necessary and sufficient for the expression of IFN-y. The distal conserved element (-96 to -80 bp)
contained a potential regulatory motif found in the promoter regions of the GM-CSF and

macrophage inflammatory protein (MIP) genes. In the GM-CSF promoter this motif is located
within an activation responsive DNase I footprint using extracts from MLA 144 cell (gibbon ape T

cells) (Nimer et al., 1988) and is part of the conserved lymphokine element 0 (CLEO) (Miyatake et
al., 1991). The concept that the IFN-y and the GM-CSF promoters may share transcription factors

is attractive. Both cytokines are expressed well by memory T cells, whereas neonatal, naive T cells
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express very little IFN-y and GM-CSF expression is diminished and delayed (Swain et al., 1991;
Budd et al., 1987; Sanders et al., 1988; Ehlers and Smith, 1991; English et al., 1992). Just 5* of the
GM-CSF/MIP motif in the distal conserved element of the IFN-y promoter is a consensus GATA
motif which is found in the promoters-enhancers of the TCR a, P, and 5 chain genes, and bind the

T lineage-restricted factor GATA-3 (Ho et al., 1991; Ko et al., 1991; Joulin et al„ 1991; Marine and
Winoto, 1991). The promoter regions of several other cytokine genes (including IL-3, IL-4, IL-5,

and GM-CSF genes, but not the IL-2 gene) contain consensus GATA motifs, suggesting that

GATA-binding proteins may contribute to regulation of these cytokines. The proximal conserved
element (-73 to -48 bp) in the human IFN-y gene contains a 17- out of 24 bp match to the NFIL-2A
site of the human IL-2 gene. In the IL-2 promoter this element is necessary for maximal induction

with activation (Durand et al., 1988), and has been shown to bind both Oct-1 and the activation

specific factor OAP-40 (Ullman et al., 1991). Unlike the NFIL-2 A element, this IFN-y element did
not bind Oct-1 (Penix et al., 1993), instead may be a target for the OAP-40 binding (Penix et al.,

1993; Ullman et al., 1991). It has been shown that the proximal region of the IFN-y promoter

appears to be differently methylated in murine CD4+ Thl and Th2 T cell clones, and this difference
correlates with the transcriptional activity of the gene (English et al., 1992). The presence of AP-1
site has been reported within the proximal regulatory element of the IFN-y promoter region (-66 to -

47)(Cippitelli et al., 1995) which is involved in the down-regulation by dexamethasone.

Furthermore, the NF-AT element, which appear to play a critical role in IL-2 promoter function

(Northrop et al., 1992; Jain et al., 1992), are not present in the IFN-y promoter sequences that were
essential for expression or yielded optimal expression (Penix et al., 1993). The current data in toto
provide an insight into potential mechanisms by which the IL-2 and IFN-y genes may be
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independently regulated, though both are expressed early after T cell activation, require the same
signals for induction and are inhibited by CsA.

IV.

GM-CSF
GM-CSF is one of a family of glycoprotein cytokines that have potent effect in stimulating

proliferation, maturation, and function of hematopoietic cells. It has molecular weight of 22 kDa
(Gasson et al., 1984; Golde et al., 1978). In the mouse the GM-CSF gene has been localized to

chromosome 11 (Barlow et al., 1987), and human GM-CSF gene has been mapped to the long arm
of chromosome 5 (Huebner et al., 1985; Le Beau et al., 1986).

Human and murine GM-CSF

cDNAs encode polypeptides of 144 and 141 amino acids, respectively (DeLamarter et al., 1985;
Burgess et al., 1987). T cells, macrophages, mast cell, endothelial cells, and fibroblasts can be
induced by specific activating signals to accumulate GM-CSF mRNA and secrete GM-CSF protein
(Kelso and Gough, 1988; Cline and Golde, 1974; Chan et al., 1986; Thorens et al., 1987; Wodnar-

Filipowicz et al., 1989; Munker et al., 1986).

Transcriptional regulation of GM-CSF expression plays an important role in activated T

lymphocytes. Sequence analysis comparing upstream regions of murine and hGM-CSF genes with

each other and other cytokine genes showed significant homologies in the 330 bp up stream of the
putative TATA box (Miyatake et al., 1985; Stanley et al., 1985).

Several groups have used

mobility shift assays to look for binding proteins that may regulate expression of the genes. Two
cytokine consensus regions (CK-1 and CK-2), also referred to as conserved lymphokine elements

(CLE-1 and CLE-2) were found at 5' of the GM-CSF promoter (Shannon et al., 1988; Miyatake et
al., 1988).

CLE-1 present between -113 and -104 is not responsible for signals from the

PMA/A23187, but is responsible for activation by a viral transactivator p40tax (Miyatake et al.,
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1988) and CD28 stimulation (Fraser and Weiss, 1992). Using mobility shift assays, Shannon et al.

(1988) demonstrated interaction of nuclear proteins with both CLE-1 and CLE-2 of hGM-CSF, and
later show that the factor binding to CLE-1 (NF-GMa) was found in many cell types, whereas the

protein binding to CLE-2 (NF-GMb) was inducible using TAP.

Work by Schreck and Baeuerle

(1990) has shown that an NF-kB consensus sequence is present in the noncoding strand of the GMCSF promoter.

Using methylation interference analysis and oligonucleotide competition

experiments, they demonstrated binding of purified NF-kB to this sequence, which overlaps the
region containing CLE-2. Point mutational analyses have defined a GC box (-84 to -75), which is

important for gene activation (Miyatake et al., 1988; Heike et al., 1989). Three proteins (Al, A2,

B) have been identified that bind to the GC box. The sequence recognized by these factors is

identical to the Spl recognition site, and indeed purified Al is indistinguishable from Spl

biochemically and immunochemically. Two factors, NF-CLE0a and NF-CLE0b, recognize the 3*
half and 5' half, respectively, of the CLEO sequence (-54 to -40). Like NF-AT of the IL-2 system,
binding of NF-CLEO to this sequence requires two signals, PMA and A23187 (Miyatake et al.,

1991).
Post-transcriptional control mechanisms are also involved in the regulation of GM-CSF

expression. Caput et al. (1986) and Shaw and Kamen (1992) identified conserved consensus
sequences in the 3' untranslated region of mRNAs encoding GM-CSF, as well as a variety of other
cytokines (TNF, IL-1, IFN-a, p, and y).

Shaw and Kamen also showed that a 62-bp AT-rich

sequence from the 3' untranslated region of the hGM-CSF gene caused destabilization of the rabbit
globin gene mRNA in recombinant constructs. The consensus sequence has been proposed to be
AUUA(Shaw and Kamen, 1986) or TTATTTAT (Caput et al., 1986) and a potential cytoplasmic-

46

binding protein that recognizes the AUUUA motif has been described (Matter, 1989). The GM-

CSF gene is constitutively transcribed in monocytes, endothelial cells, and fibroblasts, although
mRNA does not accumulate (Thorens et al., 1987; Koeffler et al., 1988). Activation of these cells

by a variety of stimuli leads to transient mRNA accumulation, both by increased transcription, as
shown by nuclear run-on assays, and by stabilization of the mRNA, perhaps mediated by the 3’ AT-

rich region (Slack et al., 1990; Kaushansky, 1989).

ASSESSMENT OF IMMUNOTOXIC EFFECTS OF ENVIRONMENTAL

CHEMICALS
I.

Overview
The functions of the immune system are the protection of the body from invading

pathogens and to provide immune surveillance against arising tumor cells. It has a first line non
specific branch that can initiate effector reactions itself, and an acquired specific branch in which
lymphocytes and antibodies carry the specificity of recognition and subsequent reactivity towards

the antigen.

The first line of innate immunity is constituted by phagocytic cells such as

macrophages and polymorphonuclear granulocytes, or cytotoxic cells such as natural killer cells.
After initial contact of the host with the pathogen, specific immune responses are induced. The

hallmark of this second line of defense is specific recognition of determinants, so-called antigens or
more specifically epitopes on these antigens, by receptors on the cell surface of

lymphocytes.

B and T

Following recognition of these antigens, lymphocytes proliferate and mature to

plasma cells and produce antibodies (B cells), or differentiate to become cytotoxic T lymphocytes.

There has been growing interest and concern within the scientific and public communities

47

on the capacity of certain chemical agents to perturb normal immune processes. Immunotoxicology

has been defined as the study of the adverse effects of environmental chemicals, certain
therapeutics and biologicals, collectively referred to as xenobiotics, on the immune system. These
adverse effects shown to occur are often chemical-specific as well as species-specific and may
result as a consequence of: (1) a direct and/or indirect effect of the xenobiotic (and/or its

biotransformation product) on the immune system, or (2) an immunologically based host response
to the compound and/or its metabolite(s), or host antigens modified by the compound or its
metabolites. When the immune system acts as a target of chemical insults, the result can be a
decreased resistance to infection, certain forms of neoplasia, or immune disregulation/stimulation
that can exacerbate or facilitate development of allergy or autoimmunity (Luster et al., 1987;

Schwartz et al., 1978; Bigazi, 1988).

Should the immune system respond to the antigenic

specificity of xenobiotic, toxicity can become manifest as allergies of autoimmune diseases (Luster

and Dean, 1982).

Animal models to investigate chemical-induced immune suppression have been developed
and a number of these methods are validated since the immune system of laboratory animals,

including rodents, is remarkably similar to that of humans with respect to organization, function,
and responsiveness.

Several xenobiotics have been identified in such studies with laboratory

animals to cause immunosuppression. The database on immune function disturbances in humans
by environmental chemicals is limited. Immunotoxicity assessment in rodents, with subsequent

extrapolation to man, forms the basis of human risk assessment.
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II.

In Vivo Studies

A.

Immunotoxicity testing in laboratory animals
Experimental animals are useful to the assessment of potential direct immunotoxicity of

xenobiotics. This approach enables well-controlled exposure studies, at dose levels that range from
frank immunotoxic doses where effects are clearly detectable, to much lower, no-observable-effect
levels (NOEL). Initial strategies have been to select and apply a tiered panel of assays to identify

immunosuppression or enhancement that may occur following chemical exposure (Vos, 1980;
Luster et al., 1988). Two examples of tiered approaches are described. The first was developed at

the National Institute of Public Health and the Environment, The Netherlands (RIVM) (Vos, 1980).
It is performed in the rat using at least 3 dose levels, i.e. one resulting in overt toxicity, one aimed
at producing no toxicity, and one intermediate level. The first tier comprises general parameters

including conventional hematology, serum immunoglobulin concentrations, bone marrow
cellularity, weight and histology of lymphoid organs (thymus, spleen, lymph nodes), and possibly

immunophenotyping of tissue section.

Once the results indicate that a chemical may be

immunotoxic, functional tests are performed to confirm and further investigate the nature of the
immunotoxic effect, and to determine its possible significance as a health hazard (Vos, 1980). The
US National Toxicology Program (NTP) at the National Institute of Environmental Health Science
(NIEHS) has developed a tiered approach in mice which is composed of two tiers (Luster et al.,
1988)(Table 4). Tier I includes conventional hematology, lymphoid organ weight, cellularity and

histology of the spleen, thymus and lymph nodes, ex vivo splenic IgM antibody plaque-forming

cell assay following sheep erythrocyte immunization, in vitro lymphocyte proliferation after
stimulation with mitogens and allogeneic cells, and an in vitro assay for natural killer (NK) cell
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activity.

Tier II, which represents an in-depth evaluation, includes additional assays for cell-

mediated immunity (CMI) and humoral mediated immunity (HMI), and nonspecific immunity, as

well as an examination of host resistance. Tier II testing is normally included only if functional

changes are seen in Tier I and at dose levels which are not overtly toxic (i.e., body weight changes).

Immune function tests in Tier II will provide information on the mechanism of the immunotoxicity
and help characterize the nature of the effect.

Table 4. Panel for detecting immune alterations following chemical or drug exposure in
rodents (Luster et al., 1988)
Parameter
Procedures
Screen (Tier I)
Immunopathology

Humoral-mediated
immunity
Cell-mediated immunity

Nonspecific immunity

Comprehensive (Tier II)
Immunopathology
Humoral-mediated
immunity
Cell-mediated immunity
Nonspecific immunity
Host resistance challenge
models (endpoints)

Hematology-Complete blood count and differential
Weights—Body, spleen, thymus, kidney, liver
Cellularity—Spleen
Histology-Spleen, thymus, lymph node
Enumerate IgM antibody plaque-forming cells to T-dependent antigen
(SRBC).
LPS mitogen response
Lymphocyte blastogenesis to mitogens (ConA)
mixed leukocyte response against allogeneic leukocytes (MLR)
Natural killer (NK) cell activity

Quantitation of Splenic B and T cell numbers
Enumeration of IgG antibody response to SRBCs
Cytotoxic T lymphocyte (CTL) cytolysis.
Delayed hypersensitive response (DHR).
Macrophage function—quantitation of resident peritoneal cells
phagocytic ability (basal and activated MAF)
Syngeneic tumor cells
PYB6 sarcoma (tumor incidence)
B16F10 melanoma (lung burden)
Bacterial models
Listeria! monocytogenes (mortality)
Streptococcus species (mortality)
Vial models
Influenza (mortality)
Parasite models
Plasmodium yoelii (parasitemia)
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B.

Immunotoxicity assessment in man

The database of immunotoxic chemicals in humans is less complete and often inconclusive

for the following reasons. 1) Tests that can be done are largely limited to ex vivo cell cultures or
assay of body fluids after in vitro, accidental or occupational exposure. 2) Population heterogeneity
increases the variability of the results hampering identification of more subtle effects. 3) For

obvious reasons, direct measurement of the effect of a xenobiotic on resistance to infections or
tumors cannot be approached experimentally. 4) Assessments after accidental, occupational and/or

environmental exposure are extremely difficult to control for actual dose level and confounding
factors, e.g., possible exposure to cigarette smoke. Thus, the most common design used in

immunotoxicity research in man is the cross-sectional study (Seigrade et al., 1995).

In such a

study, exposure status and immune function are measured at one point in time or over a short
period of time. The immune function of 'exposed' subjects is compared to the immune function of

'non-exposed' subjects by the measurement of biomarkers. A biological marker of exposure is a

xenobiotic chemical or its metabolite or the product of an interaction between the chemical and
some target cell or biomolecule. The most common markers of exposure are the concentration of
the chemical in urine, blood or target organ or tissue. Immune-specific biomarkers of exposure are

antibodies or positive skin tests to a particular chemical. A biomarker of effect is a measurable
cellular or biochemical alteration within an organism that, depending on magnitude, can be

recognized as an established or potential health impairment of disease. They range from markers
measuring slight structural or functional changes to markers that are indicators of a subclinical
stage of a disease or the manifestation of the disease itself. Functional changes in cells of the
immune system by an immunotoxic chemical may be the first step in the process towards disease.
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The best studies (but still imperfect) frequently correlate a biomarker of effect with a biomarker of
exposure.

Testing schemes for evaluation of individuals exposed to immunotoxicants are proposed by
the Subcommittee on Immunotoxicology of the US National Research Council (NRC) (Vos and

van Loveren, 1995) and by a task group of the World Health Organization (WHO) (van Loveren et
al., 1995). Table (5) is the panel proposed by the WHO and is composed of assays that cover all

major aspects of the immune system. The humoral and the cellular limbs of the immune response

have been the subjects of major studies. Humoral immunity can be assessed by measuring total
IgG, IgM, and IgA serum concentrations; specific serum antibodies to defined antigens (e.g.,

tetanus toxoid or influenza vaccine); and lymphocyte proliferation induced by B-cell mitogens
(e.g., LPS) in vitro or ex vivo. Cellular immunity can be assessed by measuring skin reactivity to
recall antigens (e.g., tuberculin, Candida, mumps, trichophyton, tetanus, or diphtheria toxoid), and

lymphocyte proliferation induced by T-cell mitogens (mainly PHA and Con A) or mixed

lymphocyte culture, in vitro or ex vivo. It should be mentioned that these tests were all developed

for diagnostic purposes, but that in the context of immunotoxicity testing in man they are to be used
in an epidemiological setting. This means that effects found in parameters between exposed group
and control group may have a different biological significance than an altered value in an individual
person. Whereas a decrease in a single immune parameter in an individual person may not be

indicative of increased susceptibility for disease, a subtle alteration in an immune biomarker in a
population may indicate immunotoxicity. For example, many pharmaceutical products such as

most psychotropic drugs and antimicrobials can induce slight to moderate immune changes without

clearly established health consequences, but the same extent of change in a population exposed to a
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xenobiotic over ‘normal’ population may be statistically and biologically significant and can be
regarded as evidence of immunotoxicity.

Table 5. Assays recommended for immunotoxicity assessment in man (van Loveren et al.,
1995)
(1) Complete blood count with differential
(2) Antibody-mediated immunity (one or more of following):
* Primary antibody response to protein antigen (e.g., epitope-labelled influenza vaccine)
* Immunoglobulin concentrations in serum (IgM, IgG, IgA, IgE)
* Secondary antibody response to protein antigen (diphtheria, tetanus or polio)
* Natural immunity to blood group antigens (e.g., anti-A, anti-B)
(3) Phenotypic analysis of lymphocytes by flow cytometry:
* Surface analysis of CD3, CD4, CDS, CD20
(4) Cellular immunity:
* DTH skin testing
* Primary DTH reaction to protein (KLH)
* Proliferation to recall antigens
(5) Autoantibodies and inflammation:
* C-reactive protein
* Autoantibody titers to nuclei (ANA), DNA, motochondria and IgG (rheumatoid factor)
* IgE or allergens
(6) Measure of non-specific immunity:
* NK cell enumerations (CDS6 or CD60) or cytolysis activity against K562
* Phagocytosis (NBT or chemiluminesce)
(7) Clinical chemistry screen
Proposal for all persons exposed to immunotoxicants

C.

Bridging the gap between animal and humans
In experimental animals assessment of immunotoxicity is relatively easy, but it is difficult

to directly extrapolate immunotoxic data from animals to humans. However, it should be noted
that experimental studies in animals and studies in man are complimentary. Comparison of similar

parameters in animal and humans, including dose, toxicokinetics, functional effects on immune
parameters, will provide insight in similarities and differences in sensitivity and mechanisms in

animals and humans, and may help to extrapolate data from animals to humans that are not easily
obtained in humans (e.g. resistance to infections).
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The similarities between the genetics,

biochemistry, and physiology of rats, mice, and other experimental animals compared to humans
are much more significant than the differences (Fan et al., 1995).
The US Environmental Protection Agency (EPA) (Fan et al., 1995) and the California EPA

Office of Environmental Health Hazard Assessment have estimated effective doses across species

on the basis of the ratio of the two species' body weights to the 2/3 power, i.e.
Dosehuman = Dose^ x (BWlluinan/BWrat)M
The US Food and Drug Administration (FDA) has extrapolated across species directly by body
weight, a process equivalent to using a body-weight ratio exponent of 1 rather than 2/3 in the above

equation. Using the higher exponent yields a higher estimated toxic dose. The true ratio of
comparable doses across species varies fairly widely for different chemicals and effects (Watanabe
et al.,

1992). More accurate cross-species extrapolations can often be produced using

physiologically based pharmacokinetics (PBPK),

although this is a costly and more time

consuming approach.

III.

In vitro Studies
In vitro testing is a promising tool for better extrapolation of animal data (Luster et al.,

1993). Sources for human material that are immunologically relevant, and that are accessible to

study (in varying degrees) are: blood; umbilical vein blood/endothelial cells; bone marrow;
bronchoalveolar lavage; nasal lavage; skin biopsies; donor organs; and cell lines. Most of such cell

populations can also be derived from animals. Cell lines that are available include: macrophages, T
cells (Thl and Th2), B cells, granulocytes, kératinocytes, and thymus epithelial cells. For the cells
from these sources many tests are available. Testing of these cells provides parameters such as
viability, phagocytosis, respiratory burst, calcium influx, cytotoxicity, antigen presentation,
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antibody production, cytokine production, proliferation, apoptosis,

expression of cell surface

markers, etc. (Vos and van Loveren, 1995).
However, it must be noted that in in vitro systems the complexity of the immune system as

it exists in vivo is not present. This pertains to interactions between different cell types. For

example, while in vivo exposure led to a severely decreased proliferative activity of lymphocytes,
the in vitro exposure model may not have such effects. Besides different cell types that may be

involved in immune responses and different effects of chemicals on each of them, metabolism of
the test compound is also a complexity that does not occur in vitro. Co-culture of different relevant

cell types, or addition of metabolizing systems to the in vitro culture may, to a certain extent,
overcome these problems. Yet, it is clear that such in vitro systems do not approach the complexity
of the in vivo situation. The strength of in vitro immunotoxicity testing, therefore, lies, in studies

aimed at prescreening for immunotoxicity of compounds and unraveling mechanisms of

immunotoxicity.

PROPANIL IMMUNOTOXICITY
I.

Overview
Previous work in our laboratory has demonstrated that propanil causes changes of lymphoid

organs, immunopathology, inhibits humoral- and cell-mediated immunity, and compromises

nonspecific immunity in animal models (Barnett and Gandy, 1989; Barnett et al., 1992). Those are
main parameters of Tier I and Tier II procedures according to the US National Toxicology

Program.
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II.
A.

Immunotoxic Properties of Propanil

Lymphoid organs
Lymphoid organs can be classified into primary and secondary organs. This division is

based on the direct role that antigens play in processes occurring in the organs. The thymus and

bone marrow are primary lymphoid organs, as cell proliferation and differentiation, in a non
antigen-derived fashion, occurs within them. All blood cells, including erythrocytes, lymphocytes,

monocytes/macrophages, granulocytes, megakaryocytes, and platelets originate in the bone
marrow.

For lymphoid cells,

hemopoietic stem cells differentiate within the bone marrow

microenvironment into the lymphoid progenitor cells. These cells further differentiate within the
bone marrow into immunocompetent lymphocytes, which subsequently home to secondary

lymphoid organs, such as spleen and lymph nodes, where they encounter antigens and initiate
antigen-specific reactions. For one lineage of lymphocytes, this differentiation requires passage

through another primary organ, the thymus.

This lineage yields T-lymphocytes that primarily

function in initiating immune reactions towards antigens, as well as modulating subsequent

functions of other cells involved in the reaction. Since rapid cell turnover occurs in bone marrow
and thymus, the disappearance of lymphoid cells from bone marrow, and a decrease in thymus

weight is a first indicator of toxic action of xenobiotics on the immune system, though the exact

mechanism may vary from chemical to chemical.
A striking manifestation of propanil treatment in the mammalian system is splenomegaly

(Barnett and Gandy, 1989; Barnett et al., 1992; Ambrose et al., 1972), with concomitant
leukocytosis, and thymic atrophy (Barnett and Gandy, 1989; Barnett et al, 1992). In mice at 7 days
following single ip exposure, the spleen of propanil-treated animals showed obvious enlargement.
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The spleen-to-body weight (S:B) ratio of mice treated with 200 and 400 mg/kg dose of propanil is

136% and 227% of control respectively. This increase in spleen weight was accompanied by an
increase in cellularity. The number of spleen cells in animals treated with 200 mg/kg increased to
145% of control and in mice treated with 400 mg/kg, to 192% of control.

The percentage of

leukocytes and erythrocytes did not change between the control and treated groups, indicating a
generalized increase in hematopoiesis, perhaps extramedullary (Barnett and Gandy, 1989). In

contrast, thymuses undergo dramatic atrophy after propanil treatment. Propanil caused a decrease
of both thymus weight and cellularity starting at dose 150 mg/kg and shows a dose-dependent
pattern (Barnett and Gandy, 1989).

The thymus-to-body weight (T:B) ratio for 400 mg/kg

propanil-treated animals is 43% of control and that for 200 mg/kg propanil-treated animals was

65% of control (Barnett and Gandy, 1989; Barnett et al., 1992). Ambrose et al. (Ambrose et al.,
1972) also report the spleen weight increases in rats after subchronic and chronic oral exposure to
propanil. In the 3 month subchronic study, the S:B ratio of rats treated with 1000, 3300, and 10000
ppm on diet was 123%, 189%, and 246% of control, respectively. In their 2 year chronic study,

increases in S:B weight ratio for spleens were noted in rats on the 1600 ppm diet. These data
indicate that primary and secondary lymphoid organs are affected by propanil.

B.

Bone marrow hematopoiesis
Although propanil does not cause a change in bone marrow cell numbers, Bly 1er et al.

(Blyler et al., 1994) reported the effect of propanil on several stem and progenitor cell types in mice

at 7 days after acute propanil exposure. The results demonstrate that at doses of 50-200 mg/kg

body weight, propanil caused a reduction in the number of myeloid stem cells and early myeloid
and erythroid progenitor cells. However, the numbers of more differentiated myeloid and erythoid
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progenitor cells show no change upon propanil exposure. Their data suggests that propanil is
myelotoxic to early hemapoietic stem cells.

C.

Humoral and cell-mediated immunity
Humoral immunity can be assessed by measuring antibody responses.

Barnett et al.

(Barnett and Gandy, 1989; Barnett et al., 1992) reported the inhibitory effect of propanil on

antibody production.

In their study, the T cell-dependent humoral immune response was

determined by enumeration the number of anti-SRBC (sheep red blood cells) hemolytic plaque

forming cells (PFC) in the spleen. Animals treated with 50, 100, 200, and 400 mg/kg propanil

show an apparent dose-related reduction in the number of PFC (Barnett and Gandy, 1989). The

response to SRBCs requires the cooperation of a number of cell populations, including B cells, T
helper cells, and macrophages. Macrophages are required for antigen processing as well as for
production of interleukin 1. T cells aid in antigen recognition via surface membrane proteins, as
well as in B-cell maturation via the production of mediators required for cell proliferation and

differentiation.

T cells are also involved in regulation of the isotype switch.

Any T cell

abnormality could hamper the antibody response to specific antigen. T cell-independent humoral
responses were determined by assaying the antibody response to DNP-Ficoll. Propanil, at 200

mg/kg, reduces the number of PFC to approximately 75% of control (Barnett et al., 1992).
The cell-mediated immunity is often assessed by measuring lymphoproliferative response

to T cell-specific mitogen, such as ConA,

the mixed leukocyte response (MLR),

delayed

hypersensitivity response (DHR), or generation of cytotoxic T cells (CTL). In acquiring a cellmediated immune response, sensitized T cells undergo blastogenesis and proliferation in response
to specific antigens. T cells also undergo blastogenesis and proliferation in response to polyclonal
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activators, such as the plant lectin ConA. Thus, the ConA-induced blastogenesis response provides
an indication of the proliferation capacity of these cells. Splenocytes from animals treated with 400
mg/kg propanil had a significantly lower ConA response than control, indicating a compromised

ability of T cells to proliferate upon stimulation. Propanil, at 400 mg/kg dose, showed a significant
suppression of MLR. The lymphoproliferative response of spleen cells to allogeneic spleen cells,

i.e., the MLR, has provided a sensitive indicator of chemical-induced immunosuppression on the

CMI system. Clinically, the MLR measures the same response involved in graft versus host graft
reactions and graft rejection, and has been shown to be predictive of host response to

transplantation and of general immunocompetence (Harmon et al., 1982). The CHR represents an

in vivo assessment of the sequential steps necessary to a cell-mediated immune response. This

includes antigen recognition and processing, blastogenesis and proliferation, migration of memory
T cells to the site of inflammation, and production and release of inflammatory mediators and
lymphokines, culminating in an inflammatory response. Propanil diminishes the CHR the dose of
400 mg/kg. The P815 CTL assay evaluates the ability of T effector cells to lyse syngeneic or

allogeneic tumor cells. Propanil did not cause a significant change in the level of CTL activity
when compared to controls at doses from 50-200 mg/kg (Barnett et al., 1992).

D.

Non-specific immunity
NK cell activity and macrophage function are parameters of nonspecific immunity in Tier 1

and Tier 2, respectively.

NK cells possess innate cytotoxicity against a variety of neoplasms,

inhibiting both growth and metastatic dissemination of tumor cells in addition to various infectious

agents. NK cell activity is quantitated from spleens of individual mice using an in vitro 51Cr release

assay in which YAC-1 tumor cells are used as the target cell (Reynolds and Herberman, 1981).
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Spleen cells from propanil treated animals showed a dose dependent, decreased NK cell activity

(Barnett et al., 1992). Theus et al. (1993) also demonstrate increased macrophage cytotoxicity in
propanil treated animals that appears to be due to an alteration of the ability of the macrophage to
produce interferon, and tumor necrosis factor-a (TNF-a).

Thus, it is apparent that propanil has differential effects on specific immune cell types.
Propanil causes significant alterations in some functional immune assays, such as the T-dependent
and T-independent antibody response, whereas other functions, such as the MLR and CHR were

relatively refractory to its effect. Cytotoxic T-cell function is not affected by propanil; however,

NK cell function is significantly depressed.

III.

Propanil Affects Multiple Target Cell Types
The apparent sensitivity of the immune system to xenobiotics is due as much to the general

properties of a chemical (e.g., toxicity, reactivity with macromolecules), as to the complex nature of
the immune system. Chemical immunosuppresants, like immunotherapeutic agents, may

demonstrate high specificity (i.e., targeting a subpopulation of lymphocytes by interacting with
specific proteins), intermediate specificity (i.e., altering specific biochemical or cellular events that
are shared by several cell types), or little specificity (i.e., general anti-proliferative or cytolytic
activity). The xenobiotics that target specific lymphoid organs or cell subpopulations are listed in
Table 6.

The components of the immune system that generally appear as primary targets of

xenobiotics include: the thymus; rapid proliferating cells that include hematopoietic stem cells and

antigen-stimulated B lymphocytes; and regulatory cells, particularly monocytes and T helper cells.

As detailed in last section, propanil causes significant alterations in some functional immune
assays, such as the T-dependent and T-independent antibody responses, whereas other functions,
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such as the MLR and CHR were relatively refractory to its effects. Differential effects of propanil
on specific immune cell types are also apparent.

Cytotoxic T-cell function is not affected by

propanil; however, NK cell function is significantly depressed. This multiple effects on immune

functions makes it difficult to construct the actual sequence of events or determine the specific
cellular chemical interactions.

Table 6. Putative site of action for selected immunotoxic xenobiotics

Site of action (ref)

Xenobiotic
Halogenated aromatic hydrocarbon

Polycyclic aromatic hydrocarbons
Dimethylbezanthracene
Benzo(a)pyrene

Benzene
Mycotoxins
0,0,5-Trimethylphosphorothioate
Dimethylnitrosamine
Organometals

Thymic epithelium (Greenlee et al., 1985)
B cell differentiation (Luster et al., 1988)
T cell regulation (Kerkvliet and Brauner, 1987)
T-helper cells (House et al., 1987)
Macrophage function (Myers et al., 1987)/
proliferation (Kawabata and White, Jr. 1987)
Microtuble assembly (Luster et al., 1990)
Protein synthesis (Luster et al., 1987)
Macrophage function (Rodgers et al., 1985)
B cell function (Johnson et al., 1986)
Cellular depletion (Miller et al., 1984;
Seinen et al,1979)/inhibition of
glucose metabolism (Penninks et al., 1983)

There are very few compounds for which the exact molecular target and mechanism of

action are known (O'Keefe et al., 1992). For many compounds there are probably multiple targets
and mechanisms of action (Cupps and Fauci, 1982; Holsapple et al., 1991; Luster et al., 1992). The
halogenated aromatic hydrocarbons (HAHs), particularly dibenzo-p-dioxins (e.g., 2,3,7,8tetrachlorodibenzo-p-dioxin; TCDD) and polychlorinated biphenyls (PCBs) have been the most

extensively studied classes of environmental pollutants from an immunologic standpoint. In mice,
the prototypical HAH, TCDD, causes thymic atrophy, myelotoxicity, as we see in propanil treated

animals. The other similarity between propanil and TCDD is that humoral immunity is evidently
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depressed while cell mediated immunity is less affected (Holsapple et al., 1991; Kerkvliet and
Brauner, 1987). However, in the case of TCDD, NK cell activity and macrophage functions appear

to be spared (Luster et al., 1987; Luster et al., 1990), whereas propanil causes inhibition of NK cell
activity and an increase of macrophage cytotoxicity (Barnett et al., 1992; Theus et al., 1993).

TCDD also showed the inhibition of complement system components, suppression of lymphocyte

function, and increased susceptibility to challenge with infectious agents or transplantable tumor
cell. Myelotoxicity, thymic atrophy, and immunosuppression by TCDD appear to be associated

with stereospecific binding to the arylhydrocarbon (Ah) receptor present in lymphoid tissue and

lymphoid cells (Luster et al., 1985; Silkworth et al., 1984). This association has been shown in

genetic studies using Ah-responsive and -nonresponsive mouse strains, including mouse stains
congenic at the Ah locus, where the immunotoxic effects of TCDD segregate with the Ah genotype.

This association has also been supported in structure-activity studies where the binding affinity of
various HAH to the Ah receptor consistently correlated with its potency to induce
immunosuppression. Furthermore, Ah receptors have been found in bone-marrow cells (Luster et

al., 1985), lymphocytes (Luster et al., 1987), and thymic epithelial cells (Greenlee et al., 1985),

which all are target tissues for HAH immunotoxicity.

Until recently a putative propanil binding membrane or cytosolic receptors which mediate

propanil caused immunosuppressive effects had not been identified. One such candidate, however,
is the IP3 receptor, as Xie et al (unpublished data) found a lack of [Ca2+] release and in increase in

IP3 in propanil-treated macrophage upon LPS stimulation.

Computer molecular modeling

(Alchemy™, Tripos, St. Louis, MO) showed that the 3-D structure of propanil and IP3 is similar
enough that it is possible that propanil may bind to the IP3 receptor as an antagonist. IP3 receptor is
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involved in multi-levels of cellular events and the hampered function of it may help to explain the

multiple effects of propanil on the immune system.

Cytokines, a group of glycoproteins, acting as cell-cell communicator, play a pivotal role in

both humoral and cell-mediated immune response. Studies on BaP and DMBA indicate that their
immunotoxicity may be mediated through the secretion of IL-2 and expression of IL-2 receptor

(Lyte et al., 1987; House et al., 1987). Further investigation reveal that the impaired CTL and
antibody production can be reconstituted by the addition of exogenous IL-2.

Therefore,

the

inhibition of cytokine production seems to be one of the mechanisms xenobiotic affecting the
immune system.
In summary, it appears that propanil targets multiple cell types, such as T cells, B cells,

Macrophages, and NK cells, the exact subcellular effect site and the mechanisms behind it is still
not clear.
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OBJECTIVES

The overall objective was to examine the effect of propanil on T cell distribution in major

lymphoid organs and on T cell cytokine production. We investigated the propanil-induced thymic
atrophy and its possible mechanism. We also studied the production of IL-2, IL-6, IFN-y, and
GM-CSF by spleen cells exposed either in vivo or in vitro to propanil. Finally we studied the

molecular mechanism of propanil caused inhibition of IL-2 gene expression in T cell line, EL-4
model.

Study I.
Acute exposure to the herbicide propanil is immunotoxic for selected immune functions, as
well as causing changes in the weights of the thymus and spleen. Although spleen cellularity and

weight increase with propanil exposure, the thymus : body weight ration decreases with increasing
doses of propanil. In this study, we have further analyzed the T cell subpopulations in the thymus,

spleen, and mesenteric lymph nodes in C57B1/6 mice at 7 days post 0, 100, 150, or 200 mg/kg
treatment using flow cytometry technique.

Study IL
The aim of this study was to further identify the particular thymocyte subpopulations that
are particularly susceptible to propanil and explore the mechanism of propanil induced thymic
atrophy and the recovery process of this atrophy. Accordingly, we have examined the kinetics of

the thymic atrophy, tested the hypothesis that glucocorticoids play a role in the observed atrophy by

64

examining thymuses in adrenalectomized, propanil-treated mice. We also used cell cycle analysis

of individual thymocytes subpopulations to assess the effect of propanil on thymocyte proliferation.
We also examined the effects of culturing thymocytes with propanil on cell survival.

Study III.
Although the spleens of propanil-treated mice showed a increase in size and cellularity,

functional studies showed a decreased mitogen response, depressed antibody production and mixed

lymphocyte response. Therefore, the purpose of this study was to test the hypothesis that the affect
of propanil on T cell function is, at least in part, through the inhibition of cytokine production by

using both in vivo and in vitro models.

Study IV.
Having demonstrated the inhibitory effect of propanil on spleen cell IL-2, IL-6, IFN-

gamma, and GM-CSF production both in vivo and in vitro, we,

investigated the molecular

mechanism of this inhibition by using EL-4 cell as our model system. We examined the effect of
propanil on IL-2 gene expression at mRNA levels, transcriptional levels, and post-transcriptional
levels.
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CHANGES IN PRIMARY AND SECONDARY LYMPHOID ORGAN
T-CELL SUBPOPULATIONS RESULTING FROM ACUTE IN VIVO

EXPOSURE TO PROPANIL

(Zhao W., Schafer R„ Cuff C. F., Gandy J. and Barnett J. B. (1995) J Toxicol. Environ. Health
46, 171-181.)

66

ABSTRACT
Acute exposure to the herbicide propanil is immunotoxic for selected immune functions,

as well as causing changes in the weights of the thymus and spleen. Although spleen cellularity
and weight increase with propanil exposure, the thymus : body weight ratio decreases with

increasing doses of propanil. The present study analyzes the thymocyte subpopulations in the
thymus, spleen, and mesenteric lymph nodes. C57B1/6 mice were treated with either 0, 100, 150,
or 200 mg/kg propanil, and 7 d later thymocyte populations were analyzed by flow cytometry. In
the thymus, propanil exposure resulted in a dose-dependent decrease in total numbers of T cells,

as would be expected with its reduced weight. Determination of the thymocyte subpopulation

distribution in the thymus showed a significant reduction in the number of CD3+CD4+CD8"
(CD3V8-), CD3+CD4’CD8+ (CD3+4'8+), and CD3+CD4+CD8+ (CD3+4+8+) cells. Percent

distribution of these thymic cell subpopulations showed similar decreases only with the highest
dose. Apparent dose-related decreases in the numbers of CD3‘CD4+CD8+ (CD3"4+8+) cells were
also noted and were attributed to the general decrease in total thymus cells. The percentage of
CD3‘ subpopulations showed an increasing trend with dose, which suggests that at 7 d

postpropanil exposure there may be a specific effect on this most immature population, Although
the size and cellularity of the spleen were increased, no change in CD4+ or CD8+ cell distribution
was observed. Similarly, mesenteric lymph nodes showed no changes in the cell subpopulation

distribution between propanil-treated and control animals.
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INTRODUCTION
Propanil (3,4-dichloro-propionaniline), a postemergent herbicide used extensively on rice

and wheat crops in the United States, caused significant decreases in both T-dependent and T

independent antibody responses (Barnett and Gandy, 1989; Barnett et al., 1992). Although
cellular immune functions measured by the mixed lymphocyte response (MLR), contact

hypersensitivity responses, and cytotoxic T-cell function were relatively unaffected, natural killer

cell function was significantly depressed (Barnett and Gandy, 1989; Barnett et al., 1992),
suggesting differential effects of propanil on specific immune cell types. In addition, we have
previously shown alterations in macrophage function following propanil exposure, which may be

due to modified interferon and tumor necrosis factor (TNF-a) production (Theus et al., 1993).

Therefore, the observed toxic effects on specific immune functions may be due to alterations in
either cytokine expression by immune regulatory cells, or responses to appropriate cytokine

stimulation.

Propanil also causes a substantial loss in capacity of myeloid bone marrow stem cells and
causes early myeloid and erythroid progenitor cells to respond to exogenous growth factors

(Blyler et al., 1994). There was no reduction in the numbers of more differentiated myeloid and
erythroid progenitor cells, even at the highest dose used, 200 mg/kg. This suggests either that

propanil myelotoxicity due to an effect on early hematopoietic stem cells may be compensated

by increased proliferation of more differentiated progenitor cells, or that extramedullary

hematopoiesis (for example, in the spleen) maintains blood cell production in treated animals.
The splenomegaly and increase in total splenic cellularity following acute exposure of
mice to propanil at doses of > 200 mg/kg was at least partially due to a dramatic increase in
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absolute numbers of splenic progenitor cells for myeloid and erythroid cell lineages (Barnett and

Gandy, 1989). This suggests that failure of bone marrow hematopoietic cell function following
propanil treatment may be, in part, compensated by increased extramedullary expansion of

hematopoiesis. However, these studies did not address the possibility that splenomegaly in these
mice included displaced hemopoietic cells.
Acute exposure to propanil also results in significant thymic atrophy (Barnett and Gandy,

1989). Since the thymus is the primary source of T cells that populate secondary lymphoid
tissues, we decided to perform a thorough assessment of the T-cell subtypes in the spleen and

mesenteric lymph nodes (MLN) as representative secondary lymphoid tissues. Interestingly, only
the thymus showed significant changes in the numbers and distribution of the various thymocyte

subtypes following propanil exposure. Therefore, a more detailed analysis of the subpopulations

for this organ was performed.
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MATERIALS AND METHODS
Animals. C57BI/6 mice weighing 18-20 g were purchased from Charles River Farms
(Willmington, Mass). All animals were allowed to acclimate to our vivarium facilities at least 7 d
prior to their inclusion in an experiment and were provided food and water ad libitum. Animals

were exposed to 12-h light and dark cycles and were maintained at temperatures ranging form 25
to 28°C.

Exposure of Mice to Propanil.

Six- to 8-wk-old female C57B1/6 mice were treated ip with 0,

100, 150, or 200 mg of propanil/kg body weight, dissolved in com oil (Mazola brand) on d 0,

and thymus cells were harvested from these animals on d 7. The propanil was purchased from
ChemService Chemicals (>97% purity) (West Chester, Pa). A maximum propanil dose of 200
mg/kg was chosen because in addition to neurotoxicity resulting in temporary unconsciousness,

this concentration caused overt immunotoxicity in previous studies (Barnett and Gandy, 1989;

Barnett et al., 1992; Blyleretal., 1994).

Cell Counts and Flow Cytometry. Thymus tissue was removed, teased apart with forceps, and a
single-cell suspension was made by expressing the cell suspension through a succession of 18-,

20, and then 23-gauge needles attached to a 5-ml syringe. The cell suspension was washed twice
with RPMI 1640 and then counted using standard hemocytometer methods, which included

trypan blue to assess viability. Staining was carried out in 96-well V-bottom plates by placing a
suspension of 106 cells in each well. The cells were then washed once with 200 pl FACS

medium (phosphate-buffered saline supplemented with 2% fetal calf serum and 0.02% NaN3).
Thymic cells were triple stained in two successive steps. In the first step the cells were

resuspended in appropriate dilutions of biotinylated anti-CD4 (GK1.5) and fluorescein
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isothiocynate

(FITC) conjugated anti-CD3 (145.2C11). These reagents were prepared from

hybridoma supernatants using standard methods (Cokigan et al. 1994). The cells were incubated

in the dark for 30 min on ice and then washed twice with FACS medium. In the second step the
cells were suspended in phycoerythrin (PE) conjugated anti-CD8 plus Third Color (TC) avidin
(Cal-Tag, San Francisco). After a 30-min incubation in the dark on ice, the cells were washed

twice in FACS medium and fixed by suspending the cells in 0.4% paraformaldehyde in
phosphate-buffered saline (PBS). Flow cytometric analysis was performed the following day.
Flow cytometric data were collected with a Becton-Dichinson FACScan running FACScan
Research Software (version B; Becton-Dichinson Immunocytometry Systems, San Jose, Calif.),

and analysis was earned out using PC-LYSIS (vl.O) software (Becton-Dichinson). Live

lymphocytes were analyzed based on forward versus 90° scatter set to exclude dead cells and
contaminating red blood cells, which are smaller than live lymphocytes.

Single-cell suspensions of mesenteric lymph nodes were prepared as described earlier for

thymic tissue, Single-cell suspensions of spleen cells were obtained by expressing the cells into
medium through a nylon mesh bag (Tetko, Inc., Biarcliff Manor, N.Y.). Cell clumps were further
dispersed by repeated passes through a 23-gauge needle. Double staining of both mesenteric
lymph node and spleen cells was performed in a single step with the addition of either FITC-antiCD3 plus PE-anti-CD4 or FITC-anti-CD3 plus PE-anti-CD8 to 106 cells. After a 30-min

incubation in the dark, the cells were washed twice in FACS medium and fixed in 0.4%
paraformaldehyde in PBS. Analysis was performed as described earlier. The absolute numbers of

cells in each lymphocyte subpopulation were calculated by multiplying the total number of
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viable cells recovered by the percentage of the total within each phenotype as determined by flow
cytometric analysis.

Statistics. In all cases, the data comparing the effect of various doses were initially checked for
homogeneity of variance using Bartlett’s test, followed by a one-way analysis of variance; then
those groups that were significantly different from each other were determined using the StudentNewman-Keuls multiple comparison (p < .05) as available using SigmaStat (Jandel Scientific,

San Rafael, Calif.) statistical software. The results from a representative experiment are shown;

however, flow cytometry was run with a minimum of three mice per dose and has been repeated
with similar results. All error bars and error values are the standard deviations.
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RESULTS
Thymus Cellularity
Total thymus cellularity was determined prior to flow cytometric analysis. The results of

these assays are shown in Figure 1. Control animals had an average of 15.07 (±1.86) x 107 cells per

thymus, while animals treated with 100, 150, or 200 mg/kg had average thymus cell counts of
11.39 (±2.48) x 107, 8.09 (±1.02) x 107, and 5.16 (±0.36) x 107, respectively. All values for the
treated animals were significantly different from the control animals.

Thymus Subpopulation Numbers
The number of cells in each of the thymus subpopulations was determined to ascertain

which thymocyte subpopulations were affected by the propanil administration. The numbers and
percentages were determined by flow cytometric analysis of triple-stained thymocytes. The number

of each CD3 subpopulation of thymocytes is shown in the upper panel of Figure 2. In the least

differentiated population measured (CD3 4 8' triple negative), control thymuses contained 6.89
(±0.88) x 106 cells and propanil-treated animals had significantly fewer cells, with values of 5.14
(±1.18), 3.83 (±0.28), and 2.68 (±0.19) x 106 cells at doses of 100, 150, and 200 mg/kg,

respectively. Although each of these values is significantly different from the control, only the cell
numbers at doses of 100 and 200 mg/kg were significantly different from each other. Within the
CD3’4+8+ cell population measured, control thymuses had 12.05 (±1.68) x 107 while thymuses

from animals treated with 100, 150, or 200 mg/kg propanil had cell numbers of 8.92 (±2.08) x I07,

6.34 (±0.83) x 107, and 4.14 (±0.39) x 107 cells, respectively. All values for treated animals were

significantly different from the control values.
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The number of CD3 4+8+, CD3+4+8 , and CD3+4'8+ cell types at all propanil doses showed
significant reductions over control animals. These data are shown in the lower panel of Figure 2.
Typically, the number of either CD3+4+8+, CD3+4+8", or CD3+4'8+ cells at 100 mg/kg were

approximately 55% of the control numbers, and each subsequent increase in propanil dose caused a
significant reduction over the previous concentration. At the highest concentration (200 mg/kg), the

number of CD3 cells as 15-19% of control. Thus, there appears to be a uniform reduction in the
number of cells in each CD3+ subpopulation.

Thymus Subpopulation Percentages
The percentage of each subpopulation was also calculated, primarily to determine whether
there was a significant increase in any subpopulation(s), which, for example, may be indicative of a

propanil-induced arrest of cell differentiation. The least mature CD3‘4'8" thymocyte subpopulation

measured (Figure 3, upper panel, left group) showed no change at any dose of propanil. CD3‘4+8+
cells (Figure 3, upper panel, right group) showed an increasing trend in percentage with increasing
dose; however, these increases were not statistically significant.

The percent distribution of each of the more mature CD3+ thymic thymocyte

subpopulations, that is, CD3 4 8 , CD3 4 8, and CD3+4‘8+ cells, was also calculated (Figure 3,
lower panel). In contrast to the CD3 populations, all CD3+ subpopulations showed a reduction in
percentage with increasing propanil dose. Although in this particular experiment, the percentages of

CD3+4’8+ cells at 100 and 150 mg/kg were not significantly different from the control, in repeats of

this experiment these doses did show significant reductions.

74

Spleen and Mesenteric Lymph Node Thymocyte Subpopulation Percentages
We also determined the number of CD4+ and CD8+ thymocyte subpopulations in the spleen
as well as mesenteric lymph nodes because of our previous results, which showed a significant

increase in spleen weight and cellularity (Barnett and Gandy, 1989). The less rigorous double

staining methods were used for these analyses because few, if any, peripheral T cells are immature
CD4+8+ cells. The result of these analysis are shown in Figure 4. No significant change in the

number of either CD4 or CD8+ cells was seen in either the spleen or mesenteric lymph nodes.
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DISCUSSION
In the study reported herein, the distribution and numbers of thymocyte subpopulations as
well as total thymocyte numbers were determined to further examine the thymic atrophy previously

reported (Barnett and Gandy, 1989). These studies were focused on the dose range of 100-200

mg/kg because the 100 mg/kg dose was previously determined to be the dose level that did not
cause significant changes in organ : body-weight ratio, while 200 mg/kg caused substantial changes
in this ratio (Barnett and Gandy, 1989). An intermediate dose was included so that it changes were

noted, the dose responsiveness of the effect could be ascertained.
The total number of T cells was reduced in a dose-responsive manner as would be expected

with the reduced thymus weight. Cell number appears to be a more sensitive indicator than gross

thymus : body weight, as the number of T cells in the animals treated with 100 mg/kg was

significantly reduced while our previous studies (Barnett and Gandy, 1989) showed no change in
organ weight.
Because of the decreased total thymocyte numbers, the thymocyte subpopulation
distribution was determined. As seen in Figure 2, the numbers of CD3' and CD3+ cells of all

subpopulations were decreased at all doses tested. Although the number of CD3+ cells of all
subpopulations showed decreases at all doses, only the percentages for the CD3+4+8" subpopulation
showed statistical significance at all doses. The increase in percentage of CD3"4+8+ cells may be a
mathematical reflection of the decrease in percentage of CD3+ cells and not an indication of

arrested development. Even though the spleen shows a significant splenomegaly (Barnett and
Gandy, 1989), no changes in the CD4+ or CD8+ cell distribution in the spleen were noted at any

dose. Similarly, the MLN CD4+ and CD8+ cell distribution was not affected by any dose of
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propanil. Thus, not all lymphoid organs were uniformly affected propanil treatment. It is noted,

however, that both organs traditionally classified as primary lymphoid organs, the bone marrow and
the thymus, show significant decreases in cellularity, while the secondary lymphoid organs show

either an increase or no change (Blyler et al., 1994).

The effect of xenobiotics on lymphoid organ cellularity and size has been noted in
numerous immunotoxicological models. Effect on the thymus have been noted frequently, and in

some instances changes in other lymphoid organs were also reported. However, the pattern of the

effects on these organs is not always the same for each of these models. For example, 2,3,7,8,terachlorodibenzo-p-dioxin (TCDD) causes severe thymic cortical atrophy, which appears to be due

to a direct effect on the epithelial cells rather than on the thymocytes (Greenlee et al., 1985; Cook et
al., 1987; De Waal et al., 1993; de Heer et al., 1994; Kremer et al., 1994). Selected organotin

compounds cause lymphocyte depletion associated with thymic and splenic atrophy (Snoeij et al.,

1985; Pieters et al., 1993). Rapamycin induces thymic atrophy resulting in a thinning of the cortex
(Luo et al., 1994). The surfactant copolymer of polyoxyethylene, T150R1, also caused severe

cortical lymphoid loss in the thymus and, in addition, induced a splenomegaly (Houssami et al.,

1990) and thus resembles the pattern we see with propanil exposure.
Focusing on the effects on the thymus, more detailed analysis of the thymocyte
subpopulations found within the thymus also reveled numerous patterns depending on how the

thymic atrophy was induced. For example, di-n-butyltin dichloride (DBTC) treatment resulted in a

transient decrease in the percentage of CD3+4+8+ cells with a concomitant increase in CD3+4+8* and
CD34"4'8+ cells (Pieters et al., 1993). Recovery occurred as a result of an increase number of CD4"

CD8" blasting cells (Pieters et al., 1994). Specific alteration of rhythm of temperature (STRT)
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stress, which also causes thymic atrophy through an effect on the adrenals, produced a pattern of

increased percentage and decreased numbers of CD3’4+8+ or CD3l04+8+ cells and a decrease in both
the percentage and numbers of CD3+4+8+ cells. This is similar to the pattern noted in the propaniltreated animals. In the SART stress model, however, CD3+4+8‘ and CD3+4'8+ cells showed a

compensatory increase in numbers of cells (Hori et al., 1993). In our propanil experiments, all
CD3+cells showed a decrease in both cell numbers and percentages.
Although SART stress is obviously not an immunotoxicant, its comparison with our data is
appropriate because of the neurologic effects of both SART and propanil (Singleton and Murphy,

1973). Thus, it is possible that the propanil-induced thymic atrophy is due to its effect on the
adrenals. In the SART stress model, as well as the T150R1 experiments, adrenalectomy abrogated
the thymic atrophy (Hori et al., 1993; Houssami et al., 1990). Future experiments with propanil

treatment of adrenalectomized mice will address this possibility in our model.

In the progression of thymocytes through the maturation scheme, the least mature cell is the
CD3 4 8 cell (von Boehmer, 1988; Brekelmans and van Ewijk, 1990). The measurable decrease in
the number of these triple negative cells may indicate that insufficient precursors were being

supplied to the thymus. However, there is a tremendous amount of proliferation, as well as
differentiation (Shortman et al., 1990), that occurs as the cells mature into CD3’4+8+ cells. Thus, the
reduced numbers of CD3"4+8+ cells could indicate that propanil is also affecting either the

proliferation of differentiation at this step in the maturation pathway, which may also result in less
of the more mature lineages as a consequence.

The increase in spleen size and cellularity is likely an independent event from the effects of

propanil on the thymus. Propanil has been shown to induce extramedullary hematopoiesis in the
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spleen-perhaps to compensate for the myelotoxic effect of propanil on the bone marrow (Barnett et
al., unpublished data). T150R1 also caused an increase in the splenic cellularity that was not

abrogated by adrenalectomy, leading these investigators to also conclude that the splenomegaly and

thymic atrophy were independently induced events (Houssami et al., 1990).
It is apparent from these results that propanil appears to affect all CD3+ thymocyte

populations equally, perhaps by affecting the maturation and differentiation the least mature triple
negative cells to the CD3"4+8+ cells. Alternatively, this may be due to a reduction in the supply of
precursor cells to the thymus due to propanil's effect on bone marrow stem-cell production (Blyler

et al., 1994).
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Figure 1. Total thymic cellular!ty. C57B1/6 mice were treated with either 0, 100, 150, or 200
mg/kg of propanil (three animals per dose), and 7 d later thymus cells were harvested and the

total number of recoverable cells enumerated as described in the Materials and Methods section.
Error bars represent the standard deviation. Data shown are from a representative experiment and
the experiment was performed two times with similar results. Bars designated with an asterisk
are significantly different from the control values by the Student-Newman-Keuls test (p < .05).
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Figure 2. Thymus cell numbers of each of the subpopulations measured. C57B1/6 mice were
treated with either 0, 100, 150, or 200 mg/kg of propanil (three animals per dose), and 7 d later
thymus cells were harvested and the number of each subpopulation enumerated by flow
cytometry as described in the Materials and Methods section. Legend is presented in Figure 1,

and error bars represent the standard deviation. Data shown are from a representative experiment,
and the experiment was performed two times with similar results. Bars designated with an aterisk
are significantly different from the control values by the Student-Newman-Keuls test (p < .05).
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Figure 3. Thymus cell percentages of each of the subpopulations measured. C57BI/6 mice were
treated with either 0, 100, 150, or 200 mg/kg of propanil (three animals per dose), and 7 d later
thymus cells were harvested and the percentage of each subpopulation determined by flow

cytometry as described in the Materials and Methods section. Legend is presented in Figure 1,

and error bars represent the standard deviation. Data shown are from a representative experiment,

and the experiment was performed two times with similar results. Bars designated with an aterisk
are significantly different from the control values by the Student-Newman-Keuls test (p < .05).
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Figure 4. Mestenteric lymph node and spleen cell numbers of each of the subpopulations
measured. C57B1/6 mice were treated with either 0 or 200 mg/kg of propanil (three animals per

dose), and 7 d later cells were harvested and the percentage of each subpopulation determined by
flow cytometry as described in the Materials and Methods section. Legend is presented in Figure

1, and error bars represent the standard deviation. Data shown are from a representative
experiment, and the experiment was performed two times with similar results.
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ABSTRACT
The herbicide 3,4-dichloro-propionanilide (propanil) has several well-documented
neurotoxic and immunotoxic effects on mice. We report here a detailed characterization of the
effects of propanil exposure on the thymus. We found that at doses of 100-200 mg/kg, propanil

induces significant thymic atrophy between 2 and 7 days post exposure.

This atrophy is

characterized by a decrease in thymus/body ratio, and a decrease in cellularity. Flow cytometric
analyses of thymuses from propanil and vehicle treated mice indicate that the CD4+ CD8+

population of thymocytes, a population of immature cells, is most significantly decreased in

proparul exposed mice.

We performed cell cycle analysis of thymocyte populations using 2

color surface staining and the DNA binding dye 7-aminoactinomycin D to determine whether

thymic atrophy was associated with changes in the percentages of cells in the S, G2, and M

phases of the cell cycle. We found a high percentage of proliferating CD4+CD8+ thymocytes 4
days after exposure.

Thus, recovery of the thymus occurs following increases in thymocyte

proliferation, most notably the immature CD4+ CD8+ thymocytes. We tested the hypothesis that

glucocorticoids play a role in the observed atrophy by examining thymuses in adrenalectomized,
propanil-treated mice. No atrophy was observed in those animals. These results suggest that
propanil has an immunotoxic effect on the thymus that appears to be mediated

endogenous glucocorticoids.
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in part, by

INTRODUCTION
The postemergent herbicide 3,4-dichloro-propionanilide (propanil) is used extensively on
rice and wheat crops.

exposure.

Thus, individuals in agriculture are particularly at risk of high level

Both neurotoxicity and immunotoxicity have been observed in rodent models of

propanil exposure. While propanil exposure at a dose of 800 mg/kg given ip is lethal in mice

(Singleton and Murphy, 1973), doses of 100-400 mg/kg are immunotoxic. Propanil exposure
decreases contact hypersensitivity responses, reduces proliferative responses to T- and B-cell

mitogens, and depresses mixed lymphocyte reactions (Barnett and Gandy, 1989). In addition,
propanil exposure in vivo leads to an inhibition of hematopoiesis by bone marrow cells (Blyler

et al., 1994). Propanil exposure has also been found to induce splenomegaly and thymic atrophy
in a dose-dependent manner in mice at 7 days post exposure (Barnett and Gandy, 1989). Closer
examination of the thymic atrophy at 7 days after exposure indicates that there is a decrease in
the percentage of relatively mature thymocytes that express CD3 (Zhao et al., 1995).

Many compounds have been shown to affect thymic development in rodents.

These

compounds include ethanol (Jerrels et al., 1990; Han et al., 1993), organotins (Pieters et al.,

1992; Pieters et al., 1993), dioxin (Lundberg, 1991; Frazier, Jr. et al., 1994) and polychlorinated

biphenyls (Shimada, 1987), T-2 mycotoxin (Holladay et al., 1993), rapamycin (Luo et al., 1994),
and phenytoin (Hirai and Ichikawa, 1991). In addition, cytokines such as tumor necrosis factor

(TNF) a and TNF p induce thymic atrophy (Hirahara et al., 1994). Some of these agents appear
to interact directly with the thymus and affect either thymocytes or thymic epithelial cells while
other agents appear to have indirect, or poorly defined effects.
thymus by

These agents may affect the

diverse mechanisms such as alterations in bone marrow-derived thymocyte
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precursors (Comment et al, 1992).

Several reports suggest that the thymic atrophy associated

with the toxicity of some of these chemicals is through the common mechanism of adrenal

glucocorticoid-induction which then depletes the thymic cortex of immature cells (reviewed in

Pruett, et al., 1993).
It is well established that glucocorticoids produced by the adrenal glands inhibit or kill

immature thymocytes in vivo (Young et al., 1981). Adrenalectomy has been shown to counter

the thymic atrophy that is observed following the induction of stress associated with specific

alterations of rhythm of temperature stress (Hori et al., 1993).

In addition, a number of studies

have demonstrated that chemical-induced thymic atrophy is associated with increased levels of

glucocorticoids and that adrenalectomy blocks the effects of toxins on the thymus. Hirai and
Ichikawa (1991) showed that phenytoin exposure increased levels of serum glucocorticoids that

were associated with thymic atrophy in mice. Jerrels et. al (1990) reported that adrenalectomy
partially protected rats from ethanol-induced thymic atrophy. This work was extended by Han et
al. (1993) who found that ethanol induced thymic atrophy in mice was associated with increases

in serum corticosterone levels and that ethanol induced atrophy results in preferential decreases
in CD4 CD8+ double positive (DP) thymocytes. Similar effects have been reported by Sei et al.
(1991) in morphine-treated mice.

In this report we investigate the effects of propanil on thymocytes in vivo and in vitro in
an effort to understand the mechanisms of propanil-induced atrophy. We examine the kinetics of
the development of thymic atrophy and identify thymocyte subpopulations that are particularly

susceptible to propanil. We also use cell cycle analysis of individual thymocyte subpopulations
to assess the effect of propanil on thymocyte proliferation.
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In addition, we treated

adrenalectomized mice with propanil and measured serum levels of corticosterone in propanil-

treated mice to determine the role of glucocorticoids in propanil-induced thymic atrophy. We

also examined the effects of culturing thymocytes with propanil on cell survival. These studies

demonstrate a potent acute effect of propanil on the thymus, and suggest that propanil toxicity of
the thymus occurs in part, through the induction of glucocorticoids.
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MATERIALS AND METHODS
Mice. Six-to-eight week old, female, C57B1/6 mice were purchased from Charles River Farms

(Willmington, MA). They were acclimated to our vivarium facilities at least 7 days prior to their

inclusion in experiments and were provided food and water ad libitum. Age matched,
adrenalectomized female C57B1/6 mice were also obtained from Charles River Farms and were
maintained on phosphate buffered saline (PBS) prior to, and during, the experiments. All mice
were housed under conditions of 12 hour light and dark cycles and at room temperatures of 20

23°C.

Propanil exposure. Mice were treated with 0, 100, or 200 mg/kg of propanil by the ip route.
Propanil, purchased from Chern Service, Inc (West Chester, PA,), was dissolved in com oil

(Mazola Brand). Propanil used in these studies was 99% pure according to the manufacturer.

The total volumes injected were 0.1 ml /10 g body weight. Control groups were given equal
amounts of the vehicle com oil. Mice were treated in groups of 3-5 animals in each experiment.

Cell Preparations. Mice were sacrificed by cervical dislocation at 2, 4, and 7 days after propanil
treatment. Thymuses were weighed and single cell suspensions were prepared by teasing the

thymuses apart and passing them sequentially through 18 - 20 - 23 gauge needles attached to 5
ml syringes. Cells were counted with a hemocytometer and viability was assessed by trypan blue

exclusion. Cell preparations were typically >95% viable. The few contaminating red blood cells
observed by this method were not counted.

Flow Cytometry and Cell Cycle Analysis. Thymus cell suspensions were stained for surface
phenotype by a one step method.
independently.

Thymus cells from individual mice were analyzed

For each sample, one million cells were washed in a medium consisting of
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phosphate buffered saline (PBS) supplemented with 0.04% sodium azide and 2% fetal bovine
serum (hereafter referred to as FACS medium).

Cells were stained with phycoerythrin-

conjugated (PE) anti-CD8 (Caltag, San Francisco, CA) and fluorescein isothiocyanateconjugated (FLU) anti-CD4 which was purified and prepared from GK1.5 hybridoma culture

supernatants. Cells were stained in a total volume of 25 pl of antibody for 30 minutes on ice in
the dark, washed twice in FACS medium, and fixed in 0.4% paraformaldehyde (PFA) in PBS.

Cells were typically analyzed the following day. Gating on mononuclear cells was accomplished
using 90° versus forward light scatter. Data collection was performed on a Becton-Dickinson
FACScan.

Collected data were analyzed on a personal computer running PC-LYSYS v 1.0

(Becton Dickinson).

For cell cycle analysis, the method of Schmid et al. (1991) was used essentially as

described.

Five million thymus cells were stained with PE-anti-CD8 and FLU-anti-CD4 as

described above. Cells were resuspended in 1 ml of 0.25% PFA for 1 hour at 4°C. Fixed cells

were washed once in PBS, gently resuspended in 1 ml of 0.2% Tween-20 in PBS, and incubated
at 37°C for 15 minutes.

Following incubation, the samples were washed in 1 ml of FACS

medium and resuspended in 1 ml of PBS containing 12.5 pg/ml of 7-aminoactinomycin-D
(7AAD, Sigma, St. Louis, MO). Cells were incubated at 4°C in the dark for at least 30 minutes

prior to analysis. Data were collected using a FACScan running CELLFit software. Cell cycle
analysis was performed on approximately 10,000 cells from each subpopulation using MODFit
(Verity Software, Topsham, ME).
fitting.

Doublets were excluded from all analyses prior to curve

The coefficient of variation for the G(/G, peak was always under 5% and typically

ranged from 2-4% using these methods.
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Serum corticosterone levels.

Serum corticosterone

levels were

measured using an

125I-radioimmunoassay kit for rats and mice from ICN Biomedicals, Inc. (Costa Mesa, CA).

All mice used for the corticosterone analysis were sacrificed between 10:30 and 11 AM to
control for changes in blood levels due to normal circadian rhythm. Efforts were made to reduce

stress in these animals by minimizing movement and extraneous noise. Animals were sacrificed
by decapitation.

In vitro cultures. Single cell suspensions of thymocytes were cultured in a medium consisting
of RPMI-1640 supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 10"2 M N-(2-

hydroxyethyl)piperazine-N’(2-ethanesulfonic acid) (HEPES) and 10‘5 M beta-mercaptoethanol.
Cells were incubated with 0, 0.01, 0.02, and 0.05 mM propanil in 48 well plates at a density of
107 cells/ml per well. The propanil was dissolved in 95% ethanol and the concentration was

adjusted so that the final ethanol concentration was 0.33%. An equal volume of ethanol was
added to control group wells. The cells were cultured at 37°C in an atmosphere of 5% CO2 for 24
hours. Viable cells were counted by trypan blue exclusion using a hemocytometer.

Statistical evaluation. Data were analyzed by Student’s t-test or analysis of variance (ANOVA)
followed by Dunnett’s test as calculated by SigmaStat statistics software (Jandel Scientific, San

Rafael, CA). Values of p <0.05 were considered statistically significant.
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RESULTS
Time course of thymic atrophy following propanil exposure
Groups of mice were given 200 mg/kg of propanil dissolved in the vehicle, com oil, by

the ip route. This dose had previously been found to cause thymic atrophy 7 days after exposure

(Barnett and Gandy, 1989; Zhao et al., 1995). At 2, 4, and 7 days post exposure, whole body and

thymus weights were determined for 3 mice from the vehicle-treated and propanil-treated groups.
Table 1 shows that thymus weight (compared to total body weight) and cell numbers decline in
propanil-treated mice as compared to vehicle-treated animals as early as 2 days after exposure.

In 3 separate experiments, the most significant decrease was observed either on day 2 or 4 after
treatment. By day 7, we consistently observed an increase in thymus size and cellularity from a

nadir at days 2-4 post exposure. However, atrophy was always statistically significant up to 7

days post exposure. By day 14 post treatment, thymus size and cellularity returned to normal
(data not shown).

Dose effects on thymus size, cellularity, and cell surface phenotype
Two color flow cytometric analyses were performed on thymocytes from mice treated 2,

4, and 7 days previously with vehicle or propanil at doses of 100 mg/kg or 200 mg/kg. Although
the numbers of thymocytes recovered from mice in propanil-treated groups were reduced, dual

staining with anti-CD4 and anti-CD8 antibodies demonstrated changes in phenotypes at only the

higher dose of propanil 4 days after treatment (Figure 1A).

A significant decrease in the

percentage of cells that expressed the double positive (DP) phenotype was most apparent. There

was a concomitant increase in the percentage of cells that expressed the CD4‘CD8" phenotype
(double negative or DN) as well as the CD4+CD8' or CD4‘CD8+
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single positive (SP)

phenotypes.

When the flow cytometry data and the cell counts were used to calculate the

absolute numbers of cells in each population, both the DP population, and the CD4+ SP

populations were significantly reduced in number (Figure IB).

In contrast, there was no

significant difference in the absolute numbers of DN and CD8+ SP populations in the propanil
treated mice (Figure 1B). By 7 days post exposure, the phenotypes of immature lymphocytes in

the thymus returned "to nearly normal in animals given propanil ((Zhao et al., 1995) and data not

shown).

Cell cycle analysis
In addition to thymic atrophy, propanil exposure increased the percentage of cells
undergoing DNA synthesis. Figure 2 shows representative scatter plots and DNA histograms

from 3 individual mice given vehicle or propanil 4 days post treatment. Light scatter dot plots
demonstrate an increase in larger thymocytes in the animals given 200 mg/kg, but not 100 mg/kg
of propanil.

Similarly, DNA content was increased in cells from mice given 200 mg/kg of

propanil.
We assessed the proliferation of various thymocyte sub-populations in treated mice using

combinations of cell surface antibodies and the DNA binding dye 7AAD.

This technique

allowed us to measure the percentage of cells that were in the Go/G,, S and G2/M stages of the

cell cycle in individual thymocyte subpopulations.

Figure 3 shows the results of cell cycle

analyses of individual thymocyte subpopulations 4 days after propanil treatment. Subpopulation

analyses indicate that the DP and CD8 SP populations had the highest increase in the percentage
of cycling cells. The apparent increase in the percentage of DN cells that are in S+G2+M was not
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statistically significant.

By day 7 following propanil exposure, the percentage of cells in

S+G2+M had returned to normal in all subpopulations (data not shown).

Effects of propanil in adrenalectomized mice
It has long been known that corticosteroids selectively deplete immature populations of

thymocytes in vivo (Young et al., 1981, Reichert et al., 1986 ).

To determine whether

corticosteroids produced by the adrenal glands play a role in propanil-induced thymic atrophy,
we exposed adrenalectomized mice to various doses of propanil and assessed thymus size,
cellularity and phenotype. Although normal and sham operated mice tolerate doses of propanil

up to 800 mg/kg, preliminary experiments indicated that doses of 150 and 200 mg/kg killed
adrenalectomized mice. Therefore, we treated groups of adrenalectomized mice with 100 mg/kg
of propanil and assessed the status of their thymuses 4 days later. As shown in Figure 1, doses
of 100 mg/kg of propanil decreased thymic cellularity in normal mice.

In contrast to normal

mice, adrenalectomized mice manifested no signs of propanil induced thymic atrophy when

given propanil at 100 mg/kg. Cell numbers and thymus weights were not significantly different

in vehicle or propanil treated adrenalectomized mice (Figure 4). In addition, the cell surface

phenotypes of lymphocytes from adrenalectomized mice treated with either com oil or propanil
were similar to cells from normal mice (data not shown).

Serum corticosterone levels
To further test the hypothesis that propanil treatment increased glucocorticoid production,

we assessed serum corticosterone levels from treated mice.

Groups of normal mice were treated

24 hours prior to sacrifice with an ip injection of PBS, com oil, or propanil at doses of either 100
mg/kg or 200 mg/kg.

Serum corticosterone levels were assessed by radioimmunoassay using a
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commercially available kit. The data from 2 separate experiments using a total of 6-8 mice per

group are shown in Figure 5. At 1 day post treatment, serum corticosterone levels are
significantly increased in mice given 200 mg/kg propanil compared to PBS-treated, but not com

oil-treated, mice.

No significant difference was found in the serum corticosterone levels from

mice treated with either the 100 mg/kg dose of propanil or the vehicle com oil compared to PBStreated animals.

Effect of propanil on thymocytes in vitro.
We

propanil.

assessed the effects of in vitro culture of thymocytes with varying doses of

Although we had no data on tissue levels of propanil or its metabolites, equal

distribution of a dose of 200/mg/kg propanil in a 20 g mouse, would produce an in vivo
concentration of approximately 0.5 mM. Thymocytes were cultured for 24 hours in the presence
of the vehicle (ethanol) or propanil at concentrations of 0.01, 0.02, or 0.05 mM (Table 2). A
loss of cells was observed in cultures pulsed with 0.05 mM propanil.

The phenotype of the

remaining cells was determined by flow cytometry. Although the absolute number of cells was

decreased in the 0.05 mM propanil-containing cultures, no significant differences were observed
in the percentages of DN, DP, CD4+ SP, or CD8+ SP populations in the propanil-treated cultures
compared to controls.
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DISCUSSION
The goal of this study was to identify mechanisms of the atrophy and recovery of the

thymus following acute propanil exposure.

To this end, we have characterized the thymic

atrophy that occurs following propanil exposure, and performed experiments to assess both direct
and indirect effects of propanil on thymocytes.

Mice treated with propanil undergo an acute

atrophy of the thymus that was measurable 2 days after exposure. This effect peaks 2-4 days
after treatment, followed by a partial recovery of cellularity by 7 days post treatment.

The

kinetics of the observed thymic atrophy and recovery are similar to those reported by others
using environmental chemicals in rodents. Such agents include ethanol (Jerrels et al., 1990; Han

et al., 1993), organotins, (Pieters et al., 1992),

and dexamethasone (Frazier, Jr. et al., 1994;

Hirahara et al., 1994). In addition, mice exposed to the stress associated with specific alterations
of rhythm of temperature for 2-3 days showed similar thymic atrophy and recovery (Hori et al.,
1993).

Because some of the effects of these chemicals are mediated by glucocorticoids, we

developed the hypothesis that propanil mediated its in vivo effects on thymus via endogenous

glucocorticoid production.
Phenotypic analysis of the thymuses from propanil-treated mice demonstrate a decrease

in the percentage of DP thymocytes and a commensurate increase in percentages of DN and SP

cells.

Calculations based on the flow cytometry and cell counts show that a statistically

significant decrease in the absolute number of DP and CD4+SP cells is observed at 4 days after
treatment. In contrast, the decrease in the absolute number of DN cells was not statistically

significant.

Furthermore,

the number of CD8+ SP cells was increased slightly (though not

statistically significant) in propanil treated mice. These data are consistent with the conclusion
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that the DP cells are most affected by propanil treatment. Immature thymocytes are extremely
sensitive to glucocorticoids in vivo (Wyllie, 1980, Wyllie and Morris, 1982), and the immature
DP thymocytes are the most sensitive population (Reichert et al. 1986).

Therefore the

phenotypic analyses are consistent with the hypothesis that glucocorticoids play a role in

propanil-induced thymic atrophy.
Thymocytes differentiate through a pathway from DN -» CD8+ SP-> DP ->
CD4+SP/CD8+ SP (Shortman et al., 1990).

Thus, preferential depletion of the DP cells should

also result in a depletion of more mature cells ‘downstream’ of the DP cells in the differentiation
pathway, resulting in a decrease in the number of mature SP cells.

Previous studies from our

group confirm this conclusion because we found a statistically significant decrease in the

percentage of mature CD3+ thymocytes 7 days post treatment (Zhao et al., 1995).
We carried out experiments to characterize the mechanism of recovery from propanil

toxicity in the thymus. Cell cycle analyses of individual thymocyte subpopulations indicate that
significant increases in the percentage of cells actively synthesizing DNA occur in both the DP

and the CD4' CD8+ populations following propanil exposure.

It is possible that most of the

proliferating CD8+ SP cells are part of the immature CD8+ CD3", heat stable antigen"*" population
that has been identified as an intermediate stage during the transition between DN and DP cells

(Shortman et al., 1990). Alternatively, we have not ruled out the possibility that these cells are
mature CD8+ cells. In addition there is an extremely modest, but statistically significant, increase

in the CD4+ SP cell population. The significance of this observation is not clear because the

percentage of

CD4+ SP cells that are in cycle is extremely low compared to the other

populations examined. It is possible however, that this increase represents a fraction of cells
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transiting between DP to SP. Thus, propanil appears to induce thymic atrophy by preferentially
eliminating the DP cells, and the thymus recovers as a result of an increase in the percentage of

DP cells that are in cycle.

We did not observe a dramatic increase in the percentage of

proliferating DN cells, the population of thymocytes reported to have the highest rate of cycling
cells in normal thymuses (Penit, 1986; Penit and Vasseur, 1988).
We also examined the effect of adrenalectomy on propanil-induced thymic atrophy. This

approach has been used by several investigators to ascertain whether chemical-induced atrophy is
mediated by products of adrenal glands such as glucocorticoids (reviewed in Pruett et al., 1993).

Adrenalectomized mice were more sensitive than normal mice to the lethal effects of propanil.
In normal mice, the lethal dose of propanil is approximately 800 mg/kg (Singleton and Murphy,

1973).

However in adrenalectomized mice, doses of 150-200 mg/kg were lethal (data not

shown). Propanil doses as low as 100 mg/kg induced thymic atrophy in normal mice, but failed

to have an effect on thymus size or cellularity in adrenalectomized mice. Thus, in
adrenalectomized mice, nearly lethal doses of propanil failed to induce thymic atrophy.

Our

results also extend the previously reported findings that adrenalectomized mice are more
sensitive than normal mice to immunotoxic chemicals (Sanders et al., 1991, Han et al., 1993).
To further establish a link between propanil-induced atrophy and endogenous

glucocorticoids, we measured serum corticosterone levels in propanil-treated mice.

Blood

levels of corticosterone were significantly increased in mice exposed to 200 mg/kg of propanil
compared to similarly handled, PBS-treated controls.

The difference in serum corticosterone

levels approached, but did not reach, statistical significance when comparing levels from com oil
-treated mice with propanil-treated mice.

In addition, the serum levels of corticosterone in
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propanil treated mice given 100 mg/kg were not significantly higher than control mice. These

results at first seemed inconsistent with our conclusion that the atrophy was mediated by
glucocorticoids. However, Pruett et al. (1993) have suggested that there is a threshold blood
level of 150 ng/ml, under which the effect of glucocorticoids on thymic atrophy is inconsistent.

Therefore the data are consistent with the conclusion that high doses of propanil at least partially

mediate atrophy through endogenous glucocorticoids because mice given 200 mg/kg of propanil

had blood levels >150 ng/ml, and a preferential loss of DP thymocytes.

Nonetheless, blood

levels were not as high as those reported in mice treated with other immunotoxic chemicals
(Pruett, 1993), and led us to examine the direct effects of propanil by culturing thymocytes with

propanil in vitro.
Results from in vitro culture experiments clearly demonstrate that propanil is toxic to
thymocytes at a dose of 0.05 mM. Although we do not know how propanil and its metabolites

are distributed in tissues, we calculated that a dose of 200 mg/kg of propanil would result in a

concentration of

approximately 0.5 mM assuming equal tissue distribution of the parent

compound. Thus, the highest in vitro dose tested is approximately 10 fold less than theoretically

achievable in vivo concentration. In other experiments, we found that in vitro doses of propanil
greater than 0.10 mM were toxic to mature leukocytes (Zhao et al., in preparation).

Flow

cytometric analysis of cultured thymocytes indicate that this direct effect does not preferentially
kill DP cells, suggesting that the direct effect observed in vitro is not responsible for the thymic

atrophy observed in vivo.

However, it should be noted that dexamethasone preferentially kills

immature cells in vivo, but this effect is not observed in vitro (Triglia and Rothenberg, 1980).

Additionally, we cultured thymocytes with propanil and dexamethasone to determine whether
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propanil and dexamethasone could act synergistically. Our results indicate that at most, there is
an additive effect of propanil with dexamethasone, but no synergistic effect was observed (data

not shown).

We therefore conclude that although propanil is directly toxic to thymocytes in

vitro, this toxicity does not mirror the in vivo effects of propanil on the thymus, and further

suggests that indirect effects such as glucocorticoid production may be significant in vivo.
Understanding in vivo mechanisms of immunotoxic agents can also be complicated by a
lack of knowledge about the toxic effects of active metabolites.

Propanil is hydrolyzed to

propionic acid and 3,4-dichloroaniline by liver acylamidase (Williams and Jacobson, 1966).

Dichloroaniline is further broken down to toxic derivatives in vivo (Chow and Murphy, 1975).
The contribution of these products to the observed thymic atrophy as well as the other

immunotoxic effects of propanil is still largely unknown. It is possible that direct effects of these
metabolites contribute to the thymic atrophy observed in propanil-treated mice, especially in
light of the observation that propanil induces splenomegaly, and not splenic atrophy, in vivo
(Gandy and Barnett, 1989, Zhao et al., 1995).

In summary, propanil induces significant thymic atrophy 2-4 days after exposure. This

atrophy is characterized by a preferential loss of immature DP cells. Recovery is mediated by
increased proliferation of the remaining DP cells as well as CDS* SP cells that might represent
the immature CDS* thymocytes that are transiting from DN to DP. This thymic toxicity appears

to be mediated, in part, by glucocorticoids because propanil does not induce thymic atrophy in
adrenalectomized mice.

However, propanil does not increase serum corticosterone levels

significantly over vehicle-treated mice, although the serum corticosterone levels are higher in
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propanil-treated mice than PBS treated mice.

These results extend our understanding of the

immunotoxicity associated with propanil, and the mechanism of recovery.
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Table 1. Thymus cell numbers and thymus/body weight ratios following

propanil exposure

Parameter
Cell No. (x IO"?)

% T/BWe

Days

Vehicle

PropaniP

2

20.2 (2.0)»

3.8 (0.8)c

4

18.0 (2.7)

5.1 (1.2)c

7

22.8(3.1)

13.3 (1.3)rf

2

0.276 (0.020)

0.137(0.014)^

4

0.263 (0.014)

0.172 (0.020)c

7

0.319(0.022)

0.191 (0.009)c

a Mice were treated with propanil at 200 mg/kg or vehicle on day 0 as described in Methods.
Results shown are from 1 of 3 experiments that yielded similar results.

Values represent the means (SE) of cell counts from 3 individual mice per group.

c p <0.02 as determined by Student’s t-test comparing the vehicle and propanil groups at each

time point.

d p < 0.05

e Values are calculated as thymus weight/body weight x 100%
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Table 2. Effects of in vitro propanil exposure on thymocytes
% Positive6

Treatment13

Cell No.
(x 10‘6)

None

3.7 (0.1)c

DP
69.7 (7.7)

ON
15.3 (6.2)

CD4+
9.9 (0.8)

CD8+
5.0 (0.6)

Eton

4.0 (0.3)

78.6 (0.2)

8.5 (0.1)

9.2 (0.0)

3.7 (0.3)

0.01 mM

3.8 (0.7)

77.7 (0.1)

8.3 (0.4)

10.1 (0.2)

3.8 (0.2)

0.02 mM

2.9 (0.3)

76.3 (0.5)

7.9 (0.7)

11.1 (0.0)

4.7 (0.2)

0.05 mM

1.3

69.7 (3.0)

10.0 (4.2)

12.7 (3.2)

7.4 (2.1)

(0.1)4

aTotal viable thymocytes were counted by trypan blue exclusion 24 hours after culture

with propanil or the vehicle ethanol as described in Materials and Methods.

^Percentages of positive cells were determined by flow cytometry as described in

Materials and Methods.

c All values represent the means (SEM) of duplicate cultures. Data represent results

from 1 of 2 separate experiments.

dp <0.05 compared to ethanol control by ANOVA followed by Dunnett’s test.
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Figure 1. Propanil-induced alterations of thymocyte phenotype and cellularity. Mice (3 per
group) were treated with com oil vehicle (open bars) or propanil at doses of 100 (shaded bars) or

200 (black bars) mg/kg.

Four days later the mice were sacrificed and thymocytes were

harvested, counted, and stained with fluorochrome conjugated anti-CD4 and anti-CD8 antibodies
as described in Methods. Results from flow cytometry are shown in Panel A. The numbers of
cells in each population in Panel B were calculated by the absolute numbers of cells and the flow

cytometry analyses from Panel A. Bars marked with asterisks are significantly different from

controls by ANOVA and Dunnett’s test (p <0.05). The figure shows representative data from 1
of 3 separate experiments.

Percent of Total
-^hOW-^OlO-MOO

Cell Number (x 10 7)

ND

—i
*

%

Cell Number (x 10 "6)
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Vehicle

100 mg/kg

200 mg/kg

25

FSC

DNA Content

Figure 2. Changes in size and cell cycle of thymocytes from propanil treated mice.
Thymocytes from vehicle treated mice or mice given 100 mg/kg or 200 mg/kg propanil 4

days earlier were stained with 7AAD as described in Methods. Shown are representative
dot plots of forward scatter versus side scatter and DNA histograms of thymocytes from

individual mice (from 3 mice per group). The marker in the dot plots are arbitrarily set to

distinguish small cells (lower forward scatter) from larger cells (higher forward scatter).

The value in the right box of each dot plot indicates the percentage of large cells.
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Figure 3. Cell cycle analysis of thymocytes from propanil treated mice. Cells from propaniltreated animals were stained with anti-CD4 and anti-CD8, permeabilized and stained with 7AAD

as described in Methods. The percentage of cells in the S or G2/M stages of the cell cycle which

were analyzed for each subpopulation. Each bar represents the mean (SE) of analyses from

individual mice in each treatment group. Data shown are from 1 representative experiment of 3
separate experiments. Asterisks represent statistically significant differences by ANOVA and
Dunnett’s test (p<0.05).
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30

Propanil-induced

atrophy

does

not

develop

in

w

adrenalectomized

mice.

Adrenalectomized mice were treated with either com oil (open bars) or 100 mg/kg of propanil

(hatched bars).

The number of viable lymphocytes and the percent thymus/body weight were

determined 4 days later. Each bar represents the mean (SE) of measurements from 3 individual

mice per group.
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Figure 5.

Serum corticosterone levels in propanil treated mice. Mice were injected i.p. with

equal volumes of PBS, com oil, or propanil dissolved in com oil (100 mg/kg or 200 mg/kg).
Twenty four hours later, mice were sacrificed by decapitation and serum corticosterone levels

were determined by radioimmunoassay.

Data are compiled from 2 separate experiments in

which all groups were tested. Each bar represents the mean (SE) of 6-8 mice per group. There
was no significant difference between blood levels in mice treated with PBS or the vehicle com

oil.
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ADDENDUM TO
3,4-DICHLORO-PROPIONANILIDE-INDUCED ATROPHY OF THE

THYMUS: MECHANISMS OF TOXICITY AND RECOVERY

The following page includes the data which was mentioned in the manuscript text, but the

figure was not presented.
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To further extend our observation of thymic atrophy and recovery process, we observed

the thymus weight and cellularity change as early as at 1 day, and as late as at 14 days after 200
mg/kg dose of propanil treatment. As shown in Figure 6, the thymus weight of the propanil-

treated group was 70% of control at day 1 after exposure. However, at 14 days post treatment,
both the thymus weight and cellularity returned to control levels in propanil treated mice (Figure
6). This result is similar to DEX induced thymic atrophy. Lundberg {#1330} reported a decrease

in total thymocytes which peaks at 3 days post exposure and returns to control levels after 14
days. Silverstone et al. {#1331} showed the similar result in which the thymus weight returned to
normal by 14 days post DEX exposure, while TCDD caused thymic atrophy was still apparent as

late as 24 days post treatment indicating a different pattern. In summary, the kinetics and
recovery of propanil induced thymic atrophy followed the pattern of DEX-induced thymic

atrophy.
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Figure 6.

Thymus weight and total cellularity of C57B1/6 mice at 1, and 14 days after 0 or 200

mg/kg propanil treatment. C57B1/6 mice were treated with 0, or 200 mg/kg propanil, and 1 or 14
days later thymuses were weighed and total cell numbers were counted. Error bars represent the
standard deviation.
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CYTOKINE PRODUCTION BY C57BL/6 MOUSE SPLEEN CELLS IS

SELECTIVELY REDUCED BY EXPOSURE TO PROPANIL

(Wei Zhao, Rosana Schafer and John B. Barnett, Submitted to Fund. Applied Toxicol.)
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ABSTRACT
Numerous immunomodulary effects are caused by propanil, an extensively used post-

emergent herbicide (Barnett and Gandy, 1989; Barnett et al., 1992). The T-dependent antibody
response is suppressed after exposure to propanil, raising the question of propanil’s effect on T
helper (TH) cell populations. In the present study, we show that the production of several T cell
cytokines is affected by propanil after in vivo or in vitro exposure. In vivo exposure to propanil

caused the reduction of IL-2 , IL-6, GM-CSF, and IFN-y production in concanavalin A (ConA)

stimulated spleen cell cultures established 2 days after exposure. IFN-y and GM-CSF production

had recovered by day 4 post-exposure, however, IL-2 and IL-6 levels continued to be depressed

through day 7 post-exposure. Continuous in vitro treatment of normal spleen cells with propanil
decreased IL-2, IL-6, GM-CSF, and IFN-y production after ConA activation. Pulsing normal
spleen cell cultures with propanil for up to 8 hours before T cell activation resulted in reduced

IL-6 but not IL-2 or IFN-y production. These data indicate that propanil can selectively inhibit

spleen cytokine production which could contribute to the immunomodulary effects previously
described.
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INTRODUCTION
Propanil [3,4-dichloropropionaniline], a member of the anilide family of herbicides, has
been extensively used for post-emergence control of weeds in rice (Bartha and Pramer, 1970).

Acute intraperitoneal (ip) mammalian exposure to propanil causes apparent central nervous system

(CNS) depression, loss of righting reflex, and cyanosis (Singleton and Murphy, 1973). Recent
studies demonstrate that propanil is myelotoxic to early hemapoietic stem cells (Blyler et al., 1994).
Propanil has been demonstrated to induce methemoglobinemia in experimental animals (Singleton
and Murphy,

1973), and occupational exposure to propanil has been associated with

methemoglobinemia in humans (Morse et al., 1979; Kimbrough, 1980). Propanil can also induce

hemolytic anemia in rats (McMillan et al., 1991). In vitro mechanistic studies by McMillan and
coworkers (1991) have identified that the metabolite, n-hydroxy-dichloroaniline was responsible

for this anemia.
Propanil causes a reduction in thymus weight and an increase in spleen weight and

cellularity in mice (Barnett and Gandy, 1989). T cell-dependent antibody responses are depressed

in a dose-dependent manner from 50-200 mg/kg (Barnett and Gandy, 1989).

The contact

hypersensitivity response (CHR) and mixed lymphocyte reaction (MLR) are decreased at a higher
dose of 400 mg/kg. Natural killer (NK) cell activity and T cell-independent antibody production

were also decreased at a dose of 200 mg/kg (Barnett et al., 1992). Interestingly, these last two
functions were significantly increased after exposure to a lower dose of 50 mg/kg propanil.

Cytokines have been shown to play a pivotal role in the regulation of immune responses. A
positive or negative effect on their homeostasis or normal production could potentially alter the
course of an immune response.

An effect on the production of one cytokine could have the
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potential of being further amplified since the production of many cytokines is up- or downregulated by others (Gajewski et al., 1989; Casey et al., 1992; Scott, 1993; Nagy et al., 1994;

Mosmann and Moore, 1991). T cells, a major class of lymphocytes, produce numerous important
regulatory cytokines (Salgame et al., 1991; Cardell and Sander, 1990). T cells are divided into two

functionally distinct populations; helper T (TH) cells and cytolytic T cells. Both types of T cells

produce cytokines in response to antigenic stimulation (Salgame et al., 1991; Gu et al., 1994). TH
cells secrete cytokines whose functions include the promotion of the proliferation and

differentiation of T cells and B cells, as well as macrophages and other cell types (Waldmann et al.,
1984; Handa et al., 1983). TH cells are further classified into two categories, TH1 and TH2 cells,

based primarily on their cytokine profile (Mosmann et al., 1986; Street and Mosmann, 1991; Cher
and Mosmann, 1987; Cherwinski et al., 1987). TH1 cells produce IL-2, IL-3, GM-CSF, IFN-y and
are thought to be primarily involved in the execution of cell-mediated immune responses; while

TH2 cells produce IL-3, GM-CSF, IL-4, IL-5, IL-6, and IL-10 and assist primarily in antibody

production for humoral immunity (Scott, 1993).

While there is some obvious overlap in the

cytokine profiles, GM-CSF and IL-3 for example, each subclass also produces distinct cytokines.
We have found that exposure to propanil has a differential effect on the production of
cytokines. This could be through a selective effect of propanil on the different cell types which

produce these cytokines, and may result in either a depression or enhancement of the immune
response. In the studies reported here, we have examined the effect of propanil on the production

of IFN-y, GM-CSF, IL-2 and IL-6 to determine whether propanil was affecting T cell cytokine
production. In this paper, we report that in vivo or in vitro exposure to propanil can affect IL-2, IL-
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6, GM-CSF, and IFN-y production by C57BL/6 mouse spleen cells. These effects appear to be

dependent on the timing between propanil exposure and T cell activation.

MATERIALS AND METHODS
Animals. Six-to-eight- week old female C57BL/6 mice, weighing 18 to 20 g were purchased
from Charles River Farms (Willmington, MA). They were provided food and water ad libitum

and allowed to acclimate to vivarium facilities at least 7 days prior to their inclusion in an
experiment.

In vivo exposure to propanil. For the experiments where mice were exposed to propanil in vivo,
normal C57BL/6 mice were treated ip with 0 or 200 mg/kg propanil (ChemService, Inc, West
Chester, PA; 99% purity), dissolved in com oil (Mazola Brand). The propanil was dissolved in

com oil at a concentration of 20 mg/ml and the total dose administered adjusted to the animal’s
body weight by adjusting the volume injected. The control animals were given the same volume of
com oil. A single propanil dose of 200 mg/kg was selected to reduce the number of animals treated

and because this dose had been previously shown to affect most immune functions assayed (Barnett

and Gandy, 1989).

Spleen cell cultures. Spleen cells were prepared by pressing the spleens of individual animals
through a nylon screen bag. Single-cell suspensions were made and the cells washed three times in
medium consisting of RPMI 1640 (BioWhittaker, Walkerville, MD) containing L-glutamine (2
mM), penicillin (100 U/ml), streptomycin (100 pg/ml), 2-mercaptoethanol (5 x 10"sM), 10% fetal

bovine serum, HEPES buffer (10 mM) and essential vitamins. The red blood cells were lysed with
tris-buffered ammonium chloride. After the final wash spin, the cells were resuspended in 5.0 ml
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of RPMI.

Viable cells were detected by trypan blue dye exclusion and counted in a

hemocytometer.
Ex vivo cultures from vehicle or propanil-treated animals were established in 24 well plates

using the medium described above at a cell density of 4 x 106 cells per ml, in a total volume of 2
ml. ConA (Sigma Chemical, St. Louis, MO) was added at a concentration of 2 pg/ml and the

cultures incubated at 37°C in 5% CO2. Supernatants were removed from representative cultures at

the various time points indicated and frozen at -70°C until assayed for cytokine content.

Spleen cells from normal C57BL/6 mice were used for the in vitro exposure experiments.
Single cell suspension cultures were established and exposed to either 0,10,20, or 50 pM propanil,
as stated in the results section for each experiment.

The propanil solutions were prepared by

dissolving the appropriate concentration of propanil in 95% ethanol.

The final ethanol

concentration in the cultures was 0.33%. Control cultures had an equal volume of ethanol added.
These concentrations of propanil and ethanol were determined to be non-toxic to the cells by

standard trypan blue dye exclusion viability assays.

For cultures that were incubated with propanil and ConA simultaneously, the spleen cells

were incubated in 24 well plates in the presence of 2 pg/ml of ConA and propanil at the

concentrations stated above.

The supernatants were harvested from 6 to 72 hours after ConA

stimulation for the measurement of IFN-y, GM-CSF, IL-2, and IL-6.
For some experiments, spleen cells were first exposed in vitro to 0, 10 or 20 pM propanil

for 1, 4, or 8 hours. The propanil was then removed by washing twice with medium. The cells
were then resuspended in complete medium and stimulated with ConA (2 pg/ml) for an additional

24 hours. The culture supernatants were then collected for cytokine measurement.
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ELISA Assays of IL-2, IL-6, GM-CSF, and IFN-y. The levels of IL-2, IFN-y, GM-CSF, and IL-6
in the cell culture supernatants were determined using a sandwich ELISA assay method

(Cherwinski et al., 1987). Paired monoclonal antibodies specific for each cytokine and standard
recombinant IL-2, IL-6, GM-CSF, and IFN-y proteins were purchased from Pharmingen (San

Diego, CA). Ninety-six well flat bottom microtiter plates were coated overnight at 4°C with
monoclonal anti-IL-2, anti-IL-6, anti-GM-CSF or anti-IFN-y capture antibodies respectively (rat

IgG). Nonspecific binding was blocked by incubating the plates with phosphate buffered saline
(PBS) containing 10% fetal bovine serum followed by washing 3 times in PBS + Tween 80

(0.05%) prior to addition of the test samples. Standard titration curves were established by using
serial dilutions of known concentrations of recombinant murine IL-2, IL-6, GM-CSF, and IFN-y.

The wells were washed the next day and incubated with biotinylated detection monoclonal anti-IL2, anti-IL-6, anti-GM-CSF, and anti-IFN-y (rat IgG). Following a series of washes, the plates were
then incubated with avidin-peroxidase (2.5 pg/ml). After the addition of substrate 2,2-Azino-Bis-

3-EthyIbenzthiazoline-6-Sulfonic Acid (ABTS) the absorbance at 405 nm was measured using an
EIA Reader (Bio-Tek EL 312e). Cytokines were quantitated using the kinetic curve-fitting

program (Bio-Tek).

Statistical analysis. SigmaStat (Jandel Scientific, San Rafael, CA) statistical software was used
for the statistical analysis. The significance of difference between the time course studies of
propanil-treated and control groups were tested by two way ANOVA test. The significance of

difference among multigroups (e.g., cell viability of the propanil-treated groups versus the

control group, and comparison of different doses of propanil versus the control) was tested by
one way ANOVA test.

Groups that were significantly different from each other were then
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determined using the Student-Newman-Keuls multicomparison test.
considered significant.

In all cases p < 0.05 was

All error bars represent standard deviations.

All experiments were

repeated at least once with similar results and the results from a typical experiment are shown.
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RESULTS
The production of IL-2 and IL-6, GM-CSF, and IFN-y is reduced after in vivo exposure to

propanil. To establish the peak time of production as well as whether propanil was able to alter
the kinetics of cytokine production, ex vivo spleen cell cultures were established from C57BL/6
mice 7 days after i.p. treatment with the vehicle or 200 mg/kg propanil. Representative cell

culture supernatant fluids were collected from cultures at several time points (2 to 72 hours) and
IFN-y, GM-CSF, IL-2, and IL-6 were measured by ELISA. IL-2 and IL-6 levels were

significantly lower in culture supernatants from the propanil-treated animals as compared to

controls (Figure 1). IFN-y and GM-CSF levels were not significantly different between the
propanil-treated and control groups at this time point (Figure 1A, IB). IL-2 production peaked

approximately 24 hours after ConA stimulation and peak supernatant IL-2 levels in control
spleen cultures were 15.4 ± 0.34 ng/ml compared to 11.3 ±0.15 ng/ml in spleen cell cultures
from propanil-treated animals (Figure IC). At the peak time of production (48 hr), supernatant

IL-6 concentrations were 715 pg/ml and 400 pg/ml for the control and propanil-treated cultures,

respectively (Figure ID). The results also showed the same kinetic patterns for the production of

all four cytokines between propanil-treated and control groups. This excludes the possibility that
the differences observed in the IL-2 and IL-6 levels was due to an affect on the peak time of
cytokine production by propanil.
To determine if the effect of propanil was dependent on the time between exposure and

assay, ConA-stimuIated spleen cell cultures were established 2, 4, or 7 days after exposure.

Supernatant fluids were collected at the peak time of cytokine production and assayed by ELISA.
IFN-y levels were decreased on day 2 after exposure, but returned to normal levels by day 4
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(Figure 2). The peak levels of IFN-y in propanil-treated and control group were 360.8 ± 5.28 and

672.61 ± 26.64 pg/ml on day 2 post exposure. GM-CSF levels showed the similar pattern with
levels of 62 ± 30 and 232 ± 50 pg/ml for the peak value of propanil-treated and control groups at
day 2 and showed no difference by day 4. Whereas IL-2 and IL-6 were reduced by 25-40% and

by =40% at all time points, compared to controls. Thus, although IFN-y and GM-CSF production
recovered by day 4, IL-2 or IL-6 production continued to be inhibited by propanil as late as 7
days after exposure.

In vitro exposure to propanil during T cell activation decreases the production of IL-2, IL-6,

GM-CSF, and IFN-y production. The previously described results established that in vivo
exposure to propanil caused a reduction in IFN-y, GM-CSF, IL-2, and IL-6 production in ex vivo

spleen cell cultures 2 days after treatment. In order to establish a model for mechanistic studies,
experiments to determine whether in vitro exposure to propanil caused a similar reduction in
cytokine production were performed. To assure that any result we obtained was not simply due to

cell death, we first determined the effect of in vitro exposure to propanil on cell viability. Spleen
cell cultures were exposed to graded concentrations of propanil and the cell viability determined
after 48 hours using standard trypan blue exclusion tests. This time point was chosen because the
peak production of all cytokines measured is at or before 48 hours. The viabilities of cells

cultured with either 0,10,20, or 50 p.M propanil were > 90% and were not significantly different
from each other (data not shown). Concentrations of 100 pM and 200 pM propanil caused a
significant reduction in cell viability after 48 hr (data not shown).

exposures used concentrations of < 50 pM.
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All subsequent in vitro

Spleen cells from normal C57BL/6 mice were treated with 0, 10, 20, or 50 pM propanil

and simultaneously activated with ConA. Culture supernatants were assayed for IFN-y, GM-

CSF, IL-2, and IL-6 production from 6 to 72 hours after stimulation. Propanil-treated groups and
the control group had a similar kinetic pattern of cytokine production (Figure 3). IL-2 and IFN-y
production in control cultures peaked at 24 hours after ConA activation. The levels for both of

these cytokines were markedly reduced by exposure to the highest dose of propanil (50 pM);
IFN-y levels were undetectable and IL-2 levels were 0.6 ng/ml (Figure 3 A and 3C). IFN-y levels
at 24 h of culture were reduced from 603 ± 32 for control cultures to 230 ± 4 pg/ml for the 20

pM propanil-treated groups. The peak IFN-y production in the propanil-treated cultures was at 48

hr, however, concentrations at this point (300 ± 14 pg/ml) were still substantially below control

levels at 24 hr (peak) or 48 h (545 ± 7 pg/ml). GM-CSF levels accumulated in control group to
169 pg/ml by 72 hours after ConA stimulation, treatment with propanil at highest dose and

intermediate dose reduced the GM-CSF production to 90 ± 8.4 and 30.6 ± 25 pg /ml (Figure
3B). Exposure to the intermediate dose of propanil (20 pM) similarly reduced IL-2 levels from

21 ± 1.4 ng/ml for controls to 8.8 ± 0.85 ng/ml in the propanil-treated cultures (Figure 3C). IL-6
production in control cultures peaked at 48 hours and treatment with propanil caused a dose
dependent reduction in IL-6 levels (Figure 3D). The intermediate dose of propanil (20 pM)

reduced IL-6 levels to approximately 40% of the control levels, 260 ± 10 pg/ml compared to 640
± 28 pg/ml (Figure 3C). IL-6 production was reduced to 64 pg/ml after exposure to a dose of

0.05 mM propanil. Thus, when spleen cells are exposed to propanil at the time of ConA
activation, there is a dose dependent reduction in the production of all four cytokines.
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Treatment with propanil prior to T cell activation inhibits IL-6 but not IL-2 and IFN-y
production. Propanil is rapidly metabolized in vivo (Chow and Murphy, 1975; Izmerov, 1984),
therefore, we performed an experiment to determine if a short pulse of propanil would be

sufficient to cause a reduction in cytokine production. For these experiments, the cells were
exposed to 0, 10, or 20 p.M propanil for 1,4, or 8 hours, the cells were thoroughly washed to
remove the propanil, and then activated with ConA (see Figure 4 for a schematic of the
experimental design). IFN-y levels showed no statistical difference between the control groups

and the groups exposed to propanil for 1,4, or 8 hours prior to activation with ConA. Cells
incubated in the presence of propanil for 8 hours, but not 1 or 4 hours, showed a small but

statistically significant difference in IL-2 levels due to an unexplained increase in control levels
(Figure 4B). In contrast, IL-6 production was substantially decreased if the cells were incubated

with propanil for either 4 or 8 hours prior to ConA activation, with levels less that 1/2 controls

for both dose levels after an 8 hr exposure (Figure 4C).
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DISCUSSION
In vivo exposure of mice to propanil causes splenomegaly and thymic atrophy (Barnett
and Gandy, 1989).

Further studies on thymus show that propanil causes thymic atrophy by

depleting immature CD4CD8 double positive cell populations (Zhao et al., 1995).

We

interpreted these data to indicate that in vivo exposure to propanil has an effect on T cell

development. In addition, the reduction of T-dependent antibody production, depressed contact
hypersensitivity response (CHR) and mixed lymphocyte reaction (MLR) reported by Barnett and

Gandy (1989) reflect the possible compromised T cell function in animals after acute exposed to
propanil. In this report, we investigated ex vivo cytokine production by ConA stimulated spleen

cells harvested 2, 4, or 7 days after intraperitoneal propanil exposure. We chose a propanil dose of
200 mg/kg because this dose had been shown to cause frank immunotoxicity in most immune
functions, e.g. antibody production, thymic atrophy, splenomegaly measured. It is also the "Lowest

Effect Level" (LEL) of toxicity to mice as defined by the U.S. Environmental Protection Agency
(1987) (U.S. Environmental Protection Agency, 1987).

The results reported herein showed

decreased IL-2, IL-6, GM-CSF, and IFN-y production by ConA stimulated spleen cells cultures
established 2 days after propanil exposure. Further studies revealed that the production of IFN-y
and GM-CSF returned to control levels by 4 day post exposure,

however, IL-2 and IL-6

production continued to be reduced in cultures established at 7 days after propanil exposure. Our

results demonstrated that the production of IL-2, IL-6, IFN-y and GM-CSF are affected by propanil.
IL-2 has multiple biological processes, including growth and differentiation of T cells, B cells, and
NK cells. IL-6 is involved in B cell differentiation and antibody production (IgG, IgM, and

IgA)(Gauldie et al., 1987) and also promotes acute-phase protein synthesis in hepatocytes (Gauldie
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et al., 1987). IFN-y and GM-CSF are involved in contact hypersensitivity response. IFN-y can
activate macrophage to kill intracellular parasites effectively and GM-CSF also enhances the

production of macrophages and their migration to the site of an immune reaction. GM-CSF has a
potent effect in simulating proliferation, maturation, and function of hematopoietic cells. The defect
of those cytokine production may account for the compromised humoral and cellular immune
response in propanil treated animals previous reported (Barnett et al., 1992; Barnett and Gandy,

1989).

The recovery of IFN-y and GM-CSF production by day 4 post-propanil-exposure as
opposed to continued reduction in IL-2 and IL-6 levels is an enigma, however, one possible theory

to explain these differences is a differential sensitivity of the induction pathways of these cytokines

to the parent compound versus its metabolite(s). Izmerov (1984) reports that the apparent half life
of propanil is approximately 72 hrs. Under this theory, the parent propanil compound would affect
cellular events that are uniquely involved in the induction of IFN-y and GM-CSF whereas propanil

and its metabolites affected cellular events involved in IL-2 or IL-6 induction. In theory, as propanil

concentrations metabolically decrease to a non-toxic level for IFN-y and GM-CSF production
between day 2 and day 4, they would recover while the “metabolite sensitive” IL-2 and IL-6

induction events continue to be inhibited; because the metabolites are present in tissues for a much
longer time. To prove this hypothesis, complete knowledge of the events associated with the

induction of each group of cytokines as well as the propanil or metabolite-specific target(s) within

these pathway would have to be known - neither of these is currently the case.
An alternative explanation centers around the significant heterogeneity in the frequency of
T cells that express individual cytokines within each clonal population. A majority of TH1 cells
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express IFN-y upon antigen stimulation, but far fewer cells in the same population express IL-2
(Buoy et al., 1994). Propanil may markedly influence the IL-2 positive cells while having more

modest effects on the IFN-y positive cells. Studies have demonstrated that IL-2 and IFN-y

expression in T cells is differentially regulated at the post-transcriptional level in which IFN-y

mRNA is more stable than IL-2 mRNA (Nagy et al., 1994). Nagy et al. (1994) report that IL-12 is
capable of stabilizing IFN-y mRNA without affecting IL-2 mRNA stability.

produced by macrophages and B cells.

IL-12 is mainly

Theus et al. (1993) reported increased of macrophage

cytotoxicity and cytokine production and we also find that propanil treated spleen cells have more
non-T non-B cells (Zhao et al. unpublished data). The increased macrophages and their ability to

produce IL-12 may help stabilize the IFN-y mRNA.

To further assess the direct effect of propanil on spleen cells, we created an in vitro
exposure model. The results showed when ConA stimulated spleen cells were incubated with

propanil, production of all four cytokines was inhibited in a dose dependent manner. These data
support the theory that production of all four cytokine is sensitive to the parent compound, as

Chow et al. (1975) report that spleen homogenates can not hydrolyze propanil into DCA. Since
all cytokine production that was measured is reduced after in vitro exposure, the possibility that

propanil was acting as a general toxic agent or as a general inhibitor of cellular protein synthesis

was considered. To exclude this we performed the proliferation and cell viability assays and the
results showed no difference between the propanil-treated and control groups (data not shown).

Inasmuch as cell proliferation requires protein synthesis, we conclude that this inhibition is not
due to either cell death or inhibition of protein synthesis.
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Since propanil is rapidly metabolized in vivo with a short half life (Chow and Murphy,
1975; Izmerov, 1984), the actual exposure time of spleen cells to propanil in vivo may be shorter

than our in vitro exposure. Moreover, by 4 or 7 days after exposure the propanil is metabolized

or eliminated from the host, thus the data generated from ex vivo ConA stimulation may imply a
possible cellular defect resulting from the in vivo exposure to propanil. To better mimic this
situation, we performed an experiment to determine if a short pulse of propanil would be

sufficient to cause a reduction in cytokine production. The result showed a constant IL-6
decrease accompanied with no change of IFN-y levels after up to 8 hrs propanil pulse. While IL-

2 showed no change in this experiment, in a separate experiment IL-2 levels were decreased after
24 hrs propanil pulse. These data, correlates with our vivo data, suggesting that pulse exposed to

propanil has an impact on cellular events which are necessary for T cell cytokine production

upon later stimulation.

In summary, we found that in vivo exposure of mice to propanil inhibits spleen cell IL-2,
IL-6 , IFN-y, and GM-CSF production in ex vivo ConA stimulated spleen cell cultures. IFN-y and
GM-CSF levels recovered by 4 days post exposure, while IL-2 and IL-6 production were still

reduced at 7 days post-exposure.

The results from in vitro exposure of propanil to ConA-

stimulated spleen cells support our conclusion that parent compound has its direct effect on those

cytokine production. Cytokines represent the essential soluble transmitters of cell-to-cell

communication and play crucial roles in many biological processes including viral infection,
inflammation, immunity, and hematopoiesis. It is clearly important that their action is closely
regulated to reach to optimal function. The disruption of this highly regulated cytokine network

would lead to the immunosuppression or autoimmunity condition.
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Figure 1. IL-2, IL-6, IFN-y and GM-CSF production by ConA stimulated spleen cells from mice
7 day after propanil treatment. C57BL/6 mice were treated with 0 or 200 mg/kg of propanil and
7 days later, spleen cells were harvested and activated with ConA. Culture supernatants were

collected and measured for IL-2, IL-6, IFN-y, and GM-CSF production by specific ELISA assay.
Error bars are the standard deviation.

IL-2 and IL-6 levels of propanil-treated groups were

significantly lower than control group according to two way ANOVA (p<0.01).
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Figure 2. IL-2, IL-6, IFN-y, and GM-CSF levels of ConA stimulated spleen cells from mice 2,
4, and 7 days post exposure. C57BL/6 mice were treated with 0 or 200 mg/kg of propanil. Spleen
cells were harvested 2, 4, and 7 days post exposure and activated with ConA. Culture
supernatants were collected and measured for IL-2, IL-6, IFN-y, and GM-CSF production by

specific ELISA assay.
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Figure 3. IL-2, IL-6, IFN-y, and GM-CSF levels of ConA stimulated spleen cells after in vitro
treatment with propanil. Splenic cells from normal C57BL/6 mice were incubated with 0, 20, or
50 |1M propanil in 24 well culture plates, the cells were activated with ConA and culture

supernatants were measured for IL-2, IL-6, IFN-y, and GM-CSF level by ELISA. (p<0.05).
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ADDENDUM TO
CYTOKINE PRODUCTION BY C57BL/6 MOUSE SPLEEN CELLS IS
SELECTIVELY REDUCED BY EXPOSURE TO PROPANIL

The data in this addendum are not included in the manuscript due to the content and space
limitation of a manuscript. They are presented here with a brief discussion.
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We found the CD4+ and CD8h spleen cell populations are not changed in mice at 7 days

after propanil treatment.

However, since the thymic atrophy peaks at 2-4 days spleen cell ex

vivo cytokine production showed a different pattern at 2, 4, and 7 days (Figure 2 of page 145),

we, therefore, measured

the T phenotypes in the spleen at 2, 4, and 7 days post propanil

exposure. The results showed that neither CD4+ nor CD8+ T cell distribution is changed in the
propanil-treated group (Figure 5). We also found that splenomegaly is still obvious at 14 days

after exposure. Our data, therefore, suggests that the splenomegaly followed a different kinetic
and recovery process from thymic atrophy and the difference in the pattern of cytokine

production at 2 and 7 days is not due to the change of T cell distribution.
Cell viability was tested at 48 hr after spleen cells were exposed to graded concentrations

of propanil in vitro. The data, not shown in the manucript, is presented in Figure 6. We also
asked the question of whether propanil can still affect cytokine production in spleen cells if it is
added after ConA T cell activation is initiated. In these experiments, spleen cells were
precultured with ConA for 0.5, 1, and 4 hours before the addition of propanil, and cell culture

supernatants were harvested after 24 hours ConA stimulation.

The results showed that IL-2

levels decreased when propanil was added at 0.5 and 1 hour after ConA stimulation, and the IL-6
levels were decreased in all three time points. In contrast, IFN-y showed no difference in all time

points between propanil-treated and control groups (Figure 7).
The T cell activation process can be divided into three stages based on the expression of

protooncogenes and cytokine genes. Immediate events such as c-myc are independent of protein

synthesis and are expressed within 30 minutes after stimulation.

Early events including the

expression of most cytokine genes require protein synthesis but precede cell division, and late
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events occur after cell division (Crabtree, 1989). According to the literature, the earliest time of

gene expression for IFN-y, IL-2, and IL-6 is 30 min, 45 min, and 6 hr, respectively Wiskocil et
al., 1985; Sehgal et al., 1987; Hirano et al., 1986). Since the IFN-y gene is being transcribed 30

min after T cell activation, lack of IFN-y inhibition when propanil was added 0.5 hr after ConA
stimulation indicates that propanil does not inhibit transcription directly. The addition of propanil

0.5 or 1 hrs after ConA stimulation inhibited IL-2 production only at higher dose level. The IL-2
gene is expressed about 45 min after T cell activation, whereas addition of propanil 4 hours after
ConA stimulation does not show the inhibitory effect. For IL-6 production, the results show that
the propanil group has a lower IL-6 level in all three treatment periods, because propanil is added

(0.5, 1, and 4 hr after ConA) prior to IL-6 gene expression (6 hr). These results indicate that
propanil may not affect the translational process of these cytokines.

Splenocytes are a mix of T cells, B cells, macrophages, NK cells, etc. Although cytokine
production of ConA stimulated spleen cells is mainly attributed to T cells, the fact that

macrophages and NK cells also produce cytokines and the cell-cell interactions also influence the
cytokine levels become problematic. To confirm that the cytokine level change in spleen cell

cultures is due to the propanil effect on T cells, we also used nylon wool enriched normal
splenic T cells (Hathcock, 1991) to perform our in vitro study. In brief, a 20 ml nylon wool

column was rinsed with 37°C medium and incubated at 37°C for 1 hour. Spleen cell preparation

was loaded on to the column which then was incubated at 37°C for an additional hour. The

column was then eluted with 37°C medium and the first 20 ml was collected as enriched T cells

and the purity of this enrichment was typically 88-95% verified using flow cytometric methods.
These T cells (2 x 106) were incubated with ConA in the presence or absence of graded doses of
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propanil and 2 x 106 accessory cells which were prepared by exposing normal spleen cells to a
2,000 rad dose of irradiation using a y-irradiator (Gammacell 1000, Atomic Energy of Canada
Limited). The cell culture supernatants were collected at 6-96 hours and were measured for IL-2,

IL-6, and IFN-y levels. As shown in Figure 8, propanil inhibition of T cell cytokine production

in the enriched T cell preparation was similar to the spleen cell population.
The effect of propanil and its metabolite, DCA on IL-6 production was investigated in a

Th2 cell line, CD25 cells. The result, shown in Figure 9, demonstrated a dose dependent
inhibitory effect of propanil and DCA. It should be noted that DCA, in the same experimental

condition, requires a higher dose than propanil to get the similar magnitude of inhibition. Barnett
et al. (1992) demonstrate that a higher DCA dose is needed to reproduce the similar in vivo

propanil effects in animals.
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Figure 5. T cell subpopulations of spleen from C57B1/6 mice at 2, 4, and 7 days after 0, or 200
mg/ml propanil ip treatment. C57B1/6 mice were treated with either 0 or 200 mg/kg of propanil
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each subpopulation determined by flow cytometry as described in the Materials and Methods
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Figure 6. Cell viability. Spleen cells form normal C57BL/6 mice were treated with propanil as
presented in the figure. The cells were collected 48 hours after incubation, stained with 0.04%

trypan blue and counted under microscope using hemocytometer. (P>0.05).
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Figure 7. Effect of propanil on IL-2, IL-6 and IFN-y production by ConA-prestimulated spleen

cells. Spleen cells were activated with ConA. After 30 min, 1, or 4 hours, propanil was added to
final concentration of 0, 10, and 20 pM. The cell culture supernatants were collected after total
ConA stimulation time of 24 hours and measured for IL-2, IL-6, and IFN-y. Data are presented as

mean values (± SD). (* represents P<0.05).
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Figure 8. IL-2, IL-6, and IFN-y levels of spleen T cell culture supernatants. Splenic cells from
normal C57BL/6 mice were passed through nylon wool. The enriched T cells were incubated
with 0, 10, 20, or 50 p.M propanil in 24 well culture plates, the cells were activated with ConA

and culture supernatants were measured for IL-2, IL-6, and IFN-y level by ELISA.
deviations were omitted for simplicity (* P <0.05).
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in 24 well culture plates, the cells were activated with ConA and culture

supernatants were collected at 24 hours and measured for IL-6 ELISA. (* P <0.05).
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PROPANIL AFFECTS THE EXPRESSION OF IL-2 IN ACTIVATED EL-4
CELLS BY TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL

MECHANISMS

(Wei Zhao, Rosana Schafer and John B. Barnett, Submitted to Toxicol. Appi. Pharmacol.)
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ABSTRACT
The amide-class herbicide, propanil, causes numerous immunomodulary effects in animal
models. In the present study, we investigated the effect of propanil on IL-2 expression and

production in the murine lymphoma T cell line, EL-4. When supernatants of cells stimulated with

phorbol 12-myristate 13-acetate (PMA) were assessed by enzyme-linked immunosorbent assay, IL-

2 levels were dose-dependently decreased in the presence of 0.02, and 0.05 mM of propanil but not
at 0.01 mM. Quantitative Northern blot analysis of peak IL-2 message levels also showed a dose
dependent decrease. The kinetic pattern of message production, however, was unaffected. To

determine if the reduced message production was due to reduced signaling or message stability,

nuclear run-on and mRNA stability assays were performed. Nuclear run on assays revealed that the
transcription rate of the IL-2 gene was decreased approximately 50% in the presence of 0.02 mM

propanil indicating that it was able to interfere with signal transduction. IL-2 message stability
assays also revealed a reduction in message stability. Thus, propanil appears to reduce IL-2

production by affecting the signal transduction pathway and IL-2 message stability.
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INTRODUCTION
Propanil (3'4'-Dichloropropionanlide), is an economically important herbicide used to control
weeds in rice and wheat fields (Bartha and Pramer, 1970). The acute toxicity of propanil is

manifested primarily by methemoglobin formation, which has been reported to lead to cyanosis in
occupationally exposed humans (Kimbrough, 1980). The immunotoxic effects of propanil on
mammalian systems, as detailed in our previous reports, include inhibition of T-dependent and T

independent antibody responses,

reduction of mixed lymphocyte response and contact

hypersensitivity responses and an alteration of macrophage function (Barnett and Gandy, 1989;

Theus et al., 1993). Recent studies showed that propaml is myelotoxic to early hemapoietic stem
cells (Blyler et al., 1994). Notably, in the mouse, ip injection of propanil induces decreased

cytokine production of spleen cells upon ex vivo ConA stimulation (Zhao et al., submitted).
T cell activation is a key step in the initiation of an immunological response. Stimulation of T

cells by specific antigens, mitogenic lectins, or monoclonal antibody directed against the TCR-CD3

complex activates a cascade of signaling events which includes the phospholipase Cy-mediated
hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2). PIP2 hydrolysis produces the second

messengers, inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) which induce increases in
[Ca2+]j and activation of the protein kinase C (PKC), respectively (Imboden and Stobo, 1985; Weiss
et al., 1986; Isakov et al., 1987). Further second messengers in this pathway have been discovered

and the combination of these interdependent events leads to the initiation of IL-2 transcription
(Crabtree, 1989; Smith, 1988). The rise and fall in IL-2 gene expression is paralleled by changes in
T cell proliferation. Thus, the regulation of IL-2 gene is critically involved in the control of T cell
growth and the normal immune response (Smith, 1988; Leonard et al., 1985). The phorbol diester
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12-myristate-13-acetate (PMA) can replace the need for the macrophage factor IL-1 in stimulating
the production of IL-2 from normal T cells (Farrar et al., 1980). PMA directly activates PKC

(Fidelus and Laughter, 1986; Nishizuka, 1984; Truneh et al., 1985) and induces the production and
secretion of lymphokines in mouse T-lymphoma cell line EL4 (Fidelus and Laughter, 1986). These

cytokines include IL-2, IL-3, IL-6, and GM-CSF (Farrar et al., 1980; Pearlstein et al., 1983;

Bleackley et al., 1983). In the present study, we noted that propanil decreases IL-2 secretion and
this decreased IL-2 production appears to be due to the ability of propanil to inhibit both signal

transduction and message stability.
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MATERIALS AND METHODS
Cell culture. EL-4 cells (1 x 106/ml; American Type Culture Collection, Rockville, MD) were
cultured in 24 well plates in medium consisting of RPMI 1640 (BioWhittaker, Walkerville, MD)
containing L-glutamine (2 mM), penicillin (100 U/ml), streptomycin (100

pg/ml), 2-

mercaptoehanol (5 x 10"5M), 10% fetal bovine serum, HEPES buffer (10 mM) and essential

vitamins in 5% CO2 at 37°C. Cytokine synthesis was induced by adding phorbol 12-myristate 13acetate (PMA, Sigma Chemical, St. Louis, MO) at a concentration of 10 ng/ml.

Propanil treatment Propanil was purchased from ChemService, Inc (West Chester, PA) with 99%
purity. EL-4 cells were exposed to either 0, 0.01, 0.02, or 0.05 mM propanil, as stated in the results

section for each experiment. The propanil solutions were prepared by dissolving the appropriate

concentration of propanil in 95% ethanol. The final ethanol concentration in the cultures was

0.33%. Control cultures received an equal volume of ethanol. These concentrations of propanil and

ethanol were determined by standard trypan blue dye exclusion viability assays to non-toxic to the
cells.

ELISA cytokine assays. The IL-2 levels in the cell culture supernatants were determined using a
sandwich ELISA assay method (Cherwinski et al., 1987). Paired monoclonal antibodies specific for
IL-2 and standard recombinant IL-2 were purchased from Pharmingen (San Diego, CA). Microtiter

plates (96 well flat bottom) were coated overnight at 4°C with monoclonal IL-2 capture antibody
(rat IgG). Nonspecific binding was blocked by incubating the plates with phosphate buffered saline

(PBS) containing 10% fetal bovine serum followed by washing in PBS + Tween 80 (0.05%) prior

to addition of the test samples and standard cytokines which were established by using serial
dilutions of known concentrations of recombinant murine IL-2. After an overnight incubation at
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4°C, the wells were washed and incubated with specific biotinylated detection monoclonal

antibodies. The antibodies were washed off and the plates were incubated with avidin-peroxidase.

Following the addition of substrate, the absorbance at 405 nm was measured using an EIA Reader
(Bio-Tek EL312e).

RNA isolation and analysis. EL4 cells were incubated with 0.05, 0.02, 0.01, and 0 mM propanil
and activated with PMA. Total RNA was extracted from 107 cells using RNAzol B system
(Cinna/Biltecx, Friendsville, TX) according to manufacturer's instructions. Briefly, cells were
washed twice using cold calcium-and-magnesium free PBS. The cells were then solubilized in 2 ml

RNAzol B. After homogenization, the entire solution was extracted with 0.2 ml chloroform (1/10

volume). The aqueous phase was precipitated with an equal volume of isopropanol, and the RNA

was washed with 75% ethanol and dissolved in H2O. The yield was quantitated by measuring
A26o/28o- Total RNA (15 pg/lane) was electrophoresed on a 1% agarose gel containing 2.2 M
formaldehyde, and transferred to Hybond-N+ nylon membrane. (Amersham Corp., Arlington
Heights, IL). After UV crosslinking, the membrane was stained with 0.03% methylene blue, 0.3 M

sodium acetate (pH 5.2) for 45 seconds, followed by rinsing with water for 1 min. It was destained
by washing with 1% SDS/1 X SSC. Membranes were prehybridized at 42°C for 6 h in
hybridization solution containing 50 % formamide, 5 X SSC, 5 X Denhardt’s solution, 25 mM

KPO4, 100 pg/ml salmon sperm DNA. Hybridization was performed overnight at 42°C in fresh
solution containing 32P-labeled cDNA probes. The membrane was washed three times in 2 X SSC,

0.1 % SOS at room temperature for 15 min, twice in 0.5 X SSC, 0.1% SOS at 65°C for 15 min, and
the final wash was in 0.1 X SSC, 0.1% SOS at 65°C for 15 min. The blot was in turn exposed to
Fuji RX film plus intensifying screen at -70°C and to phosphor screen cassette. The screen was then
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scanned with phosphorlmager™ and quantitated by using Image QuaNT™ software (Molecular

Dynamics, Sunnyvale, CA).

cDNA probes. The cDNAs utilized in these studies were as follows: IL-2, a 850-bp of Pst IZXho I
fragment for murine IL-2 (Yokota et al., 1985) were kindly provided by Dr. John Woodward (Univ,

of Kentucky); and rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a 1-kb Pst I fragment
of pRGAPDH-1 (Piechaczyc et al., 1984; Billips et al., 1992) were from Dr. Kenneth Landreth (

West Virginia University). cDNA clones were amplified in Escherichia coli DH5a competent cells
(GIBCO BRL) and gel-purified using DEAE membrane method.

Isolation of nuclei and run-on transcription assay. Following exposure to graded doses of
propaml, EL-4 cells (~5 x 107) were washed once with ice-cold phosphate-buffered saline and lysed
in 5 ml lysis buffer (20 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCI2, and 0.2% Nonidet P
40). After setting on ice for 5 min, the lysate was centrifuged at 800g for 5 min at 4°C. The nuclei

were washed once with lysis buffer and suspended in 100 pl nuclear storage buffer (40% glycerol,
50 mmol Tris-Cl (pH 8.0), 5 mmol MgCl2 0.1 mM EDTA) and frozen in -80°C. For in vitro

transcription, 4 x 107 nuclei were incubated for 20 min at 26°C with mixing in 100 pl of a reaction
solution containing a 500 pM concentration each of CTP and GTP, 1 mM of ATP, 50 mM Hepes,

pH 7.9, 100 mM KC1, 4 mM DTT, 30 pM EDTA, 2 mM MnCl2, 35 mM (NH4)2SO4, 8.8 mM

Creatine Phosphate, 40 pg/ml Creatine Phosphokinase, 250 pCi of 32P-labeled UTP (3000
Ci/mmol; ICN Pharmaceuticals, Inc., Costa Mesa, CA) and 2 U/pl RNasin (Promega Biotec,
Madison, WI). Transcription was stopped by adding RNase-free DNase (GIBCOBRL,) and

incubating for 10 min at room temperature. Samples were adjusted to 1% SDS containing 5 mM
EDTA and incubated with 250 pg/ml proteinase K (Boehringer Mannheim) for 90 min at 50°C.
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They were then treated twice with phenol/chloroform:isoamyl alcohol and once with chloroform.
Labeled RNA was ethanol precipitated and purified with Nick column (Pharmacia biotech). Equal
cpm of 32P-labeled RNA were hybridized to 2 pg denatured plasmid DNA which were spotted on

nylon membranes (Hybon N+). Hybridization was carried out in a solution containing 50%
formamide, 0.25 M NaHPO4, pH 7.2, 0.25 M NaCl, 1 mM EDTA, 100 pl/ml salmon sperm DNA,
250 pg/ml yeast tRNA and 7% SDS for 48 h at 43°C. The membranes were washed twice in 2X

SSC at 50°C for 15 min, once in 2 X SSC with 10 pg/ml RNase A at 37°C for 20 min, once in 25
mM NaHPO4(pH7.2),l mM EDTA, 1% SDS at 50°C for 15 min. They were then exposed to Fuji

RX film plus intensifying screen at -70°C and to phosphor screen cassette. The screen was then
scanned with phosphorlmager™ and quantitated by using Image QuaNT™ software.

tnRNA stability assay. EL4 cells were activated with PMA (10 ng/ml) in the absence or presence of
propanil (0.02 mM). Actinomycin D (5 pg/ml, Sigma Chemical) was added to the culture to stop

transcription at 10 hours after post activation. Total cellular RNA was isolated at 0, 1, 2, and 4
hours later and subjected to Northern blot analysis probed sequentially with IL-2 and GAPDH

cDNA. mRNA decline was measured and plotted, the tl/2 values were calculated from the slops.

Statistical analysis. SigmaStat (Jandel Scientific, San Rafael, CA) statistical software was used for
the statistical analysis. The significance of difference between studies of propanil-treated and

control groups were tested by two way ANOVA test. Groups that were significantly different from
each other were then determined using the Student-Newman-Keuls multicomparisons test. In all

cases p< 0.05 was considered significant. All error bars represent standard deviations.
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RESULTS
Effect ofpropanil on IL-2 production
To assess the effects of propanil on cytokine production, EL-4 cells were incubated with
PMA and a range of propanil concentrations and the resulting supernatants were collected and

analyzed for IL-2 by ELISA from 3-72 hours after stimulation. Negligible levels of IL-2 were
found in culture supernatants without PMA stimulation and these were unaffected by the presence
of propanil (data not shown). IL-2 production in control cultures peaked at 24 hours after PMA

activation (Figure 1) and all culture demonstrated similar kinetics of IL-2 production. The levels of

IL-2 were reduced from 29.08 ± 1.54 ng/ml in control to 14.87 ± 0.77 ng/ml by exposure to the
highest dose of propanil (0.05 mM) and modest, but statistically significant level (22.54 ± 1.66
ng/ml) in cultures incubated with an intermediate dose (0.02 mM). A propanil dose of 0.01 mM

does not affect IL-2 production.

Effect ofPropanil on IL-2 mRNA expression
Having demonstrated inhibition of IL-2 production by propanil, we then investigated the

mechanism underlying this effect by examining PMA-induced mRNA levels. EL-4 cells were

stimulated during 4, 8, 12, and 24 hours with PMA in the presence or absence of propanil (0.02
mM). Total RNA was extracted and analyzed on a 1% formaldehyde gel. Membranes were
sequentially hybridized with 12P-labeled cDNA probes for IL-2 and GAPDH genes. As shown in

Figure 2, in the absence of propanil, IL-2 mRNA increased after PMA stimulation, peaked at 8
hours and then decreased at 24 hours. IL-2 mRNA was decreased relative to controls in the

presence of propanil (Figure 2), however, both groups show a similar kinetic pattern (Figure 2).
Figure 3 shows the effect of varying the dose of propanil on peak IL-2 message levels. The highest
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dose of propanil (0.05 mM) caused a 5 fold decrease of IL-2 mRNA, 0.02 mM propanil treatment
resulted in a 2 fold decrease of IL-2 mRNA and 0.01 mM propanil caused no significant decrease in

IL-2 message level. These results demonstrated a typical dose-dependent pattern. In all cases,
GAPDH mRNA levels remained similar throughout the culture period.

Propanil decreases the IL-2 transcription rate
Inhibition of IL-2 message accumulation by propanil after PMA stimulation could be
caused either by decreased transcription rates or by increased degradation of mRNA. To elucidate
this mechanism further, we measured the IL-2 message transcription rate using nuclear run-on

assays. Upon PMA stimulation, maximum IL-2 gene expression occurs at 8 hours. Nuclei were

isolated at 8 hours after PMA stimulation, and in vitro nuclear transcription was determined in cells
treated with PMA alone or in combination with propanil (0.02 mM). Propanil inhibited the nuclear
transcription of IL-2 by 50% (Figure 4). Transcription of GAPDH gene was not affected by
propanil.

Propanil decreases the stability of IL-2 mRNA
Next, we studied whether the effect of propanil on IL-2 mRNA accumulation is mediated at
the post-transcriptional levels as a result of mRNA degradation. EL-4 cells were stimulated with
PMA in the presence or absence of propanil for 8 hours followed by actinomycin D treatment.
Total cellular RNA was isolated at 0, 1, 2, and 4 hours post-actinomycin D treatment for the

measurement of IL-2 mRNA. As shown in Figure 5, after normalization to respective GAPDH

signals, IL-2 mRNA decayed with a t]/2 of approximately 140 min in PMA stimulated EL4 cells. In
the presence of PMA plus 0.02 mM of propanil, IL-2 mRNA decayed with a t1/2 of 90 min,

indicating that propanil also affects the stability of IL-2 messages. In a separate experiment in
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which cells were exposed to 0.05 mM propanil, the IL-2 message stability half life was
approximately 43 min (data not shown). Thus, IL-2 message stability also showed a dose
dependent change.
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DISCUSSION
In the present paper, we studied the effect of the herbicide, propanil, on IL-2 production and

IL-2 gene expression in activated EL-4 cells. We demonstrate that propanil inhibits the expression

of IL-2 at the mRNA and protein levels in PMA-activated EL-4 cells. IL-2 production decreased to

78% and 51% of control, in the presence of 0.02 or 0.05 mM concentrations of propanil. The
effects of propanil on IL-2 production were further related to IL-2 gene expression. The decreased

transcription rate and increased mRNA degradation of IL-2 suggested that the effect of propanil on

IL-2 is mediated at both the transcriptional and post-transcriptional levels.
The reduced transcription rate and mRNA stability in propanil-treated cells is not surprising

given that IL-2 gene expression has been found to be regulated at the levels of transcription and
mRNA stability (Shaw et al., 1988; Naora and Young, 1994). Anastassiou et al. (Anastassiou et al.,
1992) report similar effects on IL-2 production, i.e., reduced IL-2 protein, message levels and
message half life, when cyclic adenosine monophosphate (cAMP) levels are pharmacologically

increased by treating T cells with prostaglandin E2. Increased cAMP causes the activation of protein
kinase A. IL-2 transcription requires the binding of common regulatory factors, such as OCT-1,

activation protein 1 (AP-1), and nuclear factor NF-kB, which are involved in the regulation of the
expression of several genes in lymphoid as well as nonlymphoid cells (Brunvand et al., 1988;
Muegge et al., 1989; Hoyos et al., 1989; Lenardo et al., 1988), as well as several specific regulatory
factors NF-AT which are tightly linked to T cell activation (Hivroz-Burgaud et al., 1991). Some of

these factors are constitutive in cells, e.g., c-jun, while other must be synthesized de novo upon cell

activation, e.g., c-fos. Further, the results of Garrity et al (Garrity et al., 1994) suggest that IL-2
transcription only occurs when all of these factors are bound to the enhancer/promoter region of the
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IL-2 gene. However, like Anastassiou et al. (Anastassiou et al., 1992), we noted reduced but not
absent IL-2 transcription. Paliogianni et al., (1993) found that elevated cAMP levels partially

inhibited IL-2 transcription by inhibiting calcineurin, a calcium/calmodulin dependent protein

phosphatase. Ultimately the inhibition of IL-2 nuclear transcription by propanil is likely the result
of either decreased production or function of required transcription factors. However, inasmuch as
propanil-induced inhibition (like cAMP) is not absolute, the mechanism of how it accomplishes this

inhibition is still unknown.

IL-2 transcription following T cell receptor cross-linking involves several specific signaling
events that precede the calcium/calmodulin dependent protein phosphatase. However, in our study,
the EL-4 cells were activated to produce IL-2 by directly activating protein kinase C (PKC) with
PMA. Therefore, our data indicate that the effects of propanil on IL-2 production are mediated at

steps either at PKC activation or after this event.
Propanil also decreases the stability of IL-2 mRNA. How propanil affects this reduction is a

matter for speculation at this point. In addition to transcriptional mechanisms, post-transcriptional

mechanisms have been implicated in the regulation of IL-2 gene expression (Shaw et al., 1988;
Lindstein et al., 1989). The AU-rich element (ARE), frequently containing the motif AUUUA, is
conserved in the 3'-untranslated regions of many unstable, inducible mRNAs, including those of

many oncogenes and cytokines (Caput et al., 1986). These sequences appear to mediate the

instability of several of these species and to bind specific factors (Bohjanen et al., 1991; Malter,
1989). Furthermore, a number of unstable mRNAs are stabilized by cycloheximide treatment,
implicating these AU-rich sequences as a target for a labile mechanism that destabilizes these

mRNAs and consequently mediates their rapid degradation (Shaw et al., 1987). The regulation of
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stability of IL-2 mRNA in the present system may therefore involve multiple interactions of both

common and gene specific regulatory sequences with positively and negatively acting factors, a
paradigm similar to that proposed for transcriptional control. IL-2 mRNA has at least three

reiterated copies of the sequence ALTUUA, which is known to confer instability to mature mRNA

(Lindstein et al., 1989; Shaw and Kamen, 1986; Bohjanen et al., 1991). Cytoplasmic regulatory

proteins, that appear to be specific for IL-2 and several other cytokine messages, recognize these

AUUA sequences to regulate messenger RNA stability. Bohjanen et al. (Bohjanen et al., 1992)
further showed that a minimum of 3 AUUUA sequences were necessary for these proteins to bind
to the mRNA. Propaml may affect either the production or binding of these specific proteins that

would result in altered message stability. mRNA stability is also reported to be controlled at the
level of translation, however, these data have not been specifically applied to cytokine message
stability (Oliveira and McCarthy, 1995).

In summary, these studies have allowed us to begin to elucidate some of the mechanisms
involved in the inhibition of IL-2 by propanil. Further, the inhibition of nuclear transcription of IL-

2 and the decreased stability of IL-2 mRNA indicates that propanil exerts both transcriptional and

post-transcriptional effects on IL-2 gene expression.
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Figure 1. Propanil inhibits IL-2 production. EL-4 cells (1 x 106) were incubated with 0, 0.01, 0.02,
or 0.05 mM propanil in 24 well culture plates, the cells were activated with PMA (10 ng/ml) and
culture supernatants were collected from 3 to 72 hours after stimulation and measured for IL-2 level

by ELISA assay. Error bars are standard deviation.
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Figure 2. PMA-induced IL-2 mRNA expression in the presence or absence of propanil treatment.
EL-4 cells were stimulated with PMA (10 ng/ml) in the presence or absence of 0.02 mM
concentrations of propanil for up to 24 hours. Total cellular RNA was isolated, size fractionated (15
pg/lane), and blotted onto a nylon membrane. The membrane was hybridized with 32P-labeled
cDNA probes for IL-2 and GAPDH. Equal loading and transfer of RNA were ensured by

comparable signals for GAPDH. The scatter graph represents relative IL-2 mRNA values after
normalization to the respective GAPDH signals. Results are representative of three different

experiments.
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Figure 3. Propanil inhibits PMA-induced IL-2 mRNA in a dose-dependent manner. EL-4 cells
were incubated with incremental concentrations of propanil and stimulated with PMA (10 ng/ml)

for 8 hours. Total cellular RNA was isolated and Northern blot was performed as detailed in

materials and methods section. The bar diagram represents relative IL-2 mRNA values after
normalization to the respective GAPDH signals. The experiment shown is one of two experiments
performed.
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Figure 4. Effect of propanil on the transcription rate of IL-2 gene. Nuclei were prepared from EL4
(4 x 10?) stimulated with PMA (10 ng/ml) for 8 hours in the presence and absence of propanil (0.02

mM). In vitro transcription was performed using 32P-UTP. Labeled RNA was isolated and
hybridized to nylon membrane on which IL-2 and GAPDH plasmid cDNA which had been
immobilized by the use of a slot-blot apparatus. The bar graph represents relative transcription

rates, which were calculated after normalization to the respective GAPDH signals. The experiment

shown is one of two experiments.
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Figure 5. Effect of propanil on the stability of PMA induced IL-2 mRNA. EL-4 cells were
stimulated with PMA (10 ng/ml) in the presence and absence of propanil (0.02 mM) for 8 hours.
Actinomycin D (5 pg/ml) was added, and total cellular RNA was isolated at 0, 1,2 and 4 hours
later. 15 pg RNA/sample was size fractionated on a 1% agarose-formaldehyde gel, transferred to a

nylon membrane, hybridized with 32P-labeled cDNA probes for IL-2 and GAPDH, and mRNA
decline was measured and plotted in a graph (bottom panel). From the slopes, the tI/2 values were

calculated as mentioned in the text.
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ADDENDUM TO
PROPANIL AFFECTS THE EXPRESSION OF IL-2 IN ACTIVATED EL-4

CELLS BY TRANSCRIPTIONAL AND POST TRANSCRIPTIONAL
MECHANISMS

This addendum contains the data not included in the previous manuscript but related to this
part of the study.
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To test whether propanil also inhibits production of other cytokines, we measured the

production of IL-5, IL-6, and GM-CSF by EL-4 cells after in vitro treatment with propanil (IFN-y is
not produced by EL-4 cells). Figure 6 showed a dose dependent inhibitory effect of propanil on
production of these cytokines. These results correlate very well with the results of spleen cell

cytokine production, suggesting the inhibition of cytokine production is at least one of the
mechanisms through which propanil affect host immune function.

c-fos is one of those early expressed gene upon T cell activation and its expression require

de novo protein synthesis (Crabtree, 1989). We found that c-fos mRNA was not changed by
propanil in our EL-4 model (Figure 7). This result, combined with the fact that propanil does not
affect T cell proliferation, provides further evidence that propanil does not reduce T cell cytokine

production by inhibiting its general cellular protein synthesis. As discussed later, Fos and Jun

protein forms AP-I complex, a important transcriptional factor involved in T cell activation and
cytokine gene expression. A change of c-fos expression would result in a defective AP-A complex
and in turn affect IL-2 transcription. Further more, c-fos mRNA stability is a typical example of
post-transcriptionally regulation of protooncogene and cytokine gene expression.

Thus, the no

change of c-fos expression indicates that propanil does not affect all the transcriptional and
posttranscriptional machinery the same way.

191

Figure 6. Propanil inhibits IL-5, IL-6, and GM-CSF production. EL-4 cells (1 X 106) were
incubated with graded doses of propanil in 24 well culture plates, the cells were activated with

PMA (10 ng/ml) and A23187 and culture supernatants were collected from 6 to 72 hours after

stimulation and measured for cytokine level by ELISA assay. Error bars are standard deviation.
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Figure 7. PMA-induced c-fos mRNA expression in the presence or absence of propanil treatment.
EL-4 cells were stimulated with PMA (10 ng/ml) in the presence or absence of 0.02 mM
concentrations of propanil for up to 4 hours. Total cellular RNA was isolated, size fractionated (15
pg/lane), and blotted onto a nylon membrane. The membrane was hybridized with 32P-labeled
cDNA probes for c-fos and GAPDH. Equal loading and transfer of RNA were ensured by

comparable signals for GAPDH. The scatter graph represents relative c-fos mRNA values after
normalization to the respective GAPDH signals. Results are representative of two different

experiments.
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Propanil

GENERAL DISCUSSION
The previous work in our laboratory has clearly demonstrated defects in T cell function in

propanil treated animals (Barnett and Gandy, 1989; Barnett et al., 1992). Thus, the overall goal of
this dissertation is to explore the mechanism leading to the propanil induced thymic atrophy and T

cell function change. Two working hypotheses were tested by a series of in vivo and in vitro
experiments. They are: 1) Propanil causes thymic atrophy through the induction of endogenous
glucocorticoid production. 2) Deficiencies in vivo T cell function caused by propanil are mediated

by the inhibition of cytokine production.

Propanil Induced Inhibition of T Cell Development In the Thymus Is Mediated

I.

Through Glucocorticoids
Xenobiotic induced thymic atrophy follows direct, or indirect mechanisms. Examples of

chemicals that cause thymic atrophy through a direct mechanism are TCDD, DBTC, and
rapamycin, however, each of these compounds affects a different target cell type. TCDD causes

terminal differentiation of thymic epithelial cells, which results in loss of their ability to support

thymocyte maturation (Greenlee et al., 1985). Studies on DBTC show that thymic atrophy is
initiated by a disturbed differentiation from DN to DP thymocytes (Pieters et al., 1992). Luo et al.

(1994) report that in vivo thymocyte cycling is blocked by rapamycin, thus, concluding that the
repressed thymocyte proliferation is a major mechanism causing rapamycin-induced thymic

atrophy.

There is an increasing awareness that some compounds also act indirectly on thymuses

(Sanders et al., 1991; Comment et ai., 1992). Activation of the hypothalamic-pituitary adrenal
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(HPA) axis by drugs and chemicals and consequent increases in the concentration of

immunosuppressive glucocorticoids has been implicated in the thymic atrophy caused by those
agents (Kerkvliet et al., 1990; Hirai and Ichikawa, 1991). Glucocorticoid has been known to inhibit

or kill rodent thymocytes in vivo and in vitro by inducing programmed cell death (apoptosis)
(Wyllie, 1980; Zaleskis et al., 1994; Young et al., 1981; Compton et al., 1987). Of the four major

lymphocyte subpopulations in the thymus, CD4+CD8+ cells are most susceptible to glucocorticoidinduced programmed cell death, and these cells are preferentially depleted in vivo by
glucocorticoids (Sei et al., 1991).

Regarding our first hypothesis, that propanil causes thymic

atrophy by endogenous glucocorticoid production, our results provided several pieces of evidence
indicating that glucocorticoid is involved in propanil-induced thymic atrophy. 1) Our data showed

that thymic atrophy starts at day 1, peaks at 2-4 days post exposure, while at 14 days later, both the

thymus weight and cellularity returned to control levels. This result is similar to DEX induced
thymic atrophy. Lundberg et al (1991) report a maximal decrease in total thymocytes by 3 days

post exposure and returning to control levels after 14 days. Silverstone et al. (1994) show similar
results in which the thymus weight is back to normal by 14 days post DEX exposure. SART stress

induced thymus weight and cellularity decrease, which is mediated through glucocorticoid effect, is
also back to normal by 14 days (Hori et al., 1993). 2) Glucocorticoid induced thymic atrophy is
characterized by depleting mainly DP cells in thymocyte subset (Silverstone et al., 1994).

Silverstone et al. (1994) show this distribution change is profound at day 3 and disappears by day 6.
This agrees with our data that showed maximal DP cell percentage reduction at 4 days and the

distribution of subsets by day 7 was similar to control values.

3) Our data also showed that

adrenalectomy blocked the propanil-induced thymic atrophy and phenotype change.
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It is

comparable with the work by Jerrells and colleagues (1990) who use this approach to examine the

Sei and co-workers (1991) have

role of glucocorticoids in ethanol-induced thymic atrophy.

demonstrated that adrenalectomy completely prevents morphine-induced thymic atrophy. Thus, it

seems that glucocorticoids are largely responsible for this effect.

4)

The glucocorticoid

concentration induced by a chemical is often used to assess that chemical's potential for
immunotoxicity. The blood levels of corticosterone in propanil-treated animals (200 mg/kg) were

>150 ng/ml, which is substantially, but not statistically (due to large variances), higher than com
oil-treated animals. However, after a literature search to evaluate the consistency of quantitative

relationship between glucocorticoid levels and thymic atrophy, Pruett et al. (Pruett et al., 1993)
conclude that thymic atrophy is inconsistent when glucocorticoid levels are less than 150 ng/ml. In

addition, it is suggested that elevated glucocorticoid levels must persist for some critical period of

time in order to affect the immune system, as studies demonstrate that mitogen responses in vitro
are not suppressed after incubation of splenocytes with corticosterone at concentrations as high as

100,000 ng/ml for 1 h followed by washing to remove corticosterone; in contrast, continuous
incubation with corticosterone at concentrations as low as 100 ng/ml is suppressive (Flores et al.,

1990). In summary, we believe that our data support the hypothesis that propanil causes thymic

atrophy, at least in part, by induction of glucocorticoid production.
While propanil causes thymic atrophy by glucocorticoids, changes in this hormone could
not explain its profound hyperplastic effects on the spleen.

Corticosteroids generally cause a

decrease in spleen weight (Claman, 1975). Our flow cytometiy study did not show any change in
lymphocyte subset distribution in the spleen of propanil-treated animals. In addition, Barnett et al.

(unpublished data) have found that propanil induces extramedullary hematopoiesis in spleen.
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Although glucocorticoids can stimulate granulopoiesis in laboratory animals, they do not cause
extramedullary granulopoiesis in the spleen nor do they affect red cell and platelet precursors

(Claman, 1975).

Similar results are reported for T150R1 (a ionophore copolymer)-caused

immunotoxicity by Houssami et al. (Houssami et al., 1990).

Mice after single iv injection of

T130R1 show a thymic atrophy accompanied by splenic hyperplasia.

The kinetic of thymic

atrophy, comparable with our data, shows a minimal thymus weight at day 2 and rising to normal

by day 14. The splenic enlargement is believed due to hyperplasia of the red pulp, with evidence of

proliferating erythropoietic, myelopoietic, and megakaryopoietic precursors. Thus, the increase in
spleen size and cellularity appears an independent event from the effects of propanil on the thymus.
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Propanil Inhibits T Cell Function Through Reduction of Cytokine Production
Cytokines function as intercellular messenger molecules that evoke particular biological

activities after binding to a receptor on a responsive target cell. Although a variety of cells can
secrete cytokines, the two principal producers are the Th cells and the macrophage. Cytokines
released from these two cells activate an entire network of interacting cells, as reviewed in the
Introduction. The binding of a cytokine to its receptor induces numerous physiologic responses

including the development of cellular and humoral immune responses, induction the inflammatory
response, regulation of hematopoiesis, control of cellular proliferation and differentiation, and

induction of wound healing. Because of their potent effects, it is clear that the disruption of their

production would lead to the immunocompromised condition. Therefore, we formed our next
working hypothesis that the effect of propanil on T cell function is through the inhibition of their
cytokine production. Our data have showed a reduction of IL-2, IL-6, IFN-y, and GM-CSF
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production in stimulated spleen cells using both in vivo/ex vivo and in vitro experimental models.

Those cytokines play very important roles in both humoral and cell-mediated immune
response.

Humoral immune response is characterized by the production of large numbers of

antibody molecules by B cells specific for antigenic epitopes on a foreign pathogen. The activation
of B cells requires a sequential processes including: 1) the presentation of processed antigen plus a

class II MHC molecule by the B cell to an activated Th cell specific for that antigen, 2) formation
of Th cell/B-cell conjugate, 3) generation of signals, by membrane-mediated events and localized
cytokines, that are transduced in the B cell, causing changes in gene expression that lead to

proliferation and differentiation of the B cell. IL-2, a T cell growth factor, can not only activate B
cells to proliferate, but also induce B cell differentiation and Ig secretion as well as isotype
regulation (IgM production) (Loughnan and Nossal, 1989; Coffman et al., 1988).

IFN-y can

selectively augment the production of IgG2 antibodies by increasing in the frequency of precursors

of IgG2a+ cells and enhancement of the number of IgG2+ daughter cells emerging from each
precursor (Snapper and Paul, 1987). IL-6 can promote terminal differentiation of B cell into plasma

cells and stimulate their antibody secretion (Snick, 1990). GM-CSF has been shown to expand the
numbers of potent APC as well as augment their antigen-presenting ability. Cell-mediated immune

responses can be represented by CTL activity, mixed-lymphocyte reaction (MLR), and delayed
type hypersensitivity. Although propanil does not affect CTL activity, the MLR and DTH response

are suppressed in 400 mg/kg dose treated animals (Barnett and Gandy, 1989). Cytokines are

actively involved in the MLR and DTH process. DTH is an inflammatory reaction mediated by the
cytokines produced by Thl cells (Vadas et al., 1976). In this reaction, antigen is encountered and

processed by macrophages. The processed antigen is presented to T cells which then produce
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cytokines, such as IL-2, IFN-y, GM-CSF and other chemotactic factors. IL-2 also functions in an

autocrine manner to amplify the population of cytokine-producing T cells.

induce localized hematopoiesis of the granulocyte-monocyte lineage.

GM-CSF and IL-3

IFN-y acts on nearby

endothelial cells, inducing a number of changes that facilitate extravasation of monocytes and other
nonspecific inflammatory cells. IFN-y also activates macrophage and enhances the expression of
class II MHC molecules. The MLR is the standard in vitro assay of helper function in cellular

immunity. Decreased T cell cytokine production would fully hamper the MLR in propanil-treated
mice. The propanil-treated animals also have a lower NK cell activity. T cell can regulate NK cell

activity through IL-2 production. The NK response to IL-2 is characterized by IFN-y production,
proliferation, and increased cytolytic activity (Smith, 1988; Trinchieri and Perussia, 1985). In vivo
studies show that NK response of animals treated with IL-2 are markedly elevated as compared to
responses of control mice (Swain, 1991). Thus, the decreased cytokine production found in our
study may account for the previously reported immune functional change in propanil treated

animals. Other chemicals, such as Benzo[ajpyrene (BaP) and 7,12-dimethylbenz[a]anthracene

(DMBA), have been reported to suppress the production of antibodies to T-dependent and T
independent antigens, and CTL activity as well (Lyte and Bick, 1985). House et al. (1987) and
Pallary et al. (Pallardy et al., 1989) have found that benzo[a]pyrene (BaP) and 7, 12-

dimethylbenz[a]anthracene (DMBA) suppress both the secretion of IL-2 and the expression of the
high-affinity IL-2 receptor. In addition, it is demonstrated that DMBA-induced impairment of CTL

activity in vitro can also be reconstituted by addition of exogenous IL-2 (House et al., 1987). BaP

has similar effects on IL-2; diminished IL-2 secretion and receptor expression occur in murine T
lymphocytes exposed to BaP in vivo and in vitro (Myers et al., 1988; Lyte et al., 1987). In addition,
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the suppression of T-dependent antibody responses induced by Bap may be reconstituted by IL-2

(Lyte et al., 1987), implicating either a direct or an indirect effect of Bap on T helper cells.

Although, reconstitution experiments will be needed to provide direct evidence for our theory, our
results support the hypothesis that one of the cellular mechanisms affected by propanil

administration is the production of cytokines.

III.

Mechanisms Of Propanil-Caused Cytokine Production
The last part of our study intended to use a vitro experimental system to explore the

mechanism of propanil-caused cytokine production previously found in in vivo/ex vivo and in vitro
spleen cell systems. To avoid the influence of contaminated cells in splenocytes, we used a murine

T lymphoma cell line, EL-4. The results indicate two possible levels of propanil effect. One, our

nuclear run-on data showed a decreased IL-2 transcription rate in propanil-treated cells, suggesting
an impact in the signal transduction pathway. Two, increased IL-2 tnRNA degradation in propaniltreated cells which implies that propanil interferes with RNA stability.
In T cells, signal transduction process starts from the triggering of TCR/CD3 by antigen
followed by cascade of second message and protein kinase, to the activation, nuclear translocation,

and DNA binding of various transcriptional factors, finally leads to the activation of transcription of

IL-2 and other cytokines. In EL-4 cell system, we used PMA (for IL-2 production) or PMA plus
Ca2+ ionophore, A23187. Those stimuli bypass the TCR/CD3 triggered Pl-hydrolysis step, directly
activate PKC, and induce increased [Ca2+]j levels (Isakov et al., 1987). It is, therefore, obvious that

propanil interferes with biochemical steps distal to Pl-hydrolysis, that are obligatory for signal
transduction or induction of cytokine production.
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Although this post-receptor Pl-independent

mechanism of propanil induced inhibition of T cell cytokine production is still unknown, one
possible speculation would be the defective DNA-binding activity of various transcription factors

since IL-2 is highly regulated at transcriptional levels (Shaw et al., 1988). cAMP, Vitamin D3,
DEX are known agents which inhibit IL-2 production at the transcriptional levels (Boumpas et al.,

1991; Paliogianni et al., 1993; Alroy et al., 1995; Tamir and Isakov, 1994). Alroy et al. (1995)
show Vit D3 induced inhibition of NFAT/AP-1 complex formation in Jurkat cells. Paliogianni et

al. (1993) demonstrate that DEX inhibits the binding of transcription factors AP-1 and NF-AT, but
not NF-kB and OCT-1, to their corresponding sites on the IL-2 gene promoter. Tamir and Isakov

(1994) found that cAMP inhibits c-jun expression and alters the composition of AP-1 complexes
induced by TPA plus ionomycin. We also measured the c-fos expression at mRNA levels and

found no difference between propanil-treated and control groups. This particular experiment is

significant for two reasons: 1) the unchanged c-fos expression and cell proliferation data suggest
that propanil does not act through a general toxic mechanism to inhibit all cellular macromolecule

synthesis; 2) c-fos is one of those early activation genes expressed upon T cell activation (Curran

and Franza, Jr. 1988) which is actively involved in the transcriptional regulation of IL-2 gene
expression. Fos and another proto-oncogene product Jun forms a heterodimer, AP-1 (Angel and
Herrlich, 1994; Curran and Vogt, 1992) which binds to the TREp site of the IL-2 promoter to act

as a transactivating factor to augment IL-2 expression (Serfling et al., 1989). In addition, AP-1 can

form a complex with NF-AT, the function of which is believed to stabilize the DNA binding of NF-

AT to IL-2 gene (Serfling et al., 1989). However, the normal fos mRNA levels do not necessarily
mean a normal AP-I binding activity because, under certain conditions, synthesized Fos proteins
may be impaired in their ability to form active heterodimers with Jun (Riabowol et al., 1992).
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Furthermore, Fos proteins may undergo post-translational modifications that impair their ability to
form active DNA-binding heterodimers with Jun, or enable the formation of a DNA-binding

complex that is transcriptionally inactive (Riabowol et al., 1992). On the other hand, Jun proteins
are encoded by the c-jun,jun-B, and jun-D genes (Hirai et al., 1989; Bohmann et al., 1987), Tamir

and Isakov (1994) found that jun-D is constitutively expressed in EL-4 cells, whereas jun-B is

induced by TPA plus ionomycin. Thus, any change of jun expression may lead to a defective AP-1
complex either.

Our results also showed an increase in degradation of IL-2 mRNA in propanil treated
groups.

Control of mRNA stability, as the specific posttranscriptional mechanism,

plays a

predominant role in regulating the pattern of gene expression in higher eukaryotes. The high-level
lability of cytokine mRNA allows rapid downregulation of protein synthesis after arrest of

transcription and thus provides an efficient mechanism for transient expression. One mRNA decay
pathway is initiated by shorting of the poly(A) tail followed by decapping and 5‘ to 3'
exonucleolytic degradation of the transcript (Beelman and Parker, 1995). The AU-rich element

(ARE) identified in the 3' untranslated regions (UTRs) of many labile mRNAs, such as
protooncogenes and cytokines, can promote rapid poIy(A) shortening. Shaw and Kamen (1986)

were the first to show that the multiple copy AUUUA ARE located in the 3'UTR of the GM-CSF

mRNA functions as a cis-acting destabilizing sequence. IL-2 mRNA has at least three reiterated

copies of this AUUUA sequence that may conduct the post-transcriptional mechanism implicated

in the regulation of IL-2 gene expression (Lindstein et al., 1989; Shaw et al., 1988; Shaw and
Kamen, 1986). How those ARE mediate deadenylation is still poorly understood. However, it is

speculated that AUUUA can form RNA-protein complex which may modulate the processivity of
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an RNase or recruit kinetically distinct RNase or make poly(A) tails more susceptible to RNase
attack (Bernstein et al., 1989). Bohjanen et al. (Bohjanen et al., 1992; Bohjanen et al., 1991)

described three proteins that bound to the ARE of the GM-CSF 3'-UTR that they called AU-A, AU-

B, AU-C. Bohjanen et al. (Bohjanen et al., 1991) have further found the correlation between the

binding of AU-B and increased GM-CSF mRNA turnover. Mondino et al. (1995) report that in T
cell hybridomas, AU-A,-B, -C as well as another 70-kDa protein can bind to the ARE of IL-2.
They also show coordinate appearance of these RNA-binding proteins correlated with a shorter

half-life of IL-2 mRNA, and increased rate of RNA degradation. In addition, the induction of all
four protein could occur in the presence of RNA or protein synthesis inhibitors (Mondino and
Jenkins, 1995), suggesting that these proteins are already present in resting T cells but are unable to
bind RNA until necessary signals confer on them the binding activity. This conversion could be

achieved by post-translational modification of the proteins, translocation of the proteins from a
storage compartment to the cytoplasm, or by turnover of a labile inhibitor of the binding activity.

Dex can induce the appearance of the cytosolic RNA-binding proteins (Mondino and Jenkins,
1995), although the mechanism is not clear, Peppel et al (1991) observed that the increased

turnover of IFN-p in DEX-treated cells is mediated by the AU-rich sequence found in the 3-UTR.
Thus, it is possible (though unlikely) that propanil may induce the appearance of these RNA

binding proteins through an currently unknown mechanism leading to the increased IL-2 mRNA

degradation. Other U-rich binding proteins (URBP) may function as to disrupt the formation of

functional ARE-protein complex necessary for ARE-directed mRNA decay, thus leading to the
mRNA stabilization (Chen et al., 1995).

It would be unlikely that propanil upregulates the

expression of those protein responsible for the degradation of mRNA, we, therefore, speculate that
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propanil may inhibit those URBP expression and in turn accelerate the decay of IL-2 mRNA.
It should be mentioned that our data showed no change of c-fos expression at mRNA level.

Assuming a normal mRNA half life based on this Northern data (although actual experimental is

required to prove this), the unchanged c-fos mRNA stability seems inconsistent with IL-2 data, as
the expression of c-fos is also highly regulated by RNA stability pathway (Decker and Parker,
1994). However, Chen at al. (Chen et al., 1995) proposed two deadenylation pathways represented

by c-fos and GM-CSF in that the poly(A) of GM-CSF follows an asynchronous shortening process,

while c-fos follows synchronous poly(A) shortening process which is much slower than the
synchronous way. They attribute this to the fact that the AUUUA motifs of c-fos is scattered with
nearby uridylate-rich sequences, while the other class, represented by GM-CSF, has multiple

reiterations of the AUUUA tetranucleotide. Thus, it is possible that IL-2 mRNA, which has 3
reiterated copies of this AUUUA, follows the GM-CSF pathway so that propanil can increase the
decay of IL-2 message without affect c-fos expression.

CD28 co-stimulation plays an important role in T cell activation and IL-2 expression.

Although there is evidence that CD28 regulates the IL-2 gene transcription (Fraser and Weiss,
1992), the more definite effect of this pathway is stabilizing IL-2 mRNA (Umlauf et al., 1995).

Umlaue et al. (1995) report that in the presence of anti-CD28, IL-2 mRNA shows a significant

longer half life in a anti-TCR stimulated T cell clone. While the CD28 pathway may be important
in our spleen cell study, it is unlikely involved in our EL-4 cell model in that PMA or PMA plus

A23187 were used as stimuli.

IV.

Defective T cell development and cytokine production can cause immunodeficiency

We have identified the effect of propanil on T cell subpopulations in major lymphoid
206

organs and T cell cytokine production using both in vivo and in vitro models. We found that the
propanil-induced thymic atrophy is characterized by the depletion of CD4+CD8+ cells, which at

least partially, is mediated through the induction of endogenous glucocorticoid production. The
effect can be seen as early as 1 day after exposure, and most significant at 2-4 days, followed by

total recovery by day 14. The recovery process appears to be enhanced by increased proliferation of
CD8+ SP or DP cells. Our study also demonstrated that propanil affects T cell function through the

inhibition of cytokine production. In vivo and in vitro model showed the reduction of IL-2, IL-6,
IFN-y, and GM-CSF production by spleen cells.

Further mechanistic studies on the effect of

propanil on IL-2 gene expression suggest that the inhibitory effect may be mediated at both
transcriptional and post-transcriptional mechanism.

Our results showed that a single ip exposure to propanil can cause an effect on thymic T cell
development characterized by marked thymic atrophy. Although an extramedullary mechanism

may contribute to the maintenance of normal T cell numbers in lymphoid organs such as the spleen,
these T cells are functionally deficiency as characterized by their reduced ability to produce

cytokines. Virtually all adaptive immune responses require the activation of T lymphocytes and
their differentiation into cells that produce cytokines which act on specific cytokine receptors.
Therefore, the defective cytokine production can cause immune functional changes at multiple

levels in a propanil-exposed host. As reported by Barnett and coworkers (1989), the

propanil-treated animals exhibit a compromised humoral and cell-mediated immune response.

The main effect of low antibody levels will be an inability to clear extracellular bacteria
efficiently. Many pyogenic or pus-forming bacteria have polysaccharide capsules that make them
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resistant to phagocytosis. Normal individuals can clear infections by such bacteria because antibody
and complement opsonize the bacteria, making it possible for phagocytes to ingest and destroy
them. Therefore, a lack of antibody production leads to an inability to control this class of bacterial

infections. As antibodies are important in neutralizing infectious virus, individuals with impaired
antibody production are also susceptible to certain viral infections. Since T cells play the central
role in the adaptive immune response to antigens, a defect in T cell function may lead to a patient

making neither specific T cell dependent antibody responses nor cell mediated immune responses.

Thus, individuals with defects in T cell development are highly susceptible to a broad range of
infectious agents.

This is especially important in persons with pre-existing conditions such as

undernourished field workers, aging populations and AIDS patients. The effect of propanil on
thymocyte development and antibody production could also affect ongoing immune responses.

Normal vaccination processes require a competent immune response to the vaccine. Thus, propanil-

exposed children might not develop their protective antibodies or T cells properly against the
vaccinated antigen, and they will be more liable to infection than non-exposed populations

Therefore, the overall effect of propanil on a mammalian host may be an immunodeficient
status. This immune suppression could result in decreased resistance to an infectious agent or
impaired surveillance of a neoplastic event.
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